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General introduction 
The first person to introduce the term “stress (response)” was Hans Selye in 1955 
and he described it as “the non-specific response of the body to any demand” (1). As 
all living beings strive for homeostasis, which is the ability to maintain the 
consistency of their internal milieu despite changes in their surroundings (2), the 
stress response may also be defined as: the body’s non-specific response to 
maintain homeostasis of the internal environment. One ultimate example of stress is 
critical illness (3).  
The effects of critical illness are manifold and not the least among them are 
the profound changes seen in endocrine and metabolic systems. Initially, hormones 
primarily under the control of hypothalamic-pituitary axis and the autonomic nervous 
system enact the endocrine response to critical illness. Importantly, these endocrine 
responses are under control of factors from the immune system, such as cytokines.  
It has been proposed that critical illness falls, at least in adults, into two 
endocrine and metabolically distinct phases: acute and chronic (Figure 1) (4). The 
endocrine changes during the acute phase of critical illness consist primarily of 
activation of the so-called “catabolic pathways” (cortisol) and peripheral inactivation 
of “anabolic pathways” (low IGF-I and testosterone levels), whereas pituitary activity 
is essentially maintained or amplified. In critically ill adults, these changes have 
consistently been viewed as adaptive or beneficial, as they may redirect and reduce 
energy consumption, postpone anabolism and, at the same time, activate the 
immune response while protecting the host against deleterious biological effects of 
the latter. In contrast to the changes seen in the acute phase of critical illness, 
prolonged critical illness is characterized, at least in adults, by reduced pulsatile 
secretion of anterior pituitary hormones, which correlate positively with reduced 
activity of target tissues, with cortisol secretion as the notable exception as levels 
remain elevated through a peripheral drive (4). Unlike the situation during the acute 
phase of critical illness, hormonal changes seen during the prolonged phase of adult 
critical illness have been assumed not to be adaptive.  
The course of critical illness in children differs from adults. Critical illness in 
children may develop quickly and if children survive the impact of acute critical 
illness, it is rapidly followed by recovery. Unlike adults, chronic or protracted critical 
illness is fairly uncommon in children. Although in adults the endocrine and metabolic 
changes during the acute phase of critical illness have been viewed as adaptive it is 
still unclear to which extent some of these defense mechanisms may hypo- or 
hyper-respond and as a consequence be harmful. Understanding of the endocrine 
and metabolic changes of pediatric critical illness, especially those in the acute 
phase, is important and may improve outcome, as it allows the rational use of 
pharmaceutical interventions. It may also reveal endocrine and metabolic changes to 
be used as prognostic markers. This prompted us to study and describe the acute 
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stress response of critically ill children, due to meningococcal sepsis or septic shock 
or after open-heart operation, within the first days of admission on the pediatric 
intensive care (PICU). This thesis focuses on three hormonal axes: the 
hypothalamic-pituitary-adrenal (HPA) axis, the hypothalamic-pituitary-thyroid (HPT) 
axis and the growth hormone-insulin-like growth factor-I (GH-IGF-I) axis. 
 
 
Figure 1. Simplified concept of the pituitary-dependent changes during the course of critical illness in 
adults (adapted form Van den Berghe {Van den Berghe, 1998 #455}). In the acute phase of illness 
(first hours to a few days after onset), the secretory activity of the anterior pituitary is essentially 
maintained or amplified, whereas anabolic target organ hormones are inactivated. Cortisol levels are 
elevated in concert with ACTH. In the chronic phase of protracted critical illness (intensive care 
dependent for weeks), the secretory activity of the anterior pituitary appears uniformly suppressed in 
relation to reduced circulating levels of target organ hormones. Impaired anterior pituitary hormone 
secretion allows the respective target organ hormones to decrease proportionately over time, with 
cortisol being a notable exception, the circulating levels of which remain elevated through a peripheral 
drive, a mechanism that ultimately may also fail. The onset of recovery is characterized by restored 
sensitivity of the anterior pituitary to reduced feedback control. 
 
The hypothalamic-pituitary-adrenal axis 
The adrenal cortex produces steroid hormones, which can be divided into 
mineralocorticoids, glucocorticoids and adrenal androgens (5). Mineralocorticoids, 
principally aldosterone, regulate renal retention of sodium, which influences 
intravascular volume and blood pressure. Glucocorticoids, principally cortisol, also 
known as the “stress hormone”, have a wide variety of bodily functions, such as 
maintaining vascular tone, endothelial and vascular integrity, potentiating the 
vasoconstrictor actions of catecholamines, muting the inflammatory cascade and 
promoting substrate mobilization (6). Adrenal androgens play a role in the 
mid-childhood growth spurt. These steroid hormones are produced in the three 
zones of the adrenal cortex, which appear histologically and functionally different. In 
anatomical order from outside to inside these zones are named: zona glomerulosa, 
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zona fasciculata and zona reticularis, producing mineralocorticoids, glucocorticoids 
and adrenal androgens, respectively. Figure 2 presents these steroidogenic 
pathways starting from the common substrate cholesterol. After birth the three zones 
simultaneously enlarge and differentiate. The zona glomerulosa and zona fasciculata 
reach full diffentiation at about 3 years of age and the zona reticularis may not be 
fully differentiated until about 15 years of age (5). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. A schematic representation of steroidogenesis in the three zones of the human adrenal 
cortex. Cholesterol side-chain cleavage enzyme system (CYP11A); 
3β-hydroxysteroid-dehydrogenase (3β-HSD); 21-hydroxylase (CYP21); 17-hydroxylase & 17,20-lyase 
(CYP17); 11β-hydroxylase (CYP11B1); 11β- & 18-hydroxylase (CYP11B2). 
 
Steroidogenesis in the zona fasciculata and zona reticularis is under primary 
control of the hypothalamic-pituitary unit, whereas steroidogenesis in the zona 
glomerulosa is mainly regulated by the renin-angiotensin system. In healthy, 
unstressed humans, cortisol is secreted according to a diurnal pattern under the 
stimulatory influence of corticotropin (ACTH) secreted by the pituitary gland (Figure 
3). ACTH secretion, in turn, is under stimulatory influence of the hypothalamic 
corticotropin-releasing hormone (CRH). Both CRH and ACTH are subject to negative 
feedback control by cortisol. In the circulation cortisol is bound to carrier proteins, 
mainly cortisol-binding globulin (CBG) and albumin, leaving less than 10 percent in 
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the free, bioavailable form (7). It is generally believed that the biological activity of 
cortisol depends on the free fraction of the hormone (8).  
 
 
Figure 3. Simplified concept of the hypothalamic-pituitary-adrenal axis and its regulation. 
 
In both adults and children, the physiological response to stress involves 
activation of the central nervous system with consequently stimulation of the 
hypothalamic-pituitary-adrenal (HPA) axis (9). Stressors are among other things 
cytokines, pain, tissue damage, surgery, hypoxemia, hypotension and hypoglycemia 
(10, 11). Activation of the HPA-axis will lead to increased levels of cortisol, loss of 
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the diurnal rhythm and reduced negative feedback control (12). In addition, CBG 
levels decrease rapidly in critically ill adults, resulting in increased levels of free, 
bioavailable cortisol, especially in the acute phase of critical illness (12-15).  
Stimulation of the hypothalamic-pituitary adrenal axis, resulting in elevated 
serum cortisol levels, is an essential component of the general adaptation to critical 
illness. Even minor degrees of adrenal insufficiency, by some referred to as relative 
adrenal insufficiency, increase the mortality of critically ill patients. A clear definition 
of (relative) adrenal insufficiency in critical illness is, however, lacking and there is 
also much uncertainty about the most appropriate test to assess the integrity of the 
HPA-axis. Some authors advise a random total cortisol level (16) or free cortisol level 
(13-15), whereas others advise an ACTH-stimulation test (Synacthen®) (17, 18) or a 
CRH-test (19). The ACTH-stimulation test can be performed classically with a high 
dose (250 µg) of Synacthen® (17, 20) or alternatively with a low dose (1 µg) of 
Synacthen® (18, 21, 22), which has been assumed to have higher sensitivity and 
specificity in critical illness.  
In critically ill children paradoxically lower cortisol levels in the most severely ill 
compared with the less severely ill have been reported (23-28). Data on bioavailable 
cortisol did, to our knowledge, not exist for acutely ill children. Therefore, it remained 
unclear, whether bioavailable cortisol levels in the most severely ill children were 
lowered as well. One of the explanations of low cortisol levels in children with 
meningococcal septic shock might be reduced activity of adrenal steroidogenic 
enzymes (Figure 2). During sepsis, adrenal steroidogenic enzyme function might be 
liable to circulating endotoxins, cytokines, and medication, whereas more intrinsically 
gene polymorphisms might predispose for decreased adrenal steroidogenic enzyme 
function as well (29, 30). Decreased steroidogenic enzyme function leads in general 
to lower serum levels of the downstream product in the presence of increased serum 
levels of its upstream precursor. Sepsis-induced adrenal insufficiency might also 
include functional loss of the zona glomerulosa and defects in the renin-aldosterone 
axis might thereby adversely affect cardiovascular homeostasis and thus outcome. 
Hyperreninemic hypoaldosteronism has been reported in critically ill adults (31), 
whereas lower plasma aldosterone concentrations were recently reported in children 
with meningococcal sepsis compared to other critically ill children (32). Data 
concerning the renin-aldosterone axis in relation to outcome in children with 
meningococcal sepsis were, however, lacking. 
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Figure 4. Simplified concept of the hypothalamic-pituitary-thyroid axis and its regulation. Under 
normal circumstances T4 is converted into active T3 in peripheral tissues, especially liver, kidney and 
skeletal muscle. 
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The hypothalamic-pituitary-thyroid axis 
Thyroid hormone exerts a broad range of effects on development, growth and 
metabolism (33). Thyroxine (T4), the primary secreted product of the thyroid gland, is 
inactive until it is converted to the active hormone triiodothyronine (T3) (see below). 
T4 can therefore be considered as a pro-hormone. In healthy, unstressed humans, 
thyroidal secretory activity is regulated via the hypothalamic-pituitary unit (Figure 4). 
Thyrotropin releasing hormone (TRH), synthesized in the hypothalamus, governs the 
pituitary’s release of thyrotropin or thyroid-stimulating-hormone (TSH). TSH 
stimulates the synthesis and release of thyroid hormones by the thyroid. Both TRH 
and TSH are subject to negative feedback control by T4 and T3, actually by the free 
levels of T4 and T3. Most of the thyroid hormones (T4 and T3) are bound to carrier 
proteins, mainly thyroxine-binding globulin (TBG), transthyretin and albumin, leaving 
less than 1 percent in the free, biologically available form (34). In addition, peripheral 
thyroid hormone metabolism plays an eminent role in the regulation of thyroid 
hormone bioactivity. The principal pathways of thyroid hormone metabolism are 
deiodination and conjugation, of which deiodination is the most important one (35). 
Under normal circumstances T4 is mainly deiodinated to active T3 by outer ring 
deiodination. Both T4 and T3 may also be inactivated by inner ring deiodination 
forming the inactive metabolites reverse-triiodothyronine (rT3) and 
3,3’-diiodothyronine (T2), respectively (Figure 5). 
 
Figure 5. A schematic representation of thyroid hormone deiodination pathways. Under normal 
circumstances T4 is mainly denominated to active T3 by outer ring deiodination (ORD; by type 1 and 
type 2 deiodinase). Both T4 and T3 may also be inactivated by inner ring deiodination (IDR;  by type 1 
and type 3 deiodinase) forming the inactive substrates rT3 and T2. 
 
Multiple alterations in the hypothalamus-pituitary-thyroid axis in critical illness 
have been recognized, the most prominent being the combination of high serum rT3 
at the expense of low T3 levels, without compensatory elevated TSH levels, 
frequently coinciding with low T4 levels, forming the so called entity of “euthyroid sick 
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syndrome” or “non-thyroidal illness”. In critically ill adults the degree of T3 
suppression with concomitantly low TSH generally correlates positively with disease 
severity and duration, and negatively with outcome (36, 37). Based on studies in 
critically ill adults several factors have been proposed to contribute to the euthyroid 
sick syndrome (36): a) decreased concentrations of carrier proteins; b) inhibition of 
binding to carrier proteins, transport and metabolism by increased concentrations of 
non-estherified fatty acids (NEFAs) and bilirubin (38, 39); and c) changes in 
expression of transporters and deiodinases (40). Besides this, medication is known 
to influence serum thyroid hormones as well. Dopamine infusion may induce or 
aggravate the euthyroid sick syndrome in critical illness, by its suppressive effect on 
TSH secretion by the pituitary gland (41). Glucocorticoids and somatostatin (see 
below) may also suppress pituitary TSH release (42). An iatrogenic decrease of 
circulating T3 may, therefore, in addition to illness-induced changes, perpetuate the 
catabolic state of critically ill adults.  
The euthyroid sick syndrome is well documented in children during and after 
cardiac surgery (43-53) and T3-repletion trials show promising results concerning 
improved post-operative cardiac function (50, 54, 55), although these trials did not 
show improved outcome and data on safety, and efficacy remain to be awaited (46, 
56). Data in critically ill children, however, remain limited (57-59) and the relationship 
between thyroid hormone levels and mortality is less clear than in critically ill adults: 
a few studies in critically ill children showed an association between low levels of 
total T4 (TT4) (58) and total T3 (TT3) (60) with mortality, whereas others reported 
higher TT3 and TT4 levels in children who died compared to those who survived 
(23). However, in some other studies on critically ill children no relation was found 
between thyroid hormones and outcome (57, 59). Furthermore, dopamine infusion 
may induce or aggravate the euthyroid sick syndrome in critically ill children as well 
(61). This might be especially harmful in critically ill infants, as it has been shown that 
impaired thyroid function during early infancy increases the risk for irreversible 
neurological damage (62). Besides this so far little is known about factors influencing 
changes in thyroid hormone levels in relation to outcome in critically ill children. 
The growth hormone-insulin-like growth factor-I (GH-IGF-I) axis 
The GH-IGF-I axis is a complex of exquisitely controlled physiological processes that 
regulate key aspects of growth and metabolism (63). GH is produced in and secreted 
by the pituitary gland in reaction to many different stimuli. The regular stimulus 
originates from the hypothalamus and is the result of the balance between growth 
hormone releasing hormone (GHRH) and somatostatin, the former being stimulatory 
and the latter inhibitory. In addition, GH secretion is also subject to other stimuli of 
which GH releasing peptides (GHRP), such as ghrelin, opioid peptides, cytokines, 
hypoglycemia and low levels of NEFAs are stimulatory and dopamine is inhibitory 
(63, 64). Furthermore, GH secretion is subject of the negative feedback control of 
(free) IGF-I at the level of both the hypothalamus and the pituitary. Under normal 
Acute stress response in critically ill children 
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conditions GH release takes place in a pulsatile manner with the greatest 
GH-release (70%) during sleep. Circulating GH binds partially to GH binding protein 
(GHBP), which represents the extra-cellular domain of the GH receptor (GHR) and is 
derived from cleavage of the protein or alternative splicing of the mRNA (Figure 6) 
(65). Arriving at the tissues GH binds to the GHR and after dimerization of two GHRs 
tyrosine kinase is activated (Figure 7), which results in lipolysis, the direct action of 
GH, and hepatic production of IGF-I, IGF binding protein-3 (IGFBP-3) and acid-labile 
subunit (ALS), via which GH exerts its indirect growth-promoting actions. Most of the 
circulating IGF-I (>99%) is bound to IGFBPs, of which under normal conditions the 
larger part (75-90%) is bound to IGFBP-3 in a tertiary complex with ALS. IGFBP-1 is 
regulated by metabolic stimuli and has been claimed to be the major regulator of the 
free IGF-I level, as a substantial proportion is unsaturated under normal conditions. 
Binding of IGF-I to IGFBP-1 may therefore serve as a protection mechanism against 
he hypoglycemic effects of free IGF-I.  
 
Figure 6. A general scheme showing GHBP generation. GHBP represents the extra-cellular domain 
of GHR and is derived by cleavage or by alternative splicing.  
 
Studies on the acute phase of critical illness in adults show sustained to 
enhanced GH secretion, but low levels of IGFBP-3 and ALS (66, 67). These changes 
are generally interpreted as GH resistance and are presumed to be adaptive, as they 
promote the accessibility of metabolic substrates for vital organs and postpone 
anabolism. Despite many studies on GH/IGF-I function in critically ill adults, only very 
limited research has been performed in critically ill children (68) and after pediatric 
cardiac surgery (69, 70). In a pilot study in a small group of children with 
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meningococcal septic shock, de Groof et al. encountered very high levels of GH in 
nonsurvivors with concomitantly decreased IGF-I and IGFBP-3 levels, suggesting 
GH resistance (68). Data on the bioactivity of GH, and the serum levels of GHBP 
and IGF related components, such as ALS, were however lacking. In children after 
cardiac surgery, high levels of GH with low levels of IGF-I were also found, however, 
assessment of GH pulsatility are lacking (69, 70). 
 
Figure 7. A schematic representation of the GH-GHR interaction that initiates intracellular signal 
transduction pathways. GH binds to GHR, but only after dimerization with two GHRs and 
phosphorylation the signal of GH is transduced. 
Critical illness in children described in this thesis 
Different types of acute life-threatening disease may cause critical illness, such as 
sepsis, respiratory insufficiency or hypoxia and severe neurological status. 
Furthermore, critical illness may also be initiated by trauma or surgical procedures, 
for instance open-heart surgery. This thesis will describe critical illness in children 
due to sepsis with petechiae or purpura, and in children undergoing open-heart 
operation.  
Sepsis and septic shock with purpura 
Sepsis is the rapidly evolving clinical picture of hypothermia or fever with tachycardia 
(=elevated heart rate) and tachypneu (= elevated respiratory rate) and is a 
generalized reaction to a microbial infection, usually caused by bacteria (71). In 
addition, when the clinical picture of sepsis deteriorates septic shock may develop. 
GH 
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GH-receptor
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Shock in general is a clinical picture comprising hypotension (= decreased blood 
pressure) and/or end-organ failure, for example decreased renal function. Sepsis 
and septic shock may coincide with coagulation abnormalities ranging from 
petechiae (=pin-point bleedings of the skin or mucous membranes) to purpura 
(=bleedings of the skin or mucous membranes). Sepsis and septic shock with 
coagulation abnormalities are mainly caused by N. meningitidis (72), but may also be 
caused by other microorganisms. In the clinical course of meningococcal sepsis, 
petechiae and /or purpura are a hallmark of disease and are assumed to be the first 
clear clinically detectable sign of disease. The children included in this study were 
admitted to the PICU with a clinical picture of meningococcal sepsis, i.e. sepsis with 
petechiae/purpura. 
Open-heart operations 
The development of the heart-lung machine (extracorporeal pump oxygenator or 
cardiopulmonary bypass (CPB)) in 1953 by Gibbons enabled cardiac surgeons to 
perform open-heart operations. During open-heart operations blood is diverted from 
heart and lungs through the CPB, which takes over the functions of heart and lungs, 
so that the heart can be arrested to enable surgery. In addition to CPB, patients’ 
temperature is lowered to 34° – 28° (=mild to moderate systemic hypothermia) 
during bypass to minimize oxygen consumption by both body and brain. After 
adequate CPB is established, an aortic cross clamp (AOX = a clamp which prevents 
the blood to drain retrograde into the heart) and cardioplegia (= fluid which makes 
the heart stop beating) are applied, to ensure a dry and motionless heart. The time of 
cross clamping is called the ischemic time, since no blood is circulated though the 
heart itself. After surgical correction and closure of the heart, the cross clamp is 
removed, the heart is reperfused, temperature is normalized, the CPB is weaned and 
the patient is closed. The children included in this study underwent open-heart 
operations for congenital heart disease, such as ventricular and/or atrium septum 
defects, tetralogy of Fallot, heart valve defects or the construction of a (partial or 
total) Fontan circulation.  
Design of the studies described in this thesis 
All studies in this thesis are based on data of critically ill children with sepsis 
admitted to the PICU of the Erasmus MC-Sophia Children’s Hospital between 1997 
and 2004 and of children during and after open-heart surgery at the Thorax center of 
the Erasmus MC between 2001 and 2004. The inclusion and exclusion criteria and 
outline of the study protocol are shown in Appendix A.  
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Aims and outline of the thesis 
The overall goals of the work presented in this thesis are to explore the endocrine 
adaptations of the acute stress response in critically ill children and to define 
endocrine parameters that can serve as prognostic factors for morbidity and 
mortality. We focused on three hypothalamic-pituitary-end-organ axes: the HPA-axis, 
the HPT-axis and the GH-IGF-I-axis. 
 
HPA-axis in critically ill children 
In Chapter 2 we evaluate the HPA-axis in a large group of children with suspected 
meningococcal sepsis or septic shock on admission to the PICU. The purpose of this 
thesis was to describe differences in HPA-axis response in relation with severity of 
disease. Furthermore, we investigated serum bio-available cortisol levels, 
21-hydroxylase and 11β-hydroxylase activity in relation with adrenal function and 
searched for factors associated with adrenal insufficiency and mortality. 
Chapter 3 describes retrospectively the inhibiting influence of etomidate on 
adrenal function and steroidogenical enzyme function during the first 24h after PICU 
admission in children with meningococcal sepsis. 
The HPT-axis in critically ill children 
Chapter 4 describes thyroid function in relation with disease severity in a large group 
of children admitted to the PICU with sepsis or septic shock and assesses the 
influence of deiodination, sulfation, plasma binding of thyroid hormone and dopamine 
use on serum thyroid hormone levels. 
Chapter 5 assesses the predictive value of thyroid function within the first 24h 
of admission on length of PICU stay in children who survived septic shock with 
purpura. 
The GH-IGF-I axis in critically ill children 
Chapter 6 thoroughly evaluates the GH-IGF-I axis in a large group of children with 
suspected meningococcal sepsis or septic shock on PICU admission. In addition to 
the study of GH profiles and growth factors, the purpose of this study was to assess 
the bioactivity of GH, serum levels of GHBP and IGF related components, such as 
acid-labile subunit (ALS). 
Chapter 7 evaluates the GH-IGF-I axis in a large group of children before and 
after open-heart surgery and focuses on the relation between endocrine changes 
and influencing factors.  
Chapter 8 discusses the findings of the studies described above and brings 
the data in perspective. Chapter 9 briefly presents the conclusions of the described 
studies and presents new ideas concerning the future research. Finally, in chapter 
10 the findings presented in this thesis are summarized in Dutch.  
Acute stress response in critically ill children 
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Appendix 
Inclusion criteria 
The general inclusion criteria were acutely ill children within 6h after admission to the 
PICU of the Erasmus MC - Sophia Children’s Hospital with a clinical picture of 
meningococcal sepsis or children undergoing open-heart surgery at the Erasmus 
MC – Thoraxcenter.  
 
Meningococcal sepsis was defined as sepsis with petechiae/purpura. Sepsis was 
defined as a temperature of <36.0 ºC or >38.5 ºC with tachycardia and tachypneu 
(73). In addition, children were considered to have septic shock, if they also had 
persistent hypotension (systolic blood pressure <75 mm Hg for children between 
3-12 months, <80 mm Hg for 1-5 years, <85 mm Hg for 6-12 years, <100 mm Hg for 
children older than 12 years), or evidence of poor end-organ perfusion, defined as at 
least two of the following:  
1. unexplained metabolic acidosis (pH < 7.3 or base excess < -5 
mmol/l or plasma lactate levels > 2.0 mmol/l);  
2. arterial hypoxia (PO2 < 75 mmHg, a PO2/FiO2 ratio < 250 (torr) or 
transcutaneous oxygen saturation < 96%) in patients without overt 
cardiopulmonary disease;  
3. acute renal failure (diuresis < 0.5 ml/kg/h for at least one hour 
despite acute volume loading or evidence of adequate intravascular 
volume without pre-existing renal disease); or  
4. sudden deterioration of the baseline mental status 
 
Children with the following open-heart surgical procedures were included: atrium 
and/or ventricular septum defects, total correction of tetralogy of Fallot, heart valve 
procedures, partial and total Fontan corrections and correction of aortopulmonary 
window. 
Exclusion criteria  
1. Age less than one week in term born children, age less than one month after the 
term date in ex-prematures (less than 36 weeks) and age more than 18 years. 
2. Endocrine disorders. 
3. Down’s syndrome or other chromosomal abnormalities. 
4. Severe psychomotor retardation. 
5. End-stage renal disease requiring peritoneal or hemodialysis.  
6. Immunosuppressive drug therapy, systemic corticosteroid treatment, radiation 
therapy or chemotherapy within the previous 6 months. 
7. No informed consent, no arterial line or after removal of arterial line. 
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Study design 
The studies described in Chapters 2, 4, 5 and 6 were single center prospective 
observational studies and the study described in Chapter 3 was a single center 
retrospective study. Of all children included in these studies, blood was drawn as 
soon as possible, within 6h after PICU admission and 12, 24 and 48h thereafter for 
determination of endocrine and immunological parameters. Next to the admission 
sample a 6-h GH profile was obtained, with samples taken every 30 minutes.  
The study described in Chapter 7 was a single center prospective 
observational study. Of all children described in this study blood was drawn before 
surgery (after induction), at the end of surgery and 12 and 24 h thereafter. Next to 
the blood sample at the end of surgery a 6h GH profile was obtained, with samples 
taken every 30 minutes. In addition, anthropometric measurements, such as length 
and weight, were collected before surgery. 
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Abstract 
Context: Adequate adrenal function is pivotal to survive meningococcal sepsis. 
Objectives: The objective of the study was to evaluate adrenocortical function in 
meningococcal disease. Design: This was an observational cohort study. Setting: 
The study was conducted at a university-affiliated pediatric intensive care unit. 
Patients: Sixty children with meningococcal sepsis or septic shock participated in 
the study. Main Outcome Measures: The differences in adrenal function between 
nonsurvivors (n=8), shock survivors (n=43), and sepsis survivors (n=9) on pediatric 
intensive care unit admission were measured. Results: Nonsurvivors had 
significantly lower median cortisol to ACTH ratio than shock survivors and sepsis 
survivors. Because cortisol binding globulin and albumin levels did not significantly 
differ among the groups, bioavailable cortisol levels were also significantly lower in 
nonsurvivors than sepsis survivors. Nonsurvivors had significantly lower cortisol to 
11-deoxycortisol ratios but not lower 11-deoxycortisol to 17-hydroxyprogesterone 
ratios than survivors. Using multiple regression analysis, decreased cortisol to ACTH 
ratio was significantly related to higher IL-6 levels and intubation with etomidate (one 
single bolus), whereas decreased cortisol to 11-deoxycortisol ratio was significantly 
related only to intubation with etomidate. Aldosterone levels tended to be higher in 
nonsurvivors than shock survivors, whereas plasma renin activity did not significantly 
differ. Conclusions: Our study shows that the most severely ill children with septic 
shock had signs of adrenal insufficiency. Bioavailable cortisol levels were not more 
informative on adrenal function than total cortisol levels. Besides disease severity, 
one single bolus of etomidate during intubation was related to decreased adrenal 
function and 11β-hydroxylase activity. Decreased adrenal function was not related to 
decreased 21-hydroxylase activity. Based on our results, it seems of vital importance 
to take considerable caution using etomidate and consider combining its 
administration with glucocorticoids during intubation of children with septic shock.  
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Introduction 
Despite advances in management and therapy, the mortality rate of children with 
shock due to meningococcal disease continues to be considerable (1–4). Stimulation 
of the hypothalamic-pituitary adrenal axis is one of the most important hormonal 
reactions to critical illness. Cortisol has a vital supportive role in the maintenance of 
vascular tone, endothelial and vascular integrity, and the distribution of total body 
water (5). In previously reported pilot studies (6, 7), we showed that children dying 
from meningococcal septic shock had relatively low cortisol levels and extremely 
high ACTH levels.  
It is generally believed that the biological activity of cortisol depends on the 
free fraction of the hormone, especially the fraction not bound to corticosteroid 
binding globulin (CBG), the bioavailable cortisol. Because CBG is the most important 
transport protein for cortisol, serum levels of cortisol may vary with CBG levels (8). 
Several authors demonstrated higher calculated or measured bioavailable cortisol 
levels during critical illness in adults than would have been expected on the basis of 
total cortisol levels, especially during the acute phase of critical illness (9–12). To our 
knowledge these data do not exist for acutely ill children.  
Reduced activity of adrenal steroidogenic enzymes might lead to adrenal 
insufficiency in children with meningococcal sepsis. During sepsis, adrenal 
steroidogenic enzyme function might be liable to circulating endotoxins and/or 
cytokines, medication, or more intrinsically to polymorphisms. Mild forms of a 
decreased 21-hydroxylase function would become obvious only during extremely 
stressful conditions, such as sepsis, and would lead to lower cortisol levels and 
increased levels of its upstream precursor: 17-hydroxyprogesterone (17-OHP). The 
anesthetic drug etomidate is known to inhibit adrenal function by impeding mainly the 
enzyme 11β-hydroxylase. For this reason, etomidate has been withdrawn from 
long-term sedation regimens. Etomidate, however, is still a first-line anesthetic agent 
in the setting of rapid sequence intubation, in which one single bolus is used. This 
use of one single bolus is assumed to give only transient, clinically nonrelevant 
hormonal changes (13, 14).  
In addition, adrenal insufficiency associated with meningococcal sepsis may 
also include functional loss of the zona glomerulosa and defects in the 
renin-mineralocorticoid axis may thereby adversely affect cardiovascular 
homeostasis and thus outcome. Hyperrenemic hypoaldosteronism has been 
reported in critically ill adults (15), whereas lower plasma aldosterone concentrations 
have been reported in children with meningococcal sepsis, compared with other 
critically ill children (16). Data concerning the renin-mineralocorticoid axis in relation 
to outcome in children with meningococcal sepsis are, however, lacking.  
In this study, our aim was to evaluate whether low total cortisol levels 
correspond with low bioavailable cortisol levels in children with meningococcal 
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sepsis. In addition we aimed to assess whether reduced 21-hydroxylase or 
11β-hydroxylase functions might underlie the adrenal insufficiency in children dying 
from meningococcal disease. Furthermore, we wanted to determine which factors 
were associated with adrenal insufficiency and mortality. We therefore evaluated 
adrenocortical function in a large group of children with meningococcal sepsis on 
admission to the pediatric intensive care unit (PICU). 
Patients and Methods 
Patients 
The group consisted of 69 previously healthy children admitted to the PICU of 
Erasmus Medical Center–Sophia Children’s Hospital between October 1997 and 
October 1999 and between October 2001 and January 2004, with a clinical picture of 
meningococcal sepsis, defined as sepsis with petechiae/purpura. Sepsis was 
defined as temperature lower than 36.0 ºC or higher than 38.5 ºC with tachycardia 
and tachypnea. In addition, children were assigned to have septic shock if they also 
had persistent hypotension or evidence of poor end-organ perfusion, as described 
previously (6, 17). Nine children who received corticosteroid therapy for suspected 
adrenal insufficiency before admission were excluded. It is important to note that 
administration of glucocorticoids during septic shock or after a single bolus of 
etomidate in the setting of rapid sequence intubation is not a routine procedure in 
The Netherlands. The medical ethics committee approved the study, and written 
informed consent was obtained from the parents or legal representatives of each 
patient before their participation in the study. Pilot data on total cortisol and ACTH 
levels of 27 children included between October 1997 and October 1999 have been 
published previously (6, 7). 
Concomitant therapy and caloric intake 
Concomitant therapy on admission included antibiotics (Cefotaxime; Sanofi-Aventis, 
Gouda, The Netherlands) and administration of fluids in all 60 children and inotropics 
in 51 children. At a median of 2 h 40 min before admission, 31 children were 
mechanically ventilated, of whom 23 had been intubated with one bolus of etomidate 
(median dose, 0.29 mg/kg) and eight with combinations of opiate agonists, propofol, 
ketamine, or midazolam. Mechanically ventilated children were sedated with 
benzodiazepines and/or morphine. On admission, patients received glucose iv at a 
rate of 4–6 mg/kg/min. They did not receive enteral or parenteral feeding until the 
second day. 
Clinical parameters 
Disease severity was determined using the Pediatric Risk of Mortality II (PRISM) 
score (6, 18) and the Sepsis-Related Organ Failure Assessment (SOFA) score (19) 
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and by measuring levels of established biomarkers, such as plasma IL-6, arterial 
lactate, and serum C-reactive protein (CRP). We recorded the interval between 
appearance of first petechia and PICU admission, respiratory support, drug use, 
blood pressure, and outcome. Blood pressure SD scores (Z-scores) were calculated 
based on published reference data (20). 
Collection of blood samples 
Arterial blood samples were obtained as soon as possible after admission. After 
clotting and centrifugation, serum and plasma were stored at –80 ºC until 
determination of CBG, 17-OHP, 11-deoxycortisol, and IL-6. All other laboratory 
parameters were determined immediately. The accuracy of cortisol and ACTH 
assays was guaranteed by continuously monitoring of intra- and interassay 
variabilities by estimating hormone concentrations in three serum pools in every 
assay. Whenever a pool was exhausted, samples from a new pool were estimated in 
parallel for at least five assays. A certified clinical chemistry laboratory (ISO 17025 
and 9001) determined the other parameters. 
Hormone analyses 
Serum cortisol concentrations were measured by a competitive luminescence 
immunoassay (Immulite 2000; Diagnostic Products Corp., Los Angeles, CA) and 
plasma ACTH concentrations by an immunoradiometric assay (BioInternational, Gif 
sur Yvette, France). Because reference values of cortisol and ACTH for critical 
illness do not exist, we depicted nonstressed reference values for ACTH (<11 
pmol/liter) and cortisol (between 200 and 800 nmol/liter at 0800 h) in tables and 
figures as a point of reference. 17-OHP was determined by an in-house RIA as 
described earlier (21). Values of 17-OHP below the assay’s detection limit were set 
at the detection limit of 0.1 nmol/liter. Nonstressed reference values for 17-OHP 
were less than 5 nmol/liter for children younger than 12 yr of age and less than 10 
nmol/liter for older children. Serum 11-deoxycortisol levels were obtained on 
admission and determined by RIA (22), using an antiserum from ICN Biomedicals 
(Costa Mesa, CA). Nonstressed reference values for 11-deoxycortisol were less than 
50 nmol/liter. Serum CBG concentrations were measured by RIA (Biosource, 
Nivelles, Belgium). Because reference values for CBG were not available for 
children, we used reference values for adult men (between 442 and 1596 nmol/liter), 
except for girls 12 yr and older for whom reference values for women (between 615 
and 2865 nmol/liter) were used. The within- and between-assay variation coefficients 
for the assays of cortisol, ACTH, and 17-OHP were less than 7% and for CBG and 
11-deoxycortisol less than 14%. We calculated bioavailable cortisol, which 
represents the non-CBG-bound fraction, from total cortisol, CBG, and albumin levels 
using the formula based on binding equilibrium as described earlier (23, 24) with the 
association constants of CBG and albumin for cortisol (25). Plasma aldosterone 
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levels were determined by RIA (Diagnostic Products Corp.) and plasma renin activity 
by an in-house assay, as described elsewhere (26). 
Other laboratory analyses 
Arterial lactate and glucose were measured on a blood gas analyzer (ABL 625; 
Radiometer, Copenhagen, Denmark). Serum CRP was measured by an 
immunoturbidimetric assay, and serum albumin was measured by a bromocresol 
purple method, both on a Hitachi 912 analyzer (Roche Diagnostics, Mannheim, 
Germany). The reference values were less than 2.0 mmol/liter for lactate, less than 
10 mg/liter for CRP, 2.6–11.0 mmol/liter for glucose, and 35–50 g/liter for albumin. 
Plasma IL-6 levels were analyzed using an ELISA (Sanquin, Amsterdam, The 
Netherlands). 
Statistics 
The results are expressed as medians unless specified otherwise. We used 
Mann-Whitney U, Χ2, or Fischer’s exact test for group comparison and Spearman’s 
correlation coefficients (r) to evaluate the relationship between different parameters. 
Multiple linear regression analysis was used to evaluate the relationships between 
various parameters and cortisol to ACTH and cortisol to 11-deoxycortisol ratios (both 
log transformed). Two-tailed P < 0.05 was considered statistically significant. 
 
Table 1. Patients’ characteristics on admission, divided in nonsurvivors, shock-survivors and 
sepsis-survivors. 
Variables Nonsurvivors 
(n = 8) 
Shock-survivors 
(n = 43) 
Sepsis-survivors
(n = 9) 
Male gender (%) 6 (75) 26 (60) 5 (56) 
Age (yr) 0.8 (0.5 – 1.9) a 5.0 (2.1 – 10.2) 4.8 (2.7 – 10.9) 
Time first petechia – admission (h) 5.3 (3.8 – 7.6) a 7.3 (6.2 – 9.8) 7.6 (5.7 – 9.0) 
PRISM score  34 (26 – 36) a 20 (16 – 27) b 9 (8 – 12) 
SOFA score 16 (14 – 19) a 9 (7 – 11) b 2 (2 – 4) 
IL-6 x 103 (pg/mL) 1195.5 (853.1– 1776.7) a 45.9 (4.8 – 126.9) b 0.4 (0.1 – 5.6) 
Lactate (mmol/L) 7.3 (5.9 – 8.7) a 3.9 (2.6 – 5.4) b 2.1 (1.4 – 2.5) 
CRP (mg/L) 31 (22 – 36) a 85 (58 – 131) 75 (64 – 215) 
Glucose (mmol/L) 3.9 (2.5 – 6.5) a 6.9 (5.6 – 9.1) 8.2 (7.1 – 9.7) 
Mechanical ventilation (%) 8 (100) a 23 (53) b 0 (0) 
Intubated with etomidate (%) 7 (88) a 16 (37) b 0 (0) 
Inotropic support (%) 8 (100) b 41 (95) b 2 (22) 
All values are expressed as median (25 to 75 percentile). For reference values see Patients and 
Methods. a Significantly different, compared to all survivors, P < 0.05. b Significantly different, 
compared to sepsis-survivors, P < 0.05. 
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Results 
Clinical parameters 
The study group consisted of 60 children, 37 boys and 23 girls, admitted to the PICU 
without receiving glucocorticoid therapy before study enrollment. All children showed 
a clinical picture of meningococcal sepsis and blood cultures revealed Neisseria 
meningitidis in 50 of them. Children were divided according to presence of shock and 
survival into the following disease severity groups: (shock) nonsurvivors (n=8), shock 
survivors (n=43), and sepsis survivors (n=9). Nonsurvivors were significantly 
younger and had significantly shorter time from first petechia to admission than 
survivors (Table 1). Parameters of disease severity, such as PRISM and SOFA 
score, plasma IL-6, and arterial lactate levels were significantly higher in 
nonsurvivors, compared with survivors, and in shock survivors, compared with 
sepsis survivors, whereas CRP levels were significantly lower in nonsurvivors, 
compared with survivors. Arterial glucose levels were significantly lower in 
nonsurvivors, compared with survivors. Nonsurvivors were more often mechanically 
ventilated and had been more often intubated with etomidate than survivors, and 
shock survivors more often than sepsis survivors. Nonsurvivors and shock survivors 
received more often inotropic support than sepsis survivors, whereas systolic and 
diastolic blood pressure SD scores did not significantly differ between the groups 
(data not shown). 
 
Table 2. Endocrine levels on admission, divided in nonsurvivors, shock-survivors and 
sepsis-survivors. 
Variables Shock-nonsurvivors 
(n = 8) 
Shock-survivors 
(n = 43) 
Sepsis-survivors 
(n = 9) 
Total cortisol (nmol/L) 615 (490 – 790) a 953 (696 – 1160) b 1276 (1044 – 1895) 
ACTH (pmol/L) 274.1 (164.4 – 647.1) a 49.5 (13.4 – 109.7) 5.9 (3.8 – 70.8) 
Total cortisol/ACTH ratio (x103) 2.6 (0.8 – 4.5) a 21.2 (5.4 – 90.3) b 195.3 (18.2 – 330.0)
CBG (nmol/L) 892 (466 – 1175) 700 (552 – 1108) 831 (668 – 1223) 
Albumin (g/L) 40 (28 – 41) 33 (27 – 39) 34 (31 – 39) 
Bio-available cortisol (nmol/L) 106 (30 – 220) b 173 (59 – 532) b 511 (356 – 843) 
17-OHP (nmol/L) 2.8 (1.9 – 6.5) a 8.7 (3.9 – 10.3) 11.2 (3.4 – 15.3) 
11-deoxycortisol (nmol/L) 143 (102 – 176) 70 (53 – 167) 73 (44 – 127) 
11-deoxycortisol to 17-OHP ratio 48 (17 – 72) a 10 (7 – 29) 13 (6 – 17) 
Cortisol to 11-deoxycortisol ratio 4.1 (3.1 – 4.8) a 16.0 (3.9 – 21.3) 17.3 (10.4 – 24.9) 
Aldosterone (pg/ml) 569 (320 – 803) 296 (169 – 427) 269 (216 – 1475) 
Plasma renin activity (ng AngI/ml/h) 15.9 (5.2 – 37.4) 19.5 (9.3 – 34.4) 19.1 (9.7 – 76.9) 
All values are expressed as median (25 to 75 percentile). For reference values see Patients and 
Methods. a Significantly different, compared to all survivors, P < 0.05. b Significantly different, 
compared to sepsis-survivors, P < 0.05. 
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Figure 1. Serum cortisol levels, bio-available cortisol levels, ACTH levels, cortisol/ACTH ratios, 
17-OHP levels and 11-deoxycortisol levels on admission. Nonsurvivors are depicted in the left box, 
shock-survivors in the middle box and sepsis-survivors. 
 
Cortisol and ACTH levels 
Total cortisol levels did not increase with increasing disease severity: nonsurvivors 
had significantly lower median serum cortisol levels than shock survivors as well as 
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sepsis survivors, and shock survivors had significantly lower cortisol levels than 
sepsis survivors (Table 2 and Figure 1). ACTH levels were significantly higher in 
nonsurvivors, compared with shock survivors and sepsis survivors. As a result, 
nonsurvivors had significantly lower median total cortisol to ACTH ratios, compared 
with survivors, and shock-survivors had significantly lower cortisol to ACTH ratios 
than sepsis survivors. Parameters of disease severity, such as PRISM and SOFA 
score, IL-6, and lactate levels, correlated positively with ACTH levels and negatively 
with serum cortisol levels as well as cortisol to ACTH ratios (Table 3). Arterial 
glucose levels correlated negatively with ACTH levels and positively with cortisol to 
ACTH ratio. Age and time from first petechia to admission did not correlate with 
cortisol levels, ACTH levels, or their ratio (data not shown). 
CBG and bioavailable cortisol levels 
On admission, serum CBG levels ranged from 223 to 1793 nmol/liter. CBG levels 
were within the normal range in the vast majority of children (86%), elevated in one 
girl (1.3 yr of age), and decreased in seven children, of which one girl was older than 
12 yr. Serum CBG and albumin levels did not significantly differ among nonsurvivors, 
shock survivors, and sepsis survivors (Table 2), and CBG levels did not correlate 
with parameters of disease severity (Table 3). Median bioavailable cortisol levels 
were significantly lower in nonsurvivors and shock survivors, compared with sepsis 
survivors (Table 2 and Figure 1) and correlated negatively with parameters of 
disease severity (Table 3) and positively with CRP levels but not with age or time 
from first petechia to admission. 
 
Table 3. Significant Spearman correlation coefficients of hormones of the HPA-axis with parameters 
of disease severity. 
 PRISM SOFA Lactate IL-6 CRP Glucose 
Cortisol –0.48 –0.59 –0.41 –0.45 0.46 – 
ACTH 0.49 0.60 0.54 0.66 –0.35 –0.30 
Cortisol/ACTH –0.58 –0.70 –0.62 –0.72 0.43 0.32 
CBG – – – – – – 
Bio-available cortisol  –0.35 –0.55 –0.41 –0.30 0.37 – 
17-OHP – – – – – – 
11-deoxycortisol – – – – – –0.29 
11-deoxycortisol/17-OHP – 0.38 – 0.39 – –0.38 
Cortisol/11-deoxycortisol –0.40 –0.43 –0.35 –0.47 0.27 0.37 
Cortisol/17-OHP – – – – – – 
Aldosterone – – – 0.33 – – 
Plasma renin activity – – – – – – 
Non-significant correlation coefficients are represented with a dash. 
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17-OHP and 11-deoxycortisol levels and ratios with cortisol 
On admission, serum 17-OHP ranged from values below the detection limit of 0.1 to 
28.9 nmol/liter and serum 11-deoxycortisol levels ranged from 7 to 468 nmol/liter. 
Nonsurvivors had significantly lower 17-OHP levels than survivors, whereas median 
11-deoxycortisol levels did not significantly differ between the groups (Table 2). 
Nonsurvivors had significantly higher 11-deoxycortisol to 17-OHP ratios and 
significantly lower cortisol to 11-deoxycortisol ratios than survivors, whereas these 
ratios did not significantly differ between all shock survivors and sepsis survivors and 
also between shock survivors and sepsis survivors who did not receive etomidate 
(data not shown). Most parameters of disease severity correlated positively with 
11-deoxycortisol to 17-OHP ratios and negatively with cortisol to 11-deoxycortisol 
ratios but not with serum 17-OHP and 11-deoxycortisol levels (Table 3). Arterial 
glucose levels correlated negatively with 11-deoxycortisol levels and 
11-deoxycortisol to 17-OHP ratios and positively with cortisol to 11-deoxycortisol 
ratios. Both serum 17-OHP and 11-deoxycortisol levels did not correlate with age 
and did not differ between girls and boys. Plasma ACTH levels and cortisol to ACTH 
ratios correlated significantly with 11-deoxycortisol levels (r=0.44 and r=0.39, 
respectively), whereas 17-OHP levels did not (data not shown). 
Aldosterone levels and plasma renin activity 
On admission, plasma aldosterone levels ranged from 129 to 1867 pg/ml and 
plasma renin activity from 3.3 to 97.2 ng angiotensin I per milliliter per hour. 
Aldosterone levels tended to be higher in nonsurvivors, compared with shock 
survivors (P=0.057) but did not significantly differ between shock survivors and 
sepsis survivors. Plasma renin activity did not significantly differ among 
nonsurvivors, shock survivors, and sepsis survivors. Aldosterone levels correlated 
significantly with age (r=0.69) and IL-6 levels (r=0.33) but not with other parameters 
of disease severity (Table 3), plasma renin activity, or ACTH levels (data not shown). 
Plasma renin activity correlated significantly with systolic blood pressure SD score (r 
= – 0.39) but not with diastolic blood pressure SD score, any parameter of disease 
severity, or age. Aldosterone levels and plasma renin activity did not significantly 
differ between children who received inotropics and those who did not. 
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Figure 2. Relation between cortisol/ACTH ratios and IL-6 levels, in children who received etomidate 
(●, continuous line) and children who did not receive etomidate (○, dotted line). After adjustment for 
IL-6 levels, using multiple regression, mean cortisol/ACTH ratios were significantly higher in case of 
etomidate use (p<0.001). The vertical gray dotted line (IL-6 level of 500,000 pg/L) discriminates 
survivors (left) from nonsurvivors (right). 
Multivariate analysis 
In univariate regression analyses, the cortisol to ACTH ratio was significantly related 
to IL-6, CRP, 17-OHP, 11-deoxycortisol levels, age, mechanical ventilation, and 
intubation with etomidate but not to gender and time from first petechia to admission. 
Using multiple regression analysis, we found cortisol to ACTH ratios to be 
significantly related to IL-6 levels and intubation with etomidate before admission. 
These two variables in combination explained 65% of the variation in cortisol to 
ACTH ratio on admission, whereas IL-6 alone explained 45%. The cortisol to ACTH 
ratios decreased by 19% for every doubling of IL-6 levels and by 83% when 
etomidate was administered (Figure 2). In contrast, analyzing the relation between 
cortisol to ACTH ratios and IL-6 levels, we found no significant difference between 
children who were intubated without etomidate and those who were not intubated 
(ANCOVA, P=0.774). Children who were intubated on admission, independently of 
intubation with etomidate, had significantly higher disease severity parameters, such 
as PRISM, SOFA, IL-6, and lactate levels, than children who were not intubated. In 
univariate regression analyses, the cortisol to 11-deoxycortisol ratio was significantly 
Acute stress response in critically ill children 
 38 
related to IL-6, CRP, ACTH levels, mechanical ventilation, and intubation with 
etomidate but not to age, gender, time from first petechia to admission, or 17-OHP 
levels. Using multiple regression analysis, we found only intubation with etomidate to 
be significantly predictive for cortisol to 11-deoxycortisol ratios, explaining 78% of the 
variation in cortisol to 11-deoxycortisol ratio on admission. The mean decrease of 
cortisol to 11-deoxycortisol ratios was 84% when children were intubated with 
etomidate (Figure 3). 
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Figure 3. The cortisol/11-deoxycortisol ratio in relation to IL-6 levels, in children who received 
etomidate (●, continuous line) and children who did not receive etomidate (○, dotted line). Mean 
cortisol/11-deoxycortisol ratios were significantly higher in case of etomidate use (p<0.001). The 
vertical gray dotted line (IL-6 level of 500,000 pg/L) discriminates survivors (left) from nonsurvivors 
(right). 
Discussion 
In this study we found that the most severely ill children with meningococcal septic 
shock had signs of adrenal insufficiency on PICU admission, indicated by low cortisol 
and very high ACTH levels. Low total cortisol levels proved to correspond with low 
bioavailable cortisol. Serum CBG levels were normal in the vast majority of the 
children. We did not find signs of a reduced 21-hydroxylase activity because the 
11-deoxycortisol to 17-OHP ratio was not reduced. We found, however, a reduction 
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in the cortisol to 11-deoxycortisol ratio, indicating that the 11β-hydroxylase activity 
was significantly reduced, particularly in the nonsurvivors. Nonsurvivors had 
significantly reduced cortisol to ACTH ratio, compared with the survivors. The cortisol 
to ACTH ratio was negatively related to IL-6 levels and various other disease 
severity scores. Using multiple regression analysis, it turned out that a decreased 
cortisol to ACTH ratio was significantly related to higher IL-6 levels and intubation 
with etomidate, whereas a lower cortisol to 11-deoxycortisol ratio was only 
significantly related to intubation with etomidate.  
First of all, we examined whether total cortisol levels corresponded with 
bioavailable cortisol levels. Serum CBG and to a much lesser extent albumin are the 
most important serum proteins for transport of cortisol, thereby roughly determining 
the biologically active cortisol concentration. We found normal CBG and albumin 
levels in the vast majority of the children with meningococcal disease on PICU 
admission, indicating that the low total cortisol levels do correspond with low 
bioavailable cortisol levels in these children. This is in contrast to studies in critically 
ill adults reporting decreased serum CBG and albumin levels with concomitantly 
elevated free cortisol fractions especially during the acute phase of critical illness (9, 
10, 12). A possible explanation for this difference might be that children in our study 
received plasma products from healthy adult donors as volume suppletion, which 
might have prevented a decline in CBG levels. From our study we can conclude that 
bioavailable cortisol levels were not more informative on adrenal function than total 
cortisol levels in these children on PICU admission.  
The extremely elevated ACTH levels in combination with the decreased 
cortisol levels in nonsurvivors represent an inadequate adrenal response. We 
therefore investigated whether the enzymes 21-hydroxylase and 11β-hydroxylase 
were not or less active in this condition by measuring 11-deoxycortisol to 17-OHP 
and cortisol to 11-deoxycortisol ratios. It turned out that with increasing disease 
severity there were more signs of decreased 11β-hydroxylase activity, as depicted 
by lower cortisol to 11-deoxycortisol ratios, whereas we found no signs of decreased 
21-hydroxyase activity. The median 11-deoxycortisol to 17-OHP ratio was 
significantly higher in nonsurvivors than survivors, which may have resulted from 
accumulation of 11-deoxycortisol levels by decreased 11β-hydroxylase activity. In 
search of factors influencing adrenal function, we found, besides disease severity, 
mechanical ventilation and in particular intubation with one single bolus of etomidate 
to be significantly related to decreased adrenal function at the level of 
11β-hydroxylase. As Figure 2 shows, IL-6 levels higher than 500,000 pg/ml was 
discriminating for mortality. Etomidate was found to reduce 11β-hydroxylase activity 
independently of disease severity (Figure 3).  
Our study suggests that the addition of one single bolus of etomidate to the 
existing overwhelming immune reaction in the most severely ill children might have 
increased the risk for mortality. For the less severely ill children, the addition of 
etomidate appeared not so disastrous. It is, however, difficult to identify the relative 
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contribution of the disease severity and the intubation with etomidate because the 
most severely ill children were more likely to be intubated than the less severely ill 
children. In our study the group of intubated children without etomidate was too small 
to differentiate whether etomidate was given, depending on the disease severity. We 
assume, however, it was not of influence because all children were intubated in the 
setting of a rapid sequence intubation. In vitro studies have shown that etomidate 
interferes with mainly two steroidogenic enzymes: the cholesterol (P450) side-chain 
cleavage enzyme system and 11β-hydroxylase (21, 22, 27). Already 20 yr ago 
etomidate has been withdrawn from the long-term sedation regimen due to high 
death rates; however, it still is a first-line anesthetic agent in the setting of rapid 
sequence intubation, in which one single bolus is used. This use of one single bolus 
had been assumed to give only transient, not clinically relevant, hormonal changes 
(14, 28). Although our study was not designed to study the direct effect of etomidate 
administration on adrenal function and mortality, our data suggest that in the most 
severely ill children with septic shock, the risk of death might have been increased by 
one single bolus of etomidate during intubation. This should be further investigated. 
Our present study indicates that adrenal insufficiency should be considered in 
all children with severe sepsis and septic shock but particularly so when they 
received a bolus of etomidate during intubation. Based on our results and awaiting 
the final results future studies, it seems of vital importance to take considerable 
caution using etomidate and consider combining its administration with 
glucocorticoids during intubation of children with septic shock. 
Various other mechanisms might be important in the pathogenesis of relative 
adrenal insufficiency during sepsis, such as impairment of enzymes of the 
steroidogenical pathway before 21-hydroxylase, ACTH receptor insensitivity, 
decreased levels of cholesterol, decreased (adrenal) blood flow during severe shock, 
and adrenal hemorrhage. All these factors might adversely influence cortisol 
production in the most severely ill children (29–32). 
In our study, aldosterone levels tended to be higher in nonsurvivors, 
compared with shock survivors and correlated positively but weakly with IL-6 levels. 
However, because aldosterone levels were inversely correlated with age, this trend 
was apparently influenced by the younger age of nonsurvivors, compared with 
survivors. Plasma renin activity related negatively to age-matched systolic blood 
pressure values, suggesting an adequately renin response. However, plasma renin 
activity did not correlate with aldosterone levels, suggesting an inadequate 
aldosterone response. 
In summary, our study shows that the most severely ill children with 
meningococcal septic shock had signs of adrenal insufficiency on PICU admission. 
Bioavailable cortisol levels were not more informative on adrenal function than total 
cortisol levels. Decreased adrenal function was strongly inversely related to IL-6 
levels and at least partly to a decreased 11β-hydroxylase activity but not to a 
decreased 21-hydroxylase. In addition to IL-6 levels, one single bolus of etomidate 
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during intubation was related to a decreased adrenal function and 11β-hydroxylase 
activity. Based on our results, it seems of vital importance to take considerable 
caution using etomidate during intubation of children with septic shock and consider 
combining its administration with glucocorticoids. 
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Abstract 
Objective: To investigate the influence on adrenal function of one single bolus of 
etomidate used for intubation in children with meningococcal sepsis. Design: 
Retrospective study conducted between 1997 and 2004. Setting: University-
affiliated paediatric intensive care unit (PICU). Patients and participants: Sixty 
children admitted to the PICU with meningococcal sepsis, not treated with steroids. 
Interventions: Adrenal hormone concentrations were determined as soon as 
possible after PICU admission, 12 and 24 hours thereafter. To assess disease 
severity, PRISM score and selected laboratory parameters were determined. 
Measurements and main results: On admission, before blood was drawn, 23 
children had been intubated with etomidate, 8 without etomidate and 29 were not 
intubated. Children who were intubated had significantly higher disease severity 
parameters, whereas none of these parameters significantly differed between 
children who were intubated with or without etomidate. Children who received 
etomidate had significantly lower cortisol, higher ACTH and 11-deoxycortisol levels 
than those who did not receive etomidate. Arterial glucose levels were significantly 
lower in children who were intubated with etomidate than in children who were not 
intubated. When children were intubated with etomidate, cortisol levels were 3.2 
times lower for comparable 11-deoxycortisol levels. Eight children died, 7 of them 
had received etomidate. Within 24h cortisol/ACTH ratios increased significantly in 
children who had received etomidate, but not in children who had not receive 
etomidate, resulting in comparable cortisol/ACTH ratios 24h after admission. 
Conclusions: Our data imply that even one single bolus of etomidate negatively 
influences adrenal function and thereby might increase risk of death. 
Chapter 3 
    47
Introduction  
Stimulation of the hypothalamic-pituitary adrenal axis is one of the most important 
hormonal reactions to critical illness (1). We have previously shown that children 
dying from meningococcal septic shock had relatively low cortisol levels and 
extremely high ACTH levels, indicating inappropriate adrenal function (2, 3). The 
anaesthetic drug etomidate is known to inhibit adrenal function by mainly impeding 
the enzyme 11β-hydroxylase, the last step in the biosynthesis of cortisol, resulting in 
increased levels of 11-deoxycortisol in relation to cortisol levels (4) (Figure 1). Since 
long-term etomidate use resulted in increased mortality, etomidate has been 
withdrawn from long-term sedation regimens (5). Etomidate, however, remained a 
first-line anaesthetic agent in the setting of rapid sequence intubation, because it has 
a favourable cardiopulmonary profile. One single bolus of etomidate was assumed 
by many intensive care physicians to give only transient, clinically non-relevant 
hormonal changes (6-8). This assumption was mainly based on small studies in 
healthy adults undergoing elective surgery and may not be applicable in children with 
septic shock, who are at risk for adrenal insufficiency. Recently, Malerba et al. 
reported the use of etomidate to be independently related to relative adrenal 
insufficiency in critically ill adults (9). This stimulated us to evaluate retrospectively 
whether etomidate impaired adrenal function in our cohort of children with 
meningococcal sepsis. 
Materials and Methods 
Patients 
The group consisted of 69 previously healthy children (42 boys and 27 girls) 
consecutively admitted to the PICU of the Erasmus MC-Sophia Children’s Hospital, 
with a clinical picture of meningococcal sepsis, defined as sepsis with petechiae 
and/or purpura as described previously (2, 10, 11). Blood cultures revealed Neisseria 
meningitidis in 58 children. Nine children who received corticosteroid therapy for 
suspected adrenal insufficiency before admission were excluded. The lack of 
research staff to ensure adequate 24h stand-by service necessitated two study 
periods: from October 1997 to October 1999 and from October 2001 to January 
2004. The study was approved by the local medical ethics committee and conducted 
according to declaration of Helsinki.  
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Figure 1. A schematic representation of steroidogenesis in the human adrenal gland and the effect of 
etomidate. Etomidate inhibits 11β-hydroxylase (CYP11B1), 11β- & 18-hydroxylase (CYP11B2) and 
cholesterol side-chain cleavage enzyme system (CYP11A) (shaded enzymes) with decreasing 
effectiveness. Decreased CYP11B1 activity will lead to lower levels of cortisol and increased levels of 
the upstream precursor 11-deoxycortisol. Decreased CYP11B2 will lead to lower aldosterone and 
higher 11-deoxycorticosterone levels, whereas decreased CYP11A will lead to a generally decreased 
steroidogenesis. 3β-HSD, 3β-hydroxysteroid-dehydrogenase; CYP21, 21-hydroxylase; CYP17, 17-
hydroxylase & 17,20-lyase. 
 
Concomitant therapy 
Concomitant therapy on admission included antibiotics (Cefotaxim) and 
administration of fluids in all 60 children and inotropics in 51 children. On admission 
31 children were mechanically ventilated, whereas 29 children were not. 
Mechanically ventilated children were intubated at median 2h and 40min (range, 
5min to 7h) before study enrolment with etomidate (n=23) or with combinations of 
opiate agonists, propofol, ketamine or midazolam (n=8). The median dose of the 
etomidate bolus was 0.29 mg/kg (range, 0.20 to 0.67 mg/kg) and was significantly 
higher in children who died compared with those who survived (0.46 vs. 0.29, 
P=0.038). The sedatives and doses used for rapid-sequence intubation depended on 
the physicians’ choice. After admission 4 more children were intubated with 
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etomidate. Mechanically ventilated children were all intubated for their clinical status 
only and were sedated with benzodiazepines and/or morphine. On admission, 
patients received intravenous glucose at a rate of 4–6 mg/kg/min. 
Clinical parameters 
Disease severity was determined using the Pediatric Risk of Mortality score (PRISM 
II) (12) during the first 6 hours of admission. We recorded etomidate use, respiratory 
and inotropic support, quantified with vasopressor score of Wernovsky on admission 
(13).  
Collection of blood samples and analysis 
Arterial blood samples were obtained as soon as possible after admission, 12 and 24 
hours thereafter for determination of cortisol, ACTH, glucose, lactate and IL-6 (2, 3). 
Serum 11-deoxycortisol levels obtained on admission and determined by 
radioimmunoassay with antiserum from ICN Biomedicals (Costa Mesa, CA). 
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Figure 2. Relation between ACTH and arterial lactate levels, depending on etomidate use. After 
adjustment for arterial lactate levels, using ANCOVA, mean ACTH levels were a factor 4.1 higher in 
case of etomidate use (P<0.001). Children who received etomidate (●, continuous line) and children 
who did not receive etomidate (○, dotted line).  
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Statistics 
The results are expressed as medians unless specified otherwise. We used Mann-
Whitney U, chi-square or Fischer’s exact test, Spearman’s correlation coefficient (r) 
and analysis of covariance (ANCOVA). The graph of the course of cortisol/ACTH 
ratios was constructed using mixed model analysis of variance. Two-tailed P-values 
of <0.05 were considered statistically significant.  
Results 
Clinical parameters 
Children who had been intubated before admission, independently of etomidate use, 
had significantly higher disease severity parameters – such as PRISM, IL-6, lactate – 
and vasopressor score than children who were not intubated, whereas none of these 
parameters significantly differed between children who were intubated with or without 
etomidate (Table 1). Arterial glucose levels were significantly lower in children who 
were intubated with etomidate compared to children who were not intubated 
(P=0.023) and tended to be lower than in children who were intubated without 
etomidate (P=0.082).  
Adrenal function on admission 
On admission, cortisol levels were significantly lower and ACTH levels significantly 
higher with concomitantly lower cortisol/ACTH ratios in children who were intubated 
with etomidate compared to those who did not receive etomidate, independently of 
intubation (Table 1). Furthermore, children who were intubated with etomidate had 
significantly higher 11-deoxycortisol levels with concomitantly lower cortisol/11-
deoxycortisol ratios compared to children who did not receive etomidate, 
independently of intubation. Compared to non-stressed values, 11-deoxycortisol 
levels were elevated in 95% of the children who received etomidate and in 65% of 
the children who did not receive etomidate (P=0.019), independently of intubation. 
Neither time from intubation to admission nor etomidate dose per kg body weight 
correlated significantly with serum levels of cortisol, ACTH, 11-deoxycortisol or their 
ratios on admission (data not shown).  
ANCOVA revealed ACTH levels to be significantly related with intubation with 
etomidate and disease severity, as depicted by lactate levels (R2=0.54), whereas 
age and gender were not. When children were intubated with etomidate, ACTH 
levels were a factor 4.1 higher for comparable lactate levels (Figure 2). In contrast, 
we found no difference in the relation of ACTH with lactate between children who 
were intubated without etomidate and those who were not intubated (ANCOVA, 
P=0.222). A similar model was found for ACTH levels with IL-6 levels and etomidate 
(R2=0.55), in which ACTH levels were a factor 3.3 higher if children were intubated 
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with etomidate. ANCOVA revealed 11-deoxycortisol levels and intubation with 
etomidate to be significantly related to cortisol levels (R2=0.57), whereas age and 
gender were not. Cortisol levels were a factor 3.2 lower, for comparable 11-
deoxycortisol levels, if children were intubated with etomidate (Figure 3). In contrast, 
we found no difference in the relation of cortisol with 11-deoxycortisol, between 
children who were intubated without etomidate and those who were not intubated 
(ANCOVA, P=0.303). 
Adrenal function time course 
Within 5h after study enrolment 4 other children were intubated with etomidate. 
Seven children received glucocorticoid treatment for suspected adrenal insufficiency 
after study enrolment; 6 of them (intubated with etomidate) within 5h and one 
(intubated without etomidate) after 55 h. Eight children died due to hemodynamic 
failure at median 11h after PICU admission (range, 8 – 43 h), 7 of them had received 
etomidate. Within 24h cortisol/ACTH ratios increased significantly in children who 
had received etomidate, but not in children who did not receive etomidate, resulting 
in comparable cortisol/ACTH ratios 24h after admission (Figure 4).  
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Figure 3. Relation between cortisol and 11-deoxycortisol levels, depending on etomidate use. After 
adjustment for 11-deoxycortisol levels, using ANCOVA, mean cortisol levels were a factor 3.2 lower in 
case of etomidate use (P<0.001). Children who received etomidate (●, continuous line) and children 
who did not receive etomidate (○, dotted line). 
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Figure 4. Cortisol/ACTH ratios according to patients’ actual etomidate use during the first 24h of 
admission. The two profiles differed between the groups along time (P<0.001). Data shown are 
geometric means with standard errors. Children who received etomidate (●, continuous line) and 
children who did not receive etomidate (○, dotted line). Within group difference between successive 
time point (a, P<0.05). Between group difference at time points (b, P<0.05). Numbers alongside data-
points indicate numbers of children. 
Discussion 
This retrospective study showed major differences in ACTH, cortisol and 11-
deoxycortisol levels between children intubated with one single bolus of etomidate 
compared to children who did not receive etomidate, independently of intubation.  
Although our study was not designed to investigate the direct relation between 
etomidate administration and adrenal function, we found significantly more signs of 
impaired adrenal function, as shown by the combination of significantly lower cortisol 
with much higher ACTH levels, in children who received etomidate compared to 
those who did not, even after correction for disease severity (Figure 2). Cortisol 
levels were 3.2 times lower and ACTH levels were 4.1 times higher in children who 
received etomidate compared with those who did not. Serum 11-deoxycortisol (the 
precursor of cortisol that exerts no endocrine actions) was significantly higher and 
cortisol/11-deoxycortisol lower in children who received etomidate compared to 
those who did not, indicating impaired 11β-hydroxylase activity (CYP11B1, Figure 1). 
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This is in accordance with in vitro and in vivo studies that show etomidate to interfere 
mainly with 11β-hydroxylase, and at higher concentrations also with 11β- & 18-
hydroxylase (CYP11B2) and cholesterol side-chain cleavage enzyme system 
(CYP11A) (4, 14-17). Despite the fact that etomidate is known to suppress adrenal 
function in a dose-dependent manner, we did not find such a relation, due to lack of 
study power (14). However, the dose of etomidate was higher in children who died 
compared with those who survived. Because we studied retrospectively the effect of 
etomidate in an uncontrolled setting, it is difficult to report on relevant clinical 
deterioration, such as persistent hypotension or the course of glucose levels. We 
found nevertheless significant lower glucose levels on admission in children 
receiving etomidate compared to those who did not. Furthermore, concerning 
mortality, in this study 7 of the 8 children who died during admission received 
etomidate. These numbers are too small to draw conclusions in this complex clinical 
situation, because many other variables will be of influence to survive septic shock, 
but the risk of death might be increased when etomidate is used. Significant but 
transient adrenocortical suppression 24h after a single bolus of etomidate has been 
described (9, 18). We found no different cortisol/ACTH ratios between the studied 
groups more than 24h after intubation, whereas these differences were still present 
after 12 h, suggesting also a 12-24h adrenal cortical suppression. Future 
investigations using corticotropin test should be done to prove the duration of this 
adrenocortical suppression. 
In summary, our data imply that even one single bolus of etomidate negatively 
influences adrenal function and thereby might increase risk of death. As recently 
stated (8), considerable caution should accompany the administration of etomidate in 
patients with septic shock. The potential role for concomitant steroid replacement 
should be elucidated.  
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Abstract 
Context and Objectives: The objective of this study was to elucidate the influence 
of disease severity, deiodination, sulfation, thyroid hormone binding, and dopamine 
use on thyroid function in euthyroid sick syndrome. Setting: The study was 
performed at a university-affiliated pediatric intensive care unit (PICU). Design: This 
was an observational cohort study. Patients: Sixty-nine children with meningococcal 
sepsis were studied. Main Outcome Measures: Differences in thyroid function 
among nonsurvivors, shock-survivors, and sepsis-survivors on PICU admission were 
the main outcome measures. Results: The main study group consisted of 45 
non-dopamine-treated children. All children had decreased total TT3/rT3 ratios 
without elevated TSH. T4 sulfate levels were decreased in 88%. Nonsurvivors had 
paradoxically higher TT3/rT3 ratios than shock-survivors (0.71 vs. 0.30); this ratio 
also correlated with shorter duration of disease (r = –0.43). TT4 and TBG levels 
declined with increasing disease severity. TBG levels correlated inversely with 
elastase levels (r = –0.46). Only TSH levels were significantly lower in 24 
dopamine-treated children compared with non-dopamine-treated children (0.65 vs. 
0.84), whereas other thyroid hormones did not significantly differ. Both higher 
TT3/rT3 ratios and lower TT4 levels were predictive for mortality, but this 
disappeared when IL-6 was entered into the regression model. Conclusions: All 
children with meningococcal sepsis showed signs of euthyroid sick syndrome. 
Alterations in peripheral thyroid hormone metabolism related inversely to the 
duration of disease and seemed to be enacted by profound induction of type 3 
deiodinase rather than by down-regulation of type 1. Lower TT4 levels were related 
to increased turnover of TBG by elastase. Dopamine was found to suppress only 
TSH secretion, not other thyroid hormone levels, on PICU admission. Both the 
TT3/rT3 ratio and TT4 levels were predictive for mortality, but were not superior to 
IL-6.  
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Introduction 
Meningococcal disease is one of the most severe infectious diseases in children. 
During critical illness, many endocrine changes take place. The initial phase is 
characterized by peripheral down-regulation of most hypothalamic-pituitary 
hormones, except cortisol (1). The changes in thyroid hormones during critical illness 
are called the euthyroid sick syndrome or nonthyroidal illness. Initially, serum total T3 
(TT3) values decline, and rT3 values increase (2). When the condition deteriorates, 
total T4 (TT4) values may decrease as well, producing a combined low TT3-low TT4 
state that typically does not result in compensatory higher levels of TSH, which 
generally remain normal. Alterations in peripheral thyroid hormone metabolism, such 
as deiodination, play an eminent role in the development of the euthyroid sick 
syndrome (3, 4). Altered sulfation may also lead to changes in peripheral thyroid 
hormones (5). Data on thyroid hormone sulfation in critically ill adults are scarce (6), 
whereas data in critically ill children do not exist. 
Furthermore, because thyroid hormones are mainly bound to carrier proteins, 
a decline in serum thyroid hormones may be the result of decreased concentrations 
of or decreased binding to serum carrier proteins due to serum inhibitors, such as 
non-esterified fatty acids (NEFA) (2). Additionally, elastase, a serine protease 
released by activated neutrophils, has been shown to cleave T4-binding globulin 
(TBG) during inflammation, resulting in decreased affinity of TBG for thyroid 
hormones as well as increased clearance of TBG (7, 8). Besides this, medication 
such as dopamine is known to influence serum thyroid hormones as well, via 
suppression of TSH (9, 10). 
Concerning the relationship between thyroid hormone levels and mortality, a 
few studies in critically ill children showed an association between low levels of TT4 
(11) and TT3 (12) and mortality, whereas this relation was not found in some other 
studies (13, 14). We previously reported higher TT3 and TT4 levels in a small group 
of nonsurvivors of meningococcal septic shock compared with survivors (15). To 
date, little is known about factors influencing changes in thyroid hormone levels in 
relation to outcome in critically ill children. 
We therefore evaluated thyroid function in relation to disease severity and 
assessed the influence of deiodination, sulfation, and thyroid hormone binding on 
thyroid hormone levels at pediatric intensive care unit (PICU) admission in a large 
group of acutely ill children with sepsis or septic shock, not treated with dopamine. In 
addition, we investigated the influence of dopamine on thyroid hormone levels in a 
separate group who did receive dopamine. Finally, we assessed the predictive value 
of thyroid hormone levels on mortality. 
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Patients and Methods 
Patients 
The group consisted of previously healthy children primary admitted or referred to 
the PICU of Erasmus Medical Center-Sophia Children’s Hospital between October 
1997 and February 2000 and between October 2001 and January 2004, suffering 
from meningococcal sepsis, defined as sepsis with petechiae/purpura. Sepsis was 
defined as temperature of less than 36.0 ºC or more than 38.5 ºC with tachycardia 
and tachypneu. In addition, children were determined to have septic shock if they 
had persistent hypotension or evidence of poor end-organ perfusion, as described 
previously (15). Children were not eligible for the study if they had endocrine or 
chromosomal abnormalities or had received radiation or chemotherapy within the 
previous 6 months. The local medical ethics committee approved the study, and 
written informed consent was obtained from the parents or legal representatives. 
Clinical parameters 
To access disease severity, we determined the pediatric risk of mortality (PRISM II) 
score (15, 16) and the sepsis-related organ failure assessment (SOFA) score (17) 
and analyzed plasma IL-6, lactate, and C-reactive protein (CRP) levels. We recorded 
the interval between appearance of first petechia and PICU admission, respiratory 
support, and medication use. 
Sample collection and laboratory assays 
Arterial blood samples were collected on admission; after centrifugation, 
serum/plasma was stored at –80 ºC until determination of thyroid hormones, IL-6, 
and elastase-α-1-antitripsine complex (elastase). All other laboratory parameters 
were determined immediately in a certified laboratory of clinical chemistry (ISO 
17025 and 9001). 
Serum levels of TT4, T4 sulfate (T4S), T3, rT3, and TBG were determined by 
RIA, free T4 (FT4) by single-step analog binding assay and TSH, as described 
previously (18, 19). Thyroid hormone SD scores (Z-scores) were calculated with data 
from a control group comprised of healthy age-matched children and considered 
normal between –2 and +2. 
Serum CRP was determined by immunoturbidimetric assay, and serum NEFA 
by calorimetric assay (NEFA-C kit, WAKO Diagnostics, Richmond, VA), both on a 
Hitachi 912 analyzer (Roche, Indianapolis, IN). Arterial lactate and glucose were 
determined on blood gas analyzer (ABL 625, Radiometer, Copenhagen, Denmark). 
The reference values were less than 10 mg/liter for CRP, 35–50 g/liter for albumin, 
0.2–1.2 mmol/liter for NEFA, less than 2.0 mmol/liter for lactate, and 2.6–11.0 
mmol/liter for glucose. Plasma IL-6 levels were determined with ELISA (Sanquin, 
Amsterdam, The Netherlands), with a detection limit of 10 pg/ml. Plasma elastase 
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levels were determined by RIAs (Sanquin, Amsterdam, The Netherlands; normal 
range, <100 ng/ml) in patients included between October 2001 and January 2004. 
Caloric intake 
On PICU admission, children received glucose iv (4–6 mg/kg/min), but no enteral or 
parenteral feeding until the second day. 
Statistics 
Results, analyzed with SPSS 11.5 (SPSS, Inc., Chicago, IL), are expressed as 
medians unless specified otherwise. We used Mann-Whitney U, χ2, or Fisher’s exact 
test, when necessary, and Spearman’s correlation coefficient (r). For backward 
multiple linear regression analysis and logistic regression analysis, data were log 
transformed when necessary. A value from two-tailed t test of P < 0.05 was 
considered statistical significant. 
 
Table 1. Patients’ characteristics of the main, non-dopamine-treated study group on admission, 
divided in nonsurvivors, shock-survivors and sepsis-survivors.  
Variables  Nonsurvivors 
(n=8) 
Shock-survivors 
(n=30) 
Sepsis-survivors 
(n=7) 
Age (yrs) 1.1 (0.5 – 9.4) a, b 4.3 (0.1 – 16.1) c 6.1 (2.3 – 12.2) c 
Male gender (%) 7 (88%) 19 (63%) 4 (57%) 
Time 1st petechia – admission (h) 5.7 (2.4 – 10.5) a, b 7.9 (4.2 – 26.5) c 7.6 (4.9 – 15.7) c 
PRISM score 32 (23 – 43) a, b 21 (8 – 35) a, c 9 (5 – 13) b, c 
SOFA score 15 (13 – 19) a, b 9 (3 – 17) a, c 2 (0 – 6) b, c 
IL-6 x 10-3(pmol/L) 1165.1 
(68.5 – 2934.1) a, b 
50.3 
(0.3 – 337.1) a, c 
0.4 
(0.08 – 10.5) b, c 
Lactate (mmol/L) 6.8 (4.6 – 10.9) a, b 3.7 (1.1 – 7.1) a, c 2.2 (1.2 – 3.8) b, c 
CRP (mg/L) 34 (21 – 136) b 90 (20 – 326) c 75 (20 – 252) 
Cortisol (nmol/L) 675 (320 – 3440) a 992 (138 – 5467) 1276 (999 – 2200) c 
Elastase (ng/mL) - 366 (181 – 1269) 317 (182 – 404) 
Albumin (g/L) 40 (34 – 41) 34 (29 – 39) 33 (31 – 40) 
NEFA 0.29 (0.22 – 0.42) a, b 0.68 (0.52 – 1.22) c 0.63 (0.53 – 0.68) c 
NEFA/albumin (M/M) 0.48 (0.41 – 1.13) a, b 1.41 (0.92 – 2.24) c 1.10 (1.09 – 1.33) c 
Values are expressed as median (range). a Significantly different compared to sepsis-survivors, P < 
0.05. b Significantly different compared to shock-survivors, P < 0.05. c Significantly different compared 
to nonsurvivors, P < 0.05. 
Results 
In the study period, 69 previously healthy children were admitted to the PICU with 
meningococcal sepsis. The total group was divided into the main study group (n=45), 
consisting of non-dopamine-treated children, and a dopamine-treated group (n=24). 
The latter group was separately analyzed and is presented at the end of Results.  
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Figure 1. Serum TBG levels (A) and TT4/TBG ratios (B), TT3/TBG ratios (C) and rT3/TBG ratios (D) 
of the main, non-dopamine-treated study group on admission. Nonsurvivors are depicted in the left 
box, shock-survivors in the middle box and sepsis-survivors in the right box. Box-whisker-plots: the 
boxes indicate 25 to 75 percentile with the median and the attached whiskers the complete range with 
exclusion of outliers (○) and extremes (*). Significant differences between nonsurvivors and shock-
survivors (†), between shock-survivors and sepsis-survivors (#) and between nonsurvivors and 
sepsis-survivors (‡). 
 
Non-dopamine-treated group 
Clinical parameters 
The main study group (non-dopamine-treated) consisted of 30 boys and 15 girls. 
Children were divided according to the presence of shock and survival into the 
following disease severity groups: nonsurvivors (n=8), shock-survivors (n=30), and 
sepsis-survivors (n=7). Concomitant therapy before study enrollment included 
antibiotics and administration of fluids in all children, inotropics, not dopamine, in 36 
‡ 
† # † P = 0.051 
† 
‡ 
# 
A B
C D
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children with septic shock and in one child with sepsis, and glucocorticoids in seven 
children with septic shock. Twenty-three children with septic shock were 
mechanically ventilated and sedated with benzodiazepines. 
Nonsurvivors were significantly younger than survivors and had significantly 
shorter time from first petechia to admission than shock-survivors (Table 1). 
Parameters of disease severity were significantly higher in nonsurvivors compared 
with shock-survivors and sepsis-survivors for PRISM and SOFA scores, plasma IL-6, 
and arterial lactate, whereas CRP was significantly lower in nonsurvivors compared 
with shock-survivors. IL-6 levels correlated strongly with PRISM score (r=0.80; 
P<0.001), and CRP levels correlated strongly with time from first petechia to 
admission (r=0.52; P<0.001). 
 
Table 2. Thyroid hormone levels and SD-scores of the main, non-dopamine-treated study group on 
admission, divided in nonsurvivors, shock-survivors and sepsis-survivors.  
Variables  Nonsurvivors 
(n=8) 
Shock-survivors 
(n=30) 
Sepsis-survivors 
(n=7) 
TT4 (nmol/L) 38 (25 – 46) a, b 56 (49 – 73) a, c 86 (68 – 92) b, c 
Free TT4 (pmol/L) 15 (13 – 21) 18 (15 – 20) 19  (14 – 20) 
T4S (pmol/L) 52 22 (18 – 31) 27 (19 – 43) 
TT3 (nmol/L) 0.49 (0.34 – 0.61) 0.40 (0.30 – 0.52) 0.45 (0.42 – 0.61) 
rT3 (nmol/L) 0.75 (0.55 – 1.21) b 1.40 (1.11 – 1.73) c 1.17 (1.00 – 1.28) 
TSH (mU/L) 0.88 (0.52 – 1.14) 0.84 (0.59 – 1.18) 0.80 (0.65 – 1.61) 
TT3/rT3 0.71 (0.33 – 0.80) b 0.30 (0.20 – 0.44) c 0.41 (0.36 – 0.58) 
TBG (mg/L) 9 (6 – 10) a, b 12 (10 – 15) a, c 18 (14 – 19) b, c 
TT4 SD-score –7.0 (–8.1 to –5.3) a, b –3.5 (–4.8 to –2.4) a, c –1.6 (–2.8 to –0.4) b, c 
 Free T4 SD-score –1.1 (–1.8 to 0.6) –0.3 (–1.2 to 0.3) –0.1 (–1.4 to 0.1) 
T4S SD-score –2.3 –9.2 (–12.7 to –4.7) –6.0 (–14.2 to 2.4) 
TT3 SD-score –3.9 (–4.3 to –3.7) –4.0 (–4.2 to –3.7) –3.7 (–4.0 to –3.4) 
rT3 SD-score 1.3 (0.0 to 3.5) a, b 4.3 (2.8 to 6.1) c 4.5 (4.1 to 5.6) c 
TSH SD-score –1.5 (–2.5 to –1.1) –1.6 (–2.2 to –1.0) –2.1 (–1.7 to –0.5) 
TT3/rT3 SD-score –4.5 (–7.9 to –4.0) b –7.7 (–13.2 to –5.9) c –7.3 (–11.7 to –6.4) 
TBG SD-score –5.2 (–6.8 to –3.3) a, b –2.9 (–4.4 to –2.3) a, c –1.8 (–2.0 to –1.0) b, c 
Values are expressed as median (25 to 75 percentile). a Significantly different compared to sepsis-
survivors, P < 0.05. b Significantly different compared to shock-survivors, P < 0.05. c Significantly 
different compared to nonsurvivors, P < 0.05. 
 
TT4, FT4, TT3, rT3 and TSH levels 
Compared with age-matched reference values, the vast majority of the children in 
the main, non-dopamine-treated study group had low serum TT4 levels (80%), 
normal FT4 levels (89%), low TT3 levels (100%), high rT3 levels (89%), and low 
TT3/rT3 ratios (100%), whereas none had elevated TSH levels. TT4 levels were 
lower with increasing disease severity; nonsurvivors had significantly lower TT4 
levels than survivors, and shock-survivors had significantly lower TT4 levels than 
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sepsis-survivors (Table 2), whereas FT4, TT3 and TSH levels did not significantly 
differ among the three groups. Median rT3 levels were significantly lower in 
nonsurvivors than in shock-survivors, whereas rT3 levels were significantly higher in 
shock-survivors than in sepsis survivors. As a result, the TT3/rT3 ratios were 
significantly higher in nonsurvivors compared with shock-survivors and tended to be 
lower in shock-survivors than in sepsis-survivors (P=0.057). 
Parameters of disease severity correlated negatively with TT4 levels, but not 
with FT4, TT3, rT3, or TSH levels or TT3/rT3 ratios (Table 3). Time from first 
petechia to admission correlated positively with rT3 levels and negatively with 
TT3/rT3 ratios. Serum cortisol levels correlated positively with TT4 levels, but not 
with FT4, TT3, rT3, or TSH levels or TT3/rT3 ratio, whereas age did not correlate 
with any thyroid parameter. 
T4S levels 
 On admission, serum T4S levels were measured in 34 non-dopamine-treated 
children (one nonsurvivor, 26 shock-survivors, and seven sepsis survivors). T4S 
levels were decreased in the majority of the children (88%) compared with 
age-matched reference values and did not significantly differ between 
shock-survivors and sepsis-survivors (Table 2). 
T4S levels correlated positively with time from first petechia to admission, but 
not with age or any parameter of disease severity (Table 3). Furthermore, T4S levels 
tended to correlate with rT3 levels (r=0.32; P=0.069), but not with other thyroid 
hormone values or ratios. 
TBG and albumin 
Serum TBG levels were decreased in 62% of the children, and serum albumin levels 
were decreased in 54% compared with age-matched reference values, whereas 
none of the children had elevated TBG or albumin levels. TBG levels were lower with 
increasing disease severity; nonsurvivors had significantly lower TBG levels than 
survivors, and shock-survivors had significantly lower TBG levels than 
sepsis-survivors (Figure 1), whereas albumin levels did not significantly differ among 
the three groups (Table 1). TT4/TBG ratios tended to be lower in nonsurvivors than 
in shock-survivors (P=0.051), but did not differ from sepsis-survivors (Figure 1). 
TT3/TBG ratios were significantly higher in nonsurvivors compared with 
shock-survivors and sepsis survivors, whereas rT3/TBG ratios were not significantly 
different in nonsurvivors compared with shock-survivors or sepsis survivors. 
TBG levels correlated negatively with elastase levels and parameters of 
disease severity, but not with age or time from first petechia to admission (Table 3). 
TT4/TBG ratios correlated positively with FT4 levels (r=0.46; P<0.001). 
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Elastase 
Plasma elastase levels were measured in shock-survivors and sepsis-survivors and 
were elevated in all (Table 1). Median elastase levels did not significantly differ 
between shock-survivors and sepsis survivors, but elastase levels correlated 
positively with parameters of disease severity, such as IL-6 levels (r=0.66; P<0.001) 
and SOFA score (r=0.44; P<0.021). Furthermore, elastase levels correlated 
negatively with TBG levels (Table 3). 
NEFA levels and NEFA/albumin molar ratios 
Serum NEFA levels were decreased in 5%, normal in 83%, and elevated in 13% of 
the children. NEFA levels were significantly lower in nonsurvivors than in survivors 
(Table 1). NEFA/albumin molar ratios ranged from 0.4–3.9 (median, 1.4) and were 
significantly lower in nonsurvivors compared with survivors. The NEFA/albumin 
molar ratios correlated positively with FT4 (r=0.50) and TT4/TBG (r=0.37; P<0.022) 
and negatively with TT3/rT3 ratios (r=–0.55; Table 3). 
Dopamine-treated group 
Next to the main study group, in which none of the children received dopamine, 24 
children with meningococcal septic shock received dopamine median, 3.7 h; (range, 
0.25–8.7 h) before sampling. The dopamine-treated group consisted of two 
nonsurvivors and 22 shock-survivors, but no sepsis survivors. Because all children of 
the dopamine-treated group experienced septic shock, we analyzed both the 
nonsurvivors and shock-survivors together, comparing the dopamine-treated group 
with the non-dopamine-treated group. The mortality rate did not significantly differ 
between the dopamine-treated and the non-dopamine-treated group (by Fisher’s 
exact test, P=0.29). The children with septic shock of the dopamine-treated group did 
not significantly differ in age (P=0.55), time from first petechia to admission (P=0.30), 
PRISM score (P=0.97), SOFA score (P=0.99), or lactate (P=0.32), IL-6 (P=0.56), or 
CRP levels (P=0.77) compared with children with septic shock of the non-dopamine- 
treated group. Median TSH levels were, however, significantly lower in the 
dopamine-treated children with septic shock than in the non-dopamine-treated group 
(0.65 vs. 0.84 mU/liter; P=0.025), and this applied also to the TSH/FT4 ratios (0.028 
vs. 0.056; P=0.005). However, median TT4 (56 vs. 52 nmol/liter; P=0.86), FT4 (16.9 
vs. 17.6 nmol/liter; P=0.87), TT3 (0.34 vs. 0.42 nmol/liter; P=0.10), rT3 (1.31 vs. 1.22 
nmol/liter; P=0.41), and TBG (11 vs. 10 mg/liter; P=0.58) levels did not significantly 
differ between the dopamine-treated children with septic shock and the 
non-dopamine-treated group. Furthermore, the duration of dopamine use before 
admission did not correlate with TSH levels (P=0.24), TSH/FT4 ratios (P=0.35), or 
any other thyroid parameter on admission. 
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Total study group 
Multivariate analysis 
We investigated the contribution of thyroid hormone values on mortality with logistic 
regression analysis on the total group of 69 children. The odds for mortality against 
survival increased by a factor 3.7 for every doubling of the TT3/rT3 ratio and by 1.4 
for every 10 nmol/liter lower TT4 level on admission. However, when admission 
values of IL-6 were added to the model, none of the thyroid hormone levels 
remained significantly related to mortality, and the odds for mortality against survival 
increased by a factor of 6 for every doubling of IL-6 levels. 
We investigated the simultaneous contribution of pathophysiologically 
important factors to thyroid hormone levels on admission with multiple regression 
analysis on the total group of 69 children. Using multiple regression analysis, we 
found TT4 levels to decrease by 33% for every 10 mg/liter lower TBG level and by 
4% for every halving of TSH levels. These two variables together explained 62% of 
the variation in TT4 levels, whereas TBG levels alone explained 58% of the TT4 
variation. None of the additional variables investigated in this analysis (age, gender, 
IL-6 and cortisol levels, and NEFA/albumin molar ratios) were significantly related to 
TT4 levels. The relation between TT4 levels with TBG and TSH levels was not 
affected by dopamine administration before admission (P=0.63). 
We found TT3/rT3 ratios to decrease by 5% for every additional hour between 
first petechia to admission and by 29% for every point increase in NEFA/albumin 
molar ratios (R2=0.26). None of the additional variables investigated in the multiple 
regression analysis (age, gender, and IL-6, cortisol, and TT4 levels) were 
significantly related to TT3/rT3 ratios. The relation between TT3/rT3 ratios with time 
from first petechia to admission and NEFA/albumin molar ratios was not significantly 
affected by dopamine administration before admission (P=0.19). 
We found T4S levels to increase by 38% for every 10 g/liter lower albumin 
level (R2=0.17). None of the additional variables investigated in the multiple 
regression analysis (age, gender, cortisol and FT4 levels, and time between first 
petechia and admission) were significantly related to T4S levels. The relation 
between T4S levels and albumin levels was not affected by dopamine administration 
before admission (P=0.31). 
We found TBG levels to decrease by 2.3 mg/liter for every doubling in 
elastase levels (R2=0.15). None of the additional variables investigated (age, gender, 
and time from first petechia to admission) was significantly related to TBG levels. 
The relation between TBG levels and elastase levels was not affected by dopamine 
use on admission (P=0.27). 
Finally, we found only dopamine use to be significantly related to TSH levels, 
explaining 10% of the variation in TSH levels. None of the additional variables 
investigated in the multiple regression analysis (age, gender, time from first petechia 
to admission, or IL-6, cortisol, and FT4 levels) was significantly related to TSH levels. 
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Figure 2. Peripheral thyroid hormone metabolism during normal homeostasis (A) and during critical 
illness (B). During critical illness deiodination is altered with reduced D1 activity (thin arrow) and 
increased D3 activity (thick arrow), which both result in increased rT3 levels at expense of TT3 levels 
(left side). Sulfated thyroid hormones, however, are exclusively deiodinated by D1 (right side) and 
reduced D1 levels will result in elevated levels of all sulfated thyroid hormones. Sulfation of thyroid 
hormones is indicated by dotted arrows.  
Discussion 
In this study all critically ill children with sepsis or septic shock had signs of euthyroid 
sick syndrome on PICU admission, depicted by low TT3 and TT4 levels and high rT3 
levels without compensatory elevated TSH levels. In the main, 
non-dopamine-treated study group, nonsurvivors appeared to lack time to develop 
full-blown euthyroid sick syndrome, resulting in paradoxically higher TT3/rT3 ratios in 
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nonsurvivors than in shock-survivors. In survivors, both T4S levels and TT3/rT3 
ratios were decreased, which suggests alterations in peripheral thyroid hormone 
metabolism with a profound induction of type 3 deiodinase (D3), rather than 
down-regulation of type 1 deiodinase (D1) in the initial phase of meningococcal 
sepsis (see below). Furthermore, lower TT4 levels were related to lower TBG levels, 
which may be due to increased degradation of TBG by elastase. In the 
dopamine-treated group, dopamine was found to only have a suppressive effect on 
pituitary TSH secretion, although apparently not long enough to suppress thyroid 
hormone levels at the time of PICU admission. In the total group, both higher 
TT3/rT3 ratios and lower TT4 levels were predictive for mortality, but their predictive 
value for mortality disappeared when IL-6 levels were entered in the model. 
The peripheral inactivation of circulating thyroid hormones plays an important 
role in the initial phase of critical illness (1, 3, 5). Increased levels of biologically 
inactive rT3 at the expense of decreased TT3 levels are a hallmark of the euthyroid 
sick syndrome, which are enacted by altered deiodination, the main pathway of 
peripheral thyroid hormone metabolism (4) (Figure 2). We found decreased TT3/rT3 
ratios in all children with meningococcal sepsis, suggesting altered deiodination. This 
is in agreement with studies in critically ill children and adults (11, 12, 20, 21). In 
contrast, however, we found significantly higher TT3/rT3 ratios in nonsurvivors than 
in shock-survivors. A possible explanation for this might be the more fulminant 
course of disease in nonsurvivors, represented by a shorter time between the 
appearance of first petechia and admission in those children. The appearance of 
petechiae is considered to be the first clearly detectable clinical sign of 
meningococcal sepsis. Because the TT3/rT3 ratios were significantly inversely 
related to time from appearance of first petechia to admission, this might suggest 
that the peripheral thyroid hormone metabolism in nonsurvivors lacked the time to 
develop the full-blown euthyroid sick syndrome before PICU admission. Similarly, the 
acute phase protein CRP, which is known to be induced within 6–8 h, correlated 
inversely with time from first petechia to admission as well, indicating that 
nonsurvivors had less time to produce CRP before admission than survivors. We 
cannot, however, rule out the possibility that nonsurvivors could not sufficiently adapt 
to conditions of acute critical illness. 
Increased levels of cytokines (22–24) and glucocorticoids (3, 25), from either 
endogenous or exogenous sources, are both indicated as potential mediators in the 
alterations of thyroid function that occur in critical illness. In our study, major 
differences were seen in IL-6 levels, one of the key cytokines in the inflammatory 
response, between the disease severity groups. IL-6 levels were extremely high in 
nonsurvivors and much higher than in survivors, which is in agreement with studies 
in children (26) and adults (27) with life-threatening infections. Our study, however, 
does not support the postulation that cytokines, such as IL-6, are the potential 
mediators for altered peripheral deiodination during acute critical illness, because no 
significant relations were found between IL-6 and TT3 and rT3 levels or TT3/rT3 
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ratios. An explanation for this can be found in the different cortisol response in 
children during septic shock vs. adults. Although cortisol levels in critically ill adults 
are positively correlated with disease severity and outcome (20), in children with 
meningococcal sepsis, the opposite is true (15, 26, 28). 
Next to deiodination, sulfation is another pathway of peripheral thyroid 
hormone metabolism, leading to the metabolites T4S, T3S, and rT3S (29). Data on 
thyroid hormone sulfation during critical illness are very scarce (6, 30). To our 
knowledge, we are the first to report T4S levels in the euthyroid sick syndrome. 
Contrary to our expectations, T4S levels were decreased in the vast majority of 
children with meningococcal sepsis compared with healthy age-matched children. 
Unpublished observations by H. van Toor and T. J. Visser revealed increased T4S 
levels in adults with the euthyroid sick syndrome. Recently, Peeters et al. (4) showed 
that the increased rT3 levels at the expense of TT3 levels in critical illness are not 
only due to down-regulation of D1, but also to induction of D3 (Figure 2). Because 
iodothyronine sulfates are exclusively and rapidly deiodinated by D1 (31), the 
combination of elevated rT3 levels with low T4S levels might be more suggestive of 
a profound induction of D3 rather than down-regulation of D1 in the initial phase of 
meningococcal sepsis. Decreased sulfation of TT4 or increased T4S uptake in 
tissues, however, cannot be excluded, although the latter is less likely, because 
tissue uptake of thyroid hormones in critically illness is generally decreased (2). 
Because TT4, TT3, and rT3 are mainly bound to carrier proteins, differences 
in these hormone levels might also be based on decreased concentrations of or less 
binding to serum carrier proteins, such as TBG and albumin. Changes in serum 
levels of TBG, the most important carrier protein (32), explained 58% of the variation 
in TT4 levels, whereas increasing disease severity was correlated with both lower 
TBG and TT4 levels. Elastase levels were elevated and related positively to disease 
severity and inversely to serum TBG levels. This suggests that with increasing 
disease severity, TBG was increasingly cleaved by elastase, a serine protease that 
is released by activated neutrophils (33), resulting in lower TBG levels. Dilution and 
capillary leakage might be alternative processes resulting in lower TBG levels. 
Another, but less important, carrier protein for TT4, TT3, and rT3 is albumin. 
Although albumin levels were decreased in half the children, it is unlikely that 
albumin levels contributed to the changes in TT4, TT3, and rT3, because albumin 
levels did not significantly differ between the groups, whereas TT4, TT3, and rT3 
levels did. 
Besides decreased levels of binding proteins, less binding of thyroid 
hormones to their binding proteins by circulating inhibitors, such as NEFA, has been 
reported in the euthyroid sick syndrome (34). It has been reported that increased 
NEFA levels compete directly with TT4 for binding to TBG, especially when 
NEFA/albumin molar ratios exceed 5 (2, 35). Although the NEFA/albumin molar 
ratios in all of our patients were less than 5, they ranged widely from 0.4–3.9. 
Because the NEFA/albumin molar ratios were more strongly positively related to FT4 
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than to TT4/TBG levels, it cannot be ruled out that NEFA, even at relatively low 
NEFA/albumin molar ratios, might also be involved in the displacement of thyroid 
hormones from TBG. Furthermore, we found a significant inverse relation between 
NEFA/albumin molar ratios and TT3/rT3 ratios, suggesting that NEFA-induced 
displacement of thyroid hormones from their plasma binding proteins in addition to 
declined TBG levels might accelerate the inactivation of thyroid hormones in the 
euthyroid sick syndrome. Because nonsurvivors had significantly lower NEFA levels 
compared with survivors, this might also have contributed to the less decreased 
TT3/rT3 ratios in nonsurvivors. 
Finally, in an additional group of children with meningococcal septic shock 
who received dopamine, we found significantly lower TSH levels and TSH/FT4 ratios 
than in those who did not receive dopamine, whereas other thyroid hormone levels 
did not significantly differ. The suppressive effect of dopamine infusion on the 
pituitary gland has been previously described in critically ill children and adults (9, 
10). Dopamine directly inhibits anterior pituitary function through inhibitory dopamine 
receptors, resulting in diminished TSH release (36, 37). In children recovering from 
cardiac surgery, cessation of dopamine therapy resulted in an abrupt rise in TSH 
levels, followed by increases in TT4 and TT3 levels and in the TT3/rT3 ratio 24 h 
thereafter (9). Although our study was not designed to investigate the effects of 
dopamine, we found evidence for a suppressive effect on TSH levels, but not on TT4 
or TT3 levels in critically ill children on PICU admission. An explanation for this might 
be the relatively short duration of dopamine administration at the time of sampling 
(median, 3.7 h) compared with the previously published data on dopamine 
administration of at least 21 h (9, 10). 
In conclusion, our study shows that all critically ill children with sepsis or septic 
shock have signs of euthyroid sick syndrome on PICU admission. Alterations in 
peripheral deiodination were related to duration of illness and seemed to be enacted 
by a profound induction of D3 rather than down-regulation of D1. Low TT4 levels 
were related to increased cleavage of TBG by elastase. Dopamine-treated children 
showed only a reduction of TSH levels and no difference in other thyroid hormone 
levels compared with the non-dopamine-treated children at the time of PICU 
admission. Values of TT3/rT3 and TT4 were predictive for outcome, but this 
disappeared when IL-6 was entered in the model. 
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Abstract 
Objective: To investigate the time course of thyroid function, factors that affect it, 
and its relationship to outcome in children surviving meningococcal septic shock. 
Design and setting: Observational cohort study in a university-affiliated pediatric 
intensive care unit (PICU). Patients and participants: We divided the 44 children 
admitted to the PICU who survived meningococcal septic shock into those with 
short-stay (<7 days, n=33) or long-stay (≥7 days, n=11). Measurements and 
results: Serum thyroid hormone concentrations were determined on PICU 
admission and after 24 and 48 h. The Pediatric Risk of Mortality score and selected 
laboratory parameters were used to assess disease severity. On admission all 
children showed signs of euthyroid sick syndrome: low total triiodothyronine (TT3) 
and high reverse triiodothyronine (rT3) without compensatory elevated thyrotropin 
(TSH). Admission rT3 levels and the TT3/rT3 ratio were correlated with C-reactive 
protein levels and with time from first petechia to admission. Short-stay children only 
had higher TT3 and lower interleukin 6 levels at admission than long-stay children; 
after 48 h they showed higher total thyroxin, free thyroxin, TT3, and TSH and lower 
rT3 than long-stay children. All changes in thyroid parameters within the first 24 h 
were related to length of PICU stay. In children receiving dopamine TSH levels and 
TT3/rT3 ratios remained unchanged, whereas both values increased in those who 
did not receive dopamine or in whom dopamine was discontinued. Conclusions: All 
children surviving meningococcal septic shock showed signs of euthyroid sick 
syndrome on admission. Thyroid hormone level changes in the first 24 h were 
prognostic for length of PICU stay. 
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Introduction 
Septic shock with purpura is a life threatening critical illness in adults and children. 
We have previously shown that critical illness leads to thyroid function changes of 
the sort called the euthyroid sick syndrome, characterized by reduced total 
triiodothyronine (TT3) and elevated reverse triiodothyronine (rT3) levels without 
compensatory elevation in thyrotropin (TSH) levels. These changes are less 
pronounced in children who die than in those who survive (1, 2). 
Thyroid hormones play an important role in the protein catabolism and the 
lack of capacity to synthesize proteins hinders the restoring from muscle wasting and 
thereby preventing the body from recovery (3). In adults thyroid hormones have been 
found to be an interesting parameter for evaluating disease severity and predict 
outcome (4). Furthermore, the magnitude of the TT3 decrease within 24 h reflects 
the severity of illness (4, 5). The sickest patients show the greatest abnormalities in 
thyroid hormone levels, while patients with complications show more prolonged 
depression and delayed recovery (6). In addition to disease severity, medication 
such as dopamine is known to depress thyroid axis as well (7–10). Studies in 
children have shown that thyroid function is depressed in critically ill children on 
admission, but prediction of mortality differs between reports. We previously reported 
higher total thyroxin (TT4) and TT3 levels in children dying from meningococcal 
septic shock (1, 2); some have found lower TT4 (11) and TT3 (12) levels to be 
related to mortality while others found no relationship between thyroid hormones and 
mortality (13, 14). Little is known at present about the course of thyroid function 
during pediatric intensive care unit (PICU) stay in relation to length of PICU stay. 
The aim of our study was to evaluate thyroid function in children who survive 
septic shock with purpura in relation to length of PICU stay and to investigate factors 
influencing thyroid function. 
Materials and methods 
This observational cohort study was conducted between 1997 and 2002 at the 
Erasmus Medical Center – Sophia Children’s Hospital, in Rotterdam. Part of the 
study from 1997 to 2001 consisted of a randomized, placebo-controlled dose-finding 
study of protein C concentrate (Ceproxin, provided by Baxter, Vienna, Austria) in the 
treatment of pediatric septic shock patients with petechiae and/or purpura (15). 
Patients 
A total of 54 children aged between 1 month and 18 years and surviving septic shock 
with petechiae/purpura requiring intensive care treatment were enrolled in this study 
within 6 h after PICU admission. The group consisted of children primarily admitted 
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or referred to our PICU. Ten children died after a median PICU stay of 12 h (range 
8–42), and 44 survived and remained in the PICU for a median of 4.0 days (range 
1.5–44.7 days; 27 boys, 17 girls; median age 4.9 years, range 0.1–16.1). Six 
children were discharged on day 2 and 11 on day 3. There were 33 children with a 
PICU stay shorter than 7 days (median 3.2) and 11 with a median stay of 7 days or 
longer (median 10.8); age and gender did not differ significantly between the groups 
(Table 1). 
Shock was defined as persistent hypotension or evidence of poor end-organ 
perfusion, defined as at least two of the following: unexplained metabolic acidosis, 
arterial hypoxia in patients without overt cardiopulmonary disease, acute renal failure 
or sudden deterioration in baseline mental status as described previously (1, 16). 
The Medical Ethics Committee of the Erasmus Medical Center approved the study 
protocol. Informed consent was obtained from the parents of all children. 
 
Table 1. Clinical and laboratory parameters on admission according to long and short PICU stay. 
 
 
Long-stay 
(n=11) 
Short-stay 
(n=33) 
P-value 
Age (year) a 2.5 (0.1 – 15.7) 5.0 (0.3 – 16.1) Ns 
Gender (male) (%) 6 (55%) 21 (64%) Ns 
Time between first petechia-admission (h) a 6.6 (3.0 – 12.8) 4.5 (0.0 – 22.9) Ns 
PRISM a 24 (12 – 46) 20 (9 – 35) Ns 
IL-6 (pg/ml) b 97075  
(41041 – 252893) 
13521 
(38 – 337951) 
0.019 
Lactate (mmol/l) b  4.4 (2.0 – 9.6) 3.3 (1.7 – 6.5) Ns 
CRP (mg/l) b 77 (20 – 161) 90 (18 – 326) Ns 
Results are depicted as median (range) (a) or as geometric mean (range) (b) and tested with Mann-
Whitney-U test. 
 
Clinical parameters 
The Pediatric Risk of Mortality (PRISM II) score was calculated on the basis of the 
most abnormal values of 14 physiological parameters during the first 6 h of 
admission. A higher score indicates a higher risk of mortality (17). We recorded the 
period between appearance of first petechia and PICU admission, respiratory and 
inotropic support, and the length of PICU stay. To access severity of disease we 
analyzed lactate, C-reactive protein (CRP), and interleukin 6 (IL-6) levels. A PICU 
dependency of less than 7 days was defined as a short stay and one of 7 days or 
longer as a long stay. 
Sample collection 
Arterial blood samples were collected on admission and after 24 and 48 h for 
determination of TT4, free thyroxin (fT4), TT3, rT3, TSH, CRP, lactate, and IL-6. 
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Blood was collected in glass tubes, centrifuged, and stored at –80 °C until assay 
determination of thyroid hormones and IL-6. All other laboratory parameters were 
determined immediately. The admission samples were taken prior to the 
administration of study medication. 
Hormonal assays 
Plasma concentrations of TT4, TT3 , and rT3 were measured by established radio 
immunoassay procedures, as described previously (18, 19). Serum TSH 
concentrations were measured by an ultrasensitive immunometric assay 
(AmerliteTSH-30; Ortho-Clinical Diagnostics, Strasbourg, France) or with the 
immunoradiometric DYNOtest TSH assay (Brahms Diagnostica, Berlin, Germany). 
The within-assay coefficient of variation (CV) of the Amerlite TSH assay was 4–8% 
and the between-assay CV 4–11%. The within–assay CV of the Brahms TSH assay 
was 2–5% and the between–assay CV 2–14%. Serum fT4 levels were measured by 
a direct, labeled antibody, competitive immunoassay technique (Amerlite MAB fT4 
Assay; Ortho-Clinical Diagnostics) or by Vitros ECi technology (Ortho-Clinical 
Diagnostics, Amersham, UK). The within-assay CV of the Amerlite fT4 assay was 4–
8% and the between- assay CV 4–9%. The within-assay CV of Vitros was 3–7% and 
the between-assay CV 5–10%. Adult reference values of our laboratory are 
presented in Fig. 1 and Table 2. 
Other laboratory assays 
Arterial lactate was measured on a blood gas analyzer (ABL 625, Radiometer 
Copenhagen, Denmark). Serum CRP was determined by an immunoturbidimetric 
assay (normal <2 mg/l) and examined on a 912 analyzer (Roche Molecular 
Biochemicals, Mannheim, Germany), with a within-assay CV of less than 2% and 
between–assay CV less than 10%. Plasma IL-6 levels were analyzed using 
enzyme-linked immunosorbent assay (Sanquin, Amsterdam, The Netherlands) with 
a detection limit of 5 pg/ml. 
Caloric intake 
The patients were fed enterally and/or parenterally according to a standard feeding 
protocol; on PICU admission glucose was administered intravenously at a rate of 4–
6 mg/kg per minute (glucose 5% or 10% solution). If enteral feeding could not be 
started on the second day, parenteral feeding was started. The initial daily dose of 
proteins and lipids was 1.0 g/kg (Aminovenös N-paed 10%, Fresenius, 
‘s-Hertogenbosch, The Netherlands; Intralipid 20%, Pharmacia & Upjohn, Woerden, 
The Netherlands). If clinically possible, enteral and/or parenteral nutrition was 
adjusted on days 3 and 4 to normal needs for healthy children. 
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Statistics 
Clinical parameters were expressed as medians and laboratory results as geometric 
means unless specified otherwise. Between–group comparisons were made using 
the Mann-Whitney U test for continuous data and c2 test for categorical data. 
Within-group comparisons were made using the Wilcoxon signed rank test. Graphs 
of the time course of thyroid hormone values were calculated using mixed-model 
analysis of variance on the two subsets of survivors based on duration of PICU stay, 
and data were logtransformed when necessary. Spearman’s correlation coefficient 
(r) was used to evaluate the relationship between different parameters. Multiple 
regression analysis was used to evaluate the relationship between length of PICU 
stay and various variables. All reported p values are two-tailed, and values less than 
0.05 are considered statistically significant. 
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Figure 1. Time course of thyroid hormones according to long and short PICU stay. Data shown are 
geometric means with standard errors. P-values shown in figures represent the difference between 
groups of the two profiles along time. Short-stay children (●) and long-stay (○) children. Within group 
difference between successive time point (a, p<0.05). Between group difference at time points (b, 
p<0.05). 
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Results 
Clinical parameters 
Of all the parameters for monitoring disease severity only IL-6 was significantly lower 
in the short-stay than the long-stay group (13,520 vs. 97,074 pg/ml, p=0.019); 
PRISM score, arterial lactate, and CRP did not differ significantly (Table 1). Cultures 
of blood confirmed Neisseria meningitidis in 31 children. Concomitant therapy during 
the study period included antibiotics (cefotaxim) and administration of fluids and 
inotropics in all 44 children; 20 children received dopamine prior to inclusion (15 
short-stay and 5 long-stay) and 3 thereafter (2 short-stay and 1 long-stay). Children 
receiving dopamine at any time during PICU admission did not differ significantly in 
age, time between first petechia and admission, PRISM score, IL-6, lactate, or CRP 
levels on admission, or duration of PICU stay. Twenty-seven children (9 long–stay 
and 18 short-stay) required mechanical ventilatory support and sedation with 
benzodiazepines and/or morphine. Twenty-four children were included in the protein 
C study and 20 in the sepsis-cohort study. Of the 24 children participating in the 
protein C study 19 received protein C in three different doses after admission; they 
were equally distributed between short and long-stay patients. Analysis of variance 
revealed no effect of protein C on any thyroid hormone level during the first 48 h. 
Thyroid parameters on admission 
On admission all children had lower TT3 levels and higher rT3 levels than 
age-matched reference values (data not shown) while all TSH levels remained within 
the normal range. TT4 levels were low in 50% of the children and within the normal 
range in the other 50%, while fT4 levels were normal in 50% and elevated in the 
other 50%. Low TT4 levels with concomitantly elevated fT4 levels occurred in 14% of 
the children. Only TT3 values were significantly higher in short-stay than in long-stay 
children (0.38 vs. 0.24 nmol/l, p=0.022; Fig. 1). On admission the rT3 level and 
TT3/rT3 ratio were significantly correlated with CRP levels (r=0.45 and r=–0.34, 
respectively). The TT3/rT3 ratio and CRP level were correlated with time from first 
petechia to admission (r=–0.30 and r=0.47, respectively; Fig. 2). No other thyroid 
hormone value was correlated with any parameter of disease severity. 
Length of PICU stay was correlated positively with parameters of disease 
severity on admission, such as IL-6 levels (r=0.72) and lactate levels (r=0.36), and 
negatively with TT4 (r=–0.37) and TT3 levels (r=–0.35). Changes (∆) in thyroid 
hormones from admission to 24 h are expressed as ratios (24 h/admission). Of these 
changes significant correlations with IL-6 levels on admission were found for: ∆TT4 
(r=–0.42), ∆fT4 (r=–0.40), ∆TT3 (r=–0.44), ∆rT3 (r=0.50), ∆TT3/rT3 (r=–0.49), and 
∆TSH (r=–0.41). Furthermore, changes in thyroid hormones were correlated with 
duration of PICU stay for: ∆TT4 (r=–0.49), ∆fT4 (r=–0.37), ∆TT3 (r=–0.54), ∆rT3 
(r=0.52), ∆TT3/rT3 (r=–0.60), and ∆TSH (r=–0.49). 
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Figure 2. Relation between TT3/rT3 ratio and time from first petechia to admission: 10Log (TT3/rT3) = 
0.040 – 0.724 x 10Log (Time first petechia - admission). 
 
Time course of thyroid hormones 
After 48 h short-stay children showed significantly higher TT4, fT4 , TT3 , TSH levels 
and TT3/rT3 ratio and lower rT3 levels than long-stay children. Short-stay children 
showed within 48 h an increase in TT3 and TSH levels and TT3/rT3 ratio and a 
decrease in rT3 levels; long-stay children showed a decrease in fT4 and rT3 after 24 
h and no change in TT4, TT3, TSH levels and an increase after 24 h in TT3/rT3 ratio. 
Children who were discharged from the PICU on day 2 or 3 still had elevated rT3 
levels, and all except one had still decreased TT3 levels on the day of discharge. 
Effect of dopamine 
Only TSH levels were significantly lower in children who received dopamine on 
admission than those who did not (0.4 vs. 0.7 mU/l, p=0.017). Multivariate analysis 
showed none of the following parameters to be significantly related to TSH levels on 
admission taking account of dopamine use prior to admission: age, gender, time 
between first petechia and admission, PRISM score, IL-6, lactate, and CRP levels. 
Thyroid hormone levels were available in 13 of 23 children receiving 
dopamine before and after dopamine withdrawal (Table 2). At a median of 14 h after 
dopamine withdrawal the levels of TSH (X4.5), TT3/rT3 ratio (X2.1), and TT3 (X1.6) 
were still significantly increased whereas the rT3 level (X0.7) were still significantly 
decreased. In these 13 patients the before vs. after changes in TT4 levels and 
TT3/rT3 ratio were positively correlated with duration of dopamine use (r=0.56 and 
r=0.69, respectively) and time from dopamine withdrawal to next sample (r=0.63 and 
r=0.60, respectively). Corresponding changes in other thyroid parameters were not 
correlated with either one of these parameters. Median duration of dopamine use 
was significantly shorter in short-stay patients than in long–stay patients (39 vs. 111, 
p<0.001). Analysis of variance showed, that patients with dopamine at 24 h after 
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admission had significantly lower levels of TSH after 24 h than those who stopped 
dopamine or who had never received dopamine before that time. Taking account of 
this effect, we found no difference in TSH levels between short-stay and long-stay 
children. Analysis for the effect of dopamine use on TSH levels at 48 h resulted in 
similar findings (Fig. 3).  
 
Table 2. Thyroid hormone levels prior to and after dopamine withdrawal. 
 Thyroid hormones Reference values Prior 
(n=13) 
After 
(n=13) 
P-value Ratio * 
(n=13) 
TT4 (nmol/l) 64 – 132 51 (29 – 89) 63 (25 – 131) 0.069 1.2 
FT4 (pmol/l) 11 – 25 13 (8 – 19) 17 (9 – 36) 0.087 1.3 
TT3 (nmol/l) 1.1 – 2.6 0.43 (0.18 - 1.03) 0.69 (0.10 – 1.80) 0.017 1.6 
rT3 (nmol/l) 0.15 – 0.43 1.39 (0.50 - 3.02) 1.03 (0.66 – 1.95) 0.006 0.7 
TT3/rT3 n.a. 0.32 (0.11 – 0.97) 0.67 (0.13 – 2.43) 0.002 2.1 
TSH (mU/l) < 4.5 0.5 (0.1 – 3.9) 2.2 (0.2 – 10.7) 0.011 4.5 
Geometric mean (range), Wilcoxon signed rank test and ratio of geometric mean (*). Not available 
(n.a.). 
 
Multivariate analysis 
Multiple regression analysis revealed that both IL-6 and TT4 levels on admission 
were major factors significantly related to length of PICU stay. These two variables 
together explained 50% of the variance in length of stay. The length of stay 
increased 15% for every doubling of IL-6 levels and 16% for every 10 nmol/l lower 
level of TT4 on admission. None of the other variables investigated (age, gender, 
time from first petechia, dopamine use) contributed significantly to the model. 
Multiple regression analysis with data available at admission and 24 h 
thereafter revealed the main factors predicting length of PICU stay to be PRISM 
score, admission level of TT4, change in TT4, and rT3 level within the first 24 h. 
These variables together explained 64% of the variance in length of PICU stay. The 
length of stay increased 35% for every 10 points higher PRISM score, 10% for every 
10 nmol/l lower level of TT4 on admission, 20% for every 10 nmol/l decrease in TT4 
levels within the first 24 h of admission, and 69% for every doubling of the change in 
rT3 levels within the first 24 h of admission. None of the other variables investigated 
(age, gender, dopamine use and changes in fT4, TT3 and TSH within the first 24 h) 
contributed significantly to the model. In contrast, multiple regression analysis of 
clinical parameters alone (age, gender, time from first petechia, dopamine use, IL-6 
levels, PRISM score) revealed only IL-6 levels to be significantly related to length of 
PICU stay, explaining 39% of the variance in length of PICU stay. 
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Figure 3. TSH levels and TT3/rT3 ratios according to patients’ actual dopamine use at the various 
time points. Children without dopamine (□), with dopamine (○) and after dopamine withdrawal (∆). 
Data shown are geometric means with standard errors. Between group differences were calculated 
with Student’s T-Test. Numbers alongside data-points indicate numbers of patients. (a) between 
group differences of (○) with (□) and (∆), P <0.05. (b) between group differences of (○) with (∆), P 
<0.05. 
Discussion 
In this study all patients surviving from meningococcal septic shock showed features 
of the euthyroid sick syndrome, defined as decreased levels of TT3 and TT4, 
increased levels of rT3 and without compensatory increased levels of TSH. On 
admission short-stay children only had higher TT3 and lower IL-6 levels than 
long-stay children, while 48 h thereafter short-stay children showed higher TT4, fT4 , 
TT3 , and TSH levels, lower rT3 levels, and higher TT3/rT3 ratios than long-stay 
children. Parameters of disease severity, thyroid hormone levels on admission, and 
the changes over the first 24 h strongly predicted length of PICU stay. Dopamine 
was found to have an important effect on the course of thyroid levels. 
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On admission TT3 and IL-6 levels were the only laboratory parameters that 
differed significantly between short and long-stay children. Median IL-6 levels were 
more than four time lower in short-stay than long-stay children. IL-6 levels were not 
correlated with TT3 levels or other thyroid hormones on admission, in all patients 
and those with and without dopamine, which may indicate that thyroid function is not 
affected primarily by the initial response of the cytokine cascade due to infection. 
This finding is in accordance with a study in adults undergoing abdominal surgery 
(20), but in contrast to some studies of less sick children with respiratory infection 
(mean IL-6 levels 16.7 pg/ml) or after open-heart surgery (mean IL-6 levels 124.4 
pg/ml) and healthy humans (21–23). 
Interestingly, rT3 levels and TT3/rT3 ratio were correlated significantly with 
CRP levels on admission and with time from first petechia to admission. As 
previously reported, CRP level on admission reflects the duration of illness (24, 25). 
This may indicate that the initial changes in thyroid function on admission were 
affected by the duration of illness prior to admission. 
Previous studies in adult patients have shown that the magnitude of the TT3 
decline within the first 24 h of admission reflects severity of illness (4, 5). We found 
that duration of PICU stay was related to changes in all thyroid hormone levels and 
to the TT3/rT3 ratio within the first 24 h. Moreover 64% of variance in the length of 
PICU stay was explained by TT4 levels on admission, changes in TT4, and rT3 
levels within 24 h and PRISM score, while clinical parameters alone explained 39% 
of the variation. Measurement of thyroid hormones and changes within 24 h may 
therefore be a useful tool to predict length of PICU stay and thus to identify those 
children at risk for a long stay at the PICU. 
Short-stay children showed significantly better thyroid function 48 h after 
admission than long-stay children, as revealed by increased TT3 and TSH levels and 
TT3/rT3 ratio and decreased rT3 levels. However, all but one of the children who 
were discharged from the PICU within 3 days after admission still had elevated rT3 
and decreased TT3 levels and thus euthyroid sick syndrome despite early clinical 
improvement. 
The suppressive effects of dopamine infusion on the pituitary gland have been 
reported in infants and children (8). During dopamine infusion receptors in the 
pituitary gland are highly stimulated, thereby inhibiting TSH release. In contrast, 
cessation of dopamine therapy results in an abrupt rise in TSH levels. Although our 
study was not designed to investigate the suppressive effects of dopamine, we also 
found evidence of this suppressive effect of dopamine in these critically ill children 
who were treated with dopamine. First, we found that in children treated with 
dopamine TSH levels and TT3/rT3 ratios did not significantly change during 
administration, whereas those who did not receive dopamine and those in whom 
dopamine was stopped within the first 48 h showed changes to normalization. 
Secondly, we found an increase of more than four times in TSH at a median of 14 h 
after dopamine withdrawal, which is in accordance with the findings of a study in 
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children after cardiac surgery which reported a ten times higher level of TSH 24 h 
after dopamine withdrawal (8). The duration of dopamine use has been reported to 
be related to thyroid function in adult patients (7), but we found no evidence of this 
relationship; this may have been due to the relatively short period of dopamine 
administration in children in comparison with critically ill adults. 
In conclusion, all children surviving meningococcal septic shock showed signs 
of euthyroid sick syndrome on admission. Changes in thyroid function on admission 
were affected by the duration of illness prior to admission. Changes in thyroid 
hormone levels over the first 24 h of admission, especially the TT3 decrease and rT3 
increase were prognostic of length of PICU stay. 
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Abstract 
Context and Objectives: To evaluated GH-IGF-I axis in meningococcal disease. 
Design: Observational cohort study. Setting: University-affiliated pediatric intensive 
care unit (PICU). Patients: Thirty-nine children with meningococcal sepsis or septic 
shock. Main outcome measures: Differences in GH-IGF-I axis between 
nonsurvivors (n=4), shock-survivors (n=29) and sepsis-survivors (n=6) on 
PICU-admission. Results: Most children showed elevated or normal GH levels with 
low levels of total IGF-I, total IGFBP-3 and ALS, which was most striking in 
nonsurvivors. Total GH correlated very strongly with bioactive GH levels (r=0.94). 
GHBP levels were within the normal range in the majority of children and related 
positively to total IGF-I (r=0.55), IGFBP-3 (r=0.70) and ALS (r=0.71) levels. Most 
children showed decreased intact/total IGFBP-3 ratio. Surprisingly, this ratio was 
higher with increasing disease severity. IGFBP-1 levels increased with increasing 
disease severity and correlated inversely with free IGF-I levels (r=–0.59). Using 
multiple regression analysis, mean-GH levels increased with higher IL-6 levels and 
younger age and decreased with dopamine use. Conclusions: Most children with 
meningococcal sepsis or septic shock had elevated or normal GH and low IGF-I, 
IGFBP-3 levels, indicating a GH resistance state. Serum bioactive GH tightly 
paralleled total GH levels. GHBP levels were normal and related positively with 
IGF-I, IGFBP-3 and ALS levels. In combination with elevated cytokine levels, which 
are known to induce the intracellular negative feedback loop of the suppressors of 
cytokine signaling (SOCS), this might suggest reduced post-GH-receptor (GHR) 
signaling rather than a decreased GHR function to play a role in this GH resistance 
state.  
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Introduction 
Meningococcal septic shock is a life threatening critical illness in children and 
characterized by a sudden onset and rapid progression of disease. Despite 
advances in management and therapy, the mortality rate of children with shock due 
to meningococcal disease continues to be considerable (1). Critical illness leads to a 
biphasic spectrum of neuroendocrine and metabolic changes with substantial 
differences in the acute and chronic phase (2). Studies on the acute phase of critical 
illness in adults show sustained to enhanced GH secretion, but low levels of 
IGFBP-3 and ALS (3). These changes are generally interpreted as GH resistance 
and are presumed to be adaptive, as they promote the accessibility of metabolic 
substrates for vital organs and postpone anabolism. In a previous pilot study in a 
small group of children with meningococcal septic shock, we encountered very high 
levels of GH in nonsurvivors with concomitantly decreased IGF-I and IGFBP-3 
levels, suggesting GH resistance (4). However, the bioactivity of GH, and the serum 
levels of GH binding protein (GHBP) and IGF related components, such as 
acid-labile subunit (ALS), were not investigated. A better understanding of the 
hormonal response in critically ill children is essential for proper clinical management 
of these children. Hence, in this present study we thoroughly evaluated the GH/IGF-I 
axis in a large group of children suffering from meningococcal sepsis or septic shock.  
Materials and Methods 
Patients 
Seventy-one previously healthy children were admitted to the PICU of Erasmus MC 
– Sophia Children’s Hospital, with a clinical diagnosis of meningococcal sepsis, 
defined as sepsis with petechiae/purpura. Sepsis was defined as temperature of 
<36.0 ºC or >38.5 ºC with tachycardia and tachypneu. In addition, children were 
assigned to have septic shock, if they also had persistent hypotension, or evidence 
of poor end-organ perfusion, as previously described (4). The lack of research staff 
to ensure adequate 24 hours stand-by service for inclusion of children and 
processing of the samples, necessitated two study periods: between October 1997 
and October 1999 and between October 2001 to April 2004. GH profiles could be 
obtained in 39 of the 71 children on admission. Children in whom a GH profile was 
performed did not significantly differ in age, time from first petechia to admission or 
disease severity parameters – such as PRISM, SOFA, IL-6 and lactate levels – from 
those without GH profile (data not shown). Twelve of the 39 children participated in a 
randomized, double-blinded, placebo-controlled study. In this study children received 
either placebo or one of three dosages of protein C concentrate every 6 hours for the 
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first three days of admission followed every 12 hours with a maximum of 7 days (5). 
Pilot data on GH-profiles of these 12 children have been published previously (4). 
The other 27 children participated in an observational cohort study. The medical 
ethics committee of the Erasmus MC approved the study and written informed 
consent was obtained from parents or legal representatives.  
Clinical parameters 
Severity of illness was assessed by the Pediatric Risk of Mortality score II (PRISM) 
score (6), Sepsis-related Organ Failure Assessment (SOFA) (7) and by measuring 
levels of established biomarkers, such as plasma interleukin-6 (IL-6), arterial lactate, 
and serum C-reactive protein (CRP). The interval between appearance of first 
petechia and PICU-admission, respiratory support, medication and outcome were 
recorded.  
Caloric intake 
The patients were fed according to a standard feeding protocol; on admission at the 
PICU glucose was started intravenously at a rate of 4–6 mg/kg/min (glucose 5 or 
10% solution). Enteral and/or parenteral nutrition was started on the second day, if 
clinically possible, and adjusted to the normal needs for healthy children on days 3 
and 4. 
Sample collection 
Arterial blood samples were obtained as soon as possible after admission and 
subsequently  6-h GH-profiles, with samples taken every 30 min, were obtained. 
Serum and EDTA-plasma were stored at –80°C until determination of GH, IGF-I and 
related components and cytokines. All other laboratory parameters were determined 
immediately.  
Assays 
Serum GH levels were determined with an immunoradiometric assay (CIS-Bio 
International, Gif-sur-Yvette, France) or Immulite 2000 (Diagnostic Products 
Corporation, LA, CA, USA). Plasma total IGF-I levels were determined with an 
immunometric technique on an Advantage Chemiluminescense System (Nichols 
Institute Diagnostics, San Juan Capistrano, USA). Plasma IGFBP-1 and IGFBP-3 
levels were determined with specific RIAs (Utrecht Medical Center, Utrecht, The 
Netherlands) (8, 9). Serum ALS, growth hormone binding protein (GHBP), and 
bioactive (immunofunctional) GH levels were determined with specific ELISAs 
(Diagnostic System Laboratories (DSL), Webster, TX, USA) and dissociable free 
IGF-I with IRMA (DSL). Gender- and age-specific reference values (SD-scores or 
SDS) were available for total IGF-I, IGFBP-3, ALS and free IGF-I (9, 10). SD-scores 
between –2 and +2 were considered normal. Gender and age-specific reference 
values for GHBP were provided by DSL.  
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Levels of intact IGFBP-3, capable of binding [125I] radiolabeled IGF-I, were 
obtained with a ligand immunofunctional assay (LIFA), as described previously (11). 
Intact IGFBP-3 levels were expressed as a proportion of the corresponding total 
(RIA) IGFBP-3 levels, both determined in the retentate of the plasma ultrafiltrates. 
IGFBP-3 contents of series of plasma samples from 5 randomly selected children 
were also investigated with Western immunoblotting (12), using a specific polyclonal 
antibody at a dilution of 1:5000. In all cases, the results confirmed the values of 
intact/total IGFBP-3 as determined previously with LIFA (data not shown). 
Serum insulin concentrations were determined with an immunoradiometric 
assay and serum cortisol concentrations with a competitive luminescence 
immunoassay (Immulite 2000, DPC) (13). Arterial lactate and glucose were 
determined on a blood gas analyzer (ABL 625, Radiometer Copenhagen, Denmark) 
and serum NEFA with a calorimetric assay (NEFA-C kit, WAKO Diagnostics) on a 
Hitachi 912 analyzer (Roche Diagnostics) in a certified clinical chemistry laboratory 
(ISO 17025 and 9001). The reference values were <2.0 mmol/L for lactate, 0.2–1.2 
mmol/L for NEFA, 2.6-11.0 mmol/L for glucose (fasted) and <180 pmol/L for insulin 
(fasted). Plasma IL-6 levels were analyzed with an enzyme-linked immunosorbent 
assay (Sanquin, Amsterdam, the Netherlands). 
Analysis of GH-profiles 
GH profiles were analyzed using the PULSAR program, of which areas under the 
curve above zero (AUC0) and mean-GH levels were derived. The AUC0 were divided 
by 2 to rescale time and was similar when calculated by the trapezoidal method. 
Mean-GH levels were expressed as SD-scores, using gender- and Tanner 
stage-specific reference values (14). SD-scores between –2 and +2 were considered 
normal. 
Statistics 
Data were analyzed with SPSS 11.5. Results were expressed as medians unless 
specified otherwise. We used Mann-Whitney U, chi-square or Fisher’s exact test, 
when necessary, and Spearman’s correlation coefficient (r). Data were 
log-transformed for multiple linear regression analysis when necessary. Two-tailed 
P-values <0.05 were considered statistically significant. 
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Figure 1. Mean-GH, GHBP, total and free IGF-I, IGFBP-3 and ALS SD-scores on admission. 
Nonsurvivors are depicted in the left box, shock-survivors in the middle box and sepsis-survivors in 
the right box. Box-plots indicate 25 to 75 percentile with the median and whiskers the range without 
outliers (○) and extremes (*). Normal values are between the dotted lines. Significant (P<0.05) 
differences are depicted with gray angle brackets. 
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Results 
Clinical parameters on admission 
The study group consisted of 39 children (22 boys). All children showed a clinical 
picture of meningococcal sepsis and blood cultures revealed Neisseria meningitidis 
in 35 of them. Children were divided according to presence of shock and survival into 
the following disease severity groups: (shock) nonsurvivors (n=4), shock-survivors 
(n=29) and sepsis-survivors (n=6). Concomitant therapy during the whole study 
period included antibiotics and administration of fluids in all children, administration 
of inotropics in children with septic shock and in one child with sepsis; and 
glucocorticoids in 5 children with septic shock (Table 1). Twenty-five children with 
septic shock required mechanical ventilatory support and sedation with 
benzodiazepines. Nonsurvivors were significantly younger and had significantly 
higher PRISM and SOFA scores, IL-6 and arterial lactate levels than survivors. Both 
nonsurvivors and shock-survivors had significantly lower cortisol levels than 
sepsis-survivors. Nonsurvivors died after median 13 h (range, 8 – 25 h). 
Shock-survivors had median PICU stay of 4.5 days (range, 1.1 – 14.7) and 
sepsis-survivors of 1.1 days (range, 0.5 – 2.3).  
 
Table 1. Patients’ characteristics on admission, divided in nonsurvivors, shock-survivors and 
sepsis-survivors. 
 Nonsurvivors 
(n=4) 
Shock-survivors 
(n=29) 
Sepsis-survivors 
(n=6) 
Age (y) 1.1 (0.5 – 2.0) a 4.1 (0.3 – 15.7) 5.4 (2.3 – 12.2) 
Male gender (%)  4 (100) 15 (52) 3 (50) 
Time * (h) 6.9 (2.4 – 10.5) 7.4 (4.0 – 26.5) 6.8 (4.9 – 15.7) 
PRISM score 32 (25 – 34) a 21 (9 - 46) b 9 (5 – 13) 
SOFA score 14 (13 – 19) a 9 (3  - 17) b 2 (0 - 6) 
Lactate (mmol/L) 5.5 (4.6 – 10.9) a 3.9 (1.1 – 9.6) b 2.1 (1.2 – 3.8) 
IL-6 (pg/mL) 1571923 a 
(68517 – 2934110) 
63233 b 
(205 – 362333) 
366 
(82 – 10494) 
CRP (mg/L) 28 (24 - 136) 74 (18 - 326) 80 (63 – 252) 
Cortisol (nmol/L) ‡ 810 (620 - 1050) b 1020 (138 - 2096) b 1313 (999 - 2200) 
Inotropics (%) 4 (100) b 29 (100) b 1 (17) 
Dopamine (%) 0 (0) 10 (34) 0 (0) 
Glucocorticoids (%) 1 (25) 4 (14) 0 (0) 
Mechanical ventilation (%) 4 (100) b 21 (72) b 0 (0) 
Data are expressed as median (range) or numbers. Between group difference compared with (a) all 
survivors or (b) sepsis-survivors, P < 0.05. Time * (h) = time from 1st petechia to admission in hours. ‡ 
Cortisol levels excluding glucocorticoid treated children. 
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GH-profiles, bioactive GH and GHBP levels 
On admission, mean-GH levels were elevated in about one-half of the children 
(SDS>2; 51%), normal in 46% and decreased in one child. Nonsurvivors had 
significantly higher mean-GH levels, mean-GH SD-scores and AUC0 than survivors, 
whereas these parameters did not significantly differ between shock-survivors and 
sepsis-survivors (Table 2; Figure 1). Mean-GH levels correlated positively with IL-6 
levels and inversely with cortisol levels (Table 4). 
Concentrations of bioactive GH and GHBP were determined in each first 
sample of the GH-profiles of 33 children (1 nonsurvivor, 26 shock-survivors and 6 
sepsis-survivors). Bioactive GH and the ratio bioactive/total GH did not significantly 
differ between shock-survivors and sepsis-survivors (Table 2). The ratio 
bioactive/total GH was median 0.52 of the whole group. Bioactive GH levels showed 
a very strong correlation with total GH levels (r=0.94, p<0.0001) and were inversely 
related with cortisol levels (Table 4).   
In the vast majority of children (85%) GHBP levels were within the normal 
range. GHBP levels were decreased in 4 children and elevated in one child. Median 
GHBP levels and SD-scores did not significantly differ between shock-survivors and 
sepsis-survivors (Table 2; Figure 1). GHBP levels did not correlate with IL-6 levels, 
cortisol levels (Table 4), time from first petechia to admission and mean-GH or 
bioactive GH levels (data not shown). 
 
Table 2. GH-profiles, bioactive GH and GHBP of all children on admission, divided in nonsurvivors, 
shock-survivors and sepsis-survivors. 
 Nonsurvivors 
(n=4) 
Shock-survivors 
(n=29) 
Sepsis-survivors 
(n=6) 
AUC0 (mU/L) 776 (285 – 887) * 77 (32 – 115) 99 (68 – 195) 
Mean-GH (mU/L) 131 (48 – 148) * 13 (6 – 19) 16 (11 – 32) 
    Mean-GH SDS 5.7 (3.2 to 6.0) * 1.5 (–0.2 to 2.5) 1.9 (0.1 to 3.0) 
Bioactive GH (mU/L) 88 † 8 (4 – 17) 6 (5 – 11) 
Bioactive / total GH ratio 0.74 † 0.53 (0.46 – 0.61) 0.39 0.37 – 0.58) 
GHBP (pmol/L) 470 † 505 (413 – 593) 630 (380 – 1060) 
    GHBP SDS –0.3 † –0.9 (–1.4 to –0.1) 0.0 (–0.9 to 0.7) 
All values are expressed as median (25 to 75 percentile). For reference values see methods. * 
Significant difference between nonsurvivors and all survivors, P < 0.05. † Data of one nonsurvivor 
available. 
 
Total IGF-I, total IGFBP-3 and ALS levels 
On admission, total IGF-I SD-scores were less than -2 in 44% of the children and 
normal in the others (Table 3; Figure 1). Total IGFBP-3 and ALS SD-scores were 
decreased in the vast majority of children (92% and 86%, respectively) and normal in 
the others. Nonsurvivors had significantly lower levels of total IGF-I, total IGFBP-3 
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and ALS than either shock-survivors or sepsis-survivors, whereas these parameters 
did not significantly differ between shock-survivors and sepsis-survivors. When 
corrected for gender and age, nonsurvivors exhibited lower levels for total IGF-I 
(p=0.074), IGFBP-3 (p=0.003) and ALS (p=0.030) than survivors. 
Total IGF-I, total IGFBP-3 and ALS levels correlated positively with GHBP 
levels, but not with mean-GH or bioactive GH levels (Table 4). Total IGF-I levels 
correlated inversely with IL-6 levels, whereas total IGFBP-3 levels tended to do so 
(p=0.089) and ALS levels did not. Total IGF-I levels correlated strongly with total 
IGFBP-3 and ALS levels. 
 
Table 3. Growth factors, glucose, insulin and NEFA on admission, divided in nonsurvivors, 
shock-survivors and sepsis-survivors.  
 Nonsurvivors 
(n=4) 
Shock-survivors 
(n=29) 
Sepsis-survivors 
(n=6) 
Total IGF-I (nmol/L) 1.1 (0.4 – 2.9) a 5.8 (4.6 – 8.3) 5.8 (2.6 – 23.7) 
    Total IGF-I SDS -3.9 (-5.9 to –1.9) -2.2 (-2.8 to –1.2) -1.4 (-3.8 to –0.6) 
Free IGF-I (pmol/L) 3 (3 – 6) a 20 (7 – 41) 30 (13 – 144) 
    Free IGF-I SDS -8.7 (-10.6 to –5.8) a -1.4 (-4.7 to –0.5) -0.2 (-2.3 to 1.2) 
Free/total IGF-I (%) 0.28 (0.21 – 0.94) 0.25 (0.15 – 0.57) 0.54 (0.43 – 0.60) 
IGFBP-3 (nmol/L) 11 (9 – 12) a 20 (16 – 28) 26 (15 – 59) 
    IGFBP-3 SDS -7.5 (-8.7 to –6.7) a -4.9 (-5.6 to –3.2) -3.2 (-6.6 to –1.8) 
Intact/total IGFBP-3 ratio 0.7 (0.4 – 1.1) b 0.5 (0.2 – 0.7) b 0.1 (0.1 – 0.2) 
ALS (nmol/L) 19 and 28 * a 55 (35 – 82) 82 (38 – 193) 
    ALS SDS -2.6 and –2.4 * -2.9 (-4.4 to –2.5) -2.3 (-2.9 to –1.5) 
IGFBP-1 (nmol/L) 33.4 (10.2 – 47.6) a 5.1 (3.2 – 8.1) 2.3 (0.7 – 6.1) 
Glucose (mmol//L) 4.6 (1.6 – 10.8) 6.5 (5.5 – 10.1) 8.5 (7.6 – 11.4) 
Insulin (pmol/L) 29 (29 – 336) 104 (40 – 242) 81.6 (52 – 203) 
Insulin/Glucose (10E-6) 15 (6 –34) 15 (7 – 32) 10 (5 –19) 
NEFA (mmol/L) 0.23 (0.20 – 0.28) a 0.82 (0.47 – 1.30) 0.65 (0.53 – 0.70) 
All values are expressed as median (25 to 75 percentile). For reference values see methods. 
Between group difference compared with (a) all survivors or (b) sepsis-survivors, P < 0.05. * Data of 
two nonsurvivors available. 
 
Free IGF-I levels 
On admission, free IGF-I levels and SD-scores were significantly lower in 
nonsurvivors than in survivors (Table 3; Figure 1). In 3 nonsurvivors and 2 
shock-survivors free IGF-I levels were even under the detection limit. Free IGF-I 
levels correlated inversely with the IL-6, IGFBP-1 levels, intact/total IGFBP-3 ratios 
(r=–0.61, p<0.001), and positively with levels of IGF-I, IGFBP-3 and ALS (Table 4). 
Free IGF-I levels correlated also inversely with mean-GH and bioactive GH levels.  
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Intact IGFBP-3 levels 
Although, on admission, total IGFBP-3 levels tended to be lower with increasing 
disease severity, the intact/total IGFBP-3 ratio did not. This ratio was even higher in 
nonsurvivors and shock-survivors than in sepsis-survivors (Table 3). The intact/total 
IGFBP-3 ratio correlated positively with IL-6 levels (r=0.49), negatively with total 
IGF-I levels (r=–0.42) and ALS levels (r=–0.47). 
IGFBP-1 levels 
On admission IGFBP-1 levels were higher with increasing disease severity: IGFBP-1 
levels were significantly higher in nonsurvivors than shock-survivors and tended to 
be higher in shock-survivors than in sepsis-survivors (Table 3; p=0.053). The 
IGFBP-1 levels correlated significantly with IL-6 levels (r=0.48), but not with insulin, 
glucose or cortisol levels (Table 4).  
Glucose, insulin and NEFA levels 
On admission the majority of children had glucose (79%), insulin (68%) and NEFA 
(73%) levels within the normal range for (fasted) children. Glucose levels were 
decreased in 2 children (both nonsurvivors) and increased in 6 (1 nonsurvivor, 4 
shock-survivors, 1 sepsis-survivor). Glucose and insulin levels and their ratio did not 
significantly differ among the groups (Table 3). NEFA levels were decreased in 2 
children (1 nonsurvivor, 1 shock-survivor) and elevated in 8 (all shock-survivors). 
NEFA levels were significantly lower in nonsurvivors than in survivors.  
Multiple regression analysis  
With multiple regression analysis we investigated the influence of disease severity 
and various factors on mean-GH levels on admission. We found mean-GH levels to 
be significantly related to IL-6 levels, dopamine use and age, whereas free IGF-I 
levels and gender did not contribute to this model. Mean-GH levels increased with 
36% for every 10-fold increase of IL-6 levels and with 27% for every halving of age, 
whereas mean-GH-levels decreased with 66% when dopamine was administered 
(R2=0.401). As both IL-6 and cortisol levels correlated with mean-GH levels, we 
performed an additional model in which cortisol levels were added. In that model 
mean-GH levels increased with 55% for every halving of cortisol levels, whereas IL-6 
levels just lost significance (p=0.146). 
Using multiple regression analysis, we found total IGF-I levels to decrease 
with 21% for every halving of age, with 44% for every halving of time between first 
petechia and admission, and with 21% for every 100-pmol/L lower GHBP levels, 
together explaining 67% of the variation of total IGF-I levels. None of the additional 
variables investigated in this analysis (IL-6 levels, gender or steroid therapy) 
contributed significantly to this model.  
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Discussion 
In this study, we found in the majority of the acutely ill children with sepsis high or 
normal GH levels with low levels of total IGF-I, total IGFBP-3 and ALS on PICU 
admission, suggesting a GH resistance state. Nonsurvivors had extremely high GH 
profiles and the lowest growth factors, whereas the GH profiles and growth factors 
did not differ between shock-survivors and sepsis-survivors. Total GH correlated 
very strongly with bioactive GH levels. GHBP levels were within the normal range in 
the vast majority of children and correlated positively with IGF-I, IGFBP-3 and ALS 
levels, suggesting that the GHR was still functioning. Contrary to our expectations, 
the intact/total IGFBP-3 ratio increased with disease severity. IGFBP-1 levels 
increased with increasing disease severity and correlated inversely with free IGF-I 
levels, emphasizing its counter-regulatory role in critical illness.  
We found normal to extremely elevated GH values in the majority of children. 
This is in accordance with data of critically ill adults in whom GH values show a large 
variation in GH values (3, 15) and the scarce data in critically ill children (4, 16). Not 
only nonsurvivors but also some survivors showed extremely elevated GH levels, 
which is a new finding compared with previously reported data in children (4). One 
explanation for the elevated GH levels might be the extreme cytokine load in reaction 
to endotoxins, comparable with experimental in vivo studies reporting elevated GH 
levels after endotoxin challenge (17, 18). We found elevated IL-6 levels to be one of 
the major factors related to elevated GH levels, besides age and dopamine use, 
which were both inversely related to GH levels. In addition, an interesting finding was 
the relation between decreased cortisol and elevated GH levels. Both cortisol and 
GH exert direct substrate mobilizing actions, while in the acute phase of critical 
illness anabolism is postponed (3, 19). As cortisol levels decreased with increasing 
disease severity, which has been previously reported (13, 20, 21), the extremely 
elevated GH levels might have been an ultimate attempt of the body to provide 
essential substrates for survival. Furthermore, nutritional factors might have had their 
influence as well (3, 19), as all the children in our study were fasted on admission.  
Circulating GH consists of a mixture of molecular isoforms arising from both 
posttranscriptional and posttranslational modifications (22). GH bioactivity depends 
on many factors, including these isoforms and serum levels of GHBP. In our study, 
bioactive GH levels tightly paralleled total GH levels. As there was no relation 
between bioactive GH levels and GHBP levels, it suggests that for critically ill 
children GHBP does not play a major role in determining the bioactivity of serum GH. 
In addition, the median ratio of bioactive over total GH in our study did not differ from 
data in healthy volunteers (23).  
Despite elevated or normal GH levels in the majority of children we found low 
levels of total IGF-I, total IGFBP-3 and ALS, suggesting a GH resistant state. GH 
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resistance may be associated with reduced GHR density, the latter assumed to be 
reflected by reduced levels of GHBP, the circulating part of the GHR (24). On the 
basis of this assumption, one would assume GHR density to be normal in the vast 
majority of the critically ill children as their GHBP levels were within the normal 
range. This is in contrast to studies in adults after abdominal surgery, reporting 
decreased GHBP levels (25). However, GHBP levels may not invariably reflect GH 
receptor status during the acute phase of critical illness due to sepsis (26). Studies in 
animals report conflicting data on GHBP levels and hepatic GHR density: one study 
in rats reports hepatic GHR density to fall after endotoxins injection in the presence 
of normal serum GHBP levels (27), whereas another study reports normal hepatic 
GHR density in the presence of elevated GHBP levels (28). In fact, the regulation of 
GHBP serum concentrations is complex and various factors, such as increased 
proteolytic cleavage of the GH-receptor or alternative splicing may be involved (29). 
On the other hand, the GHBP levels were related strongly and positively with IGF-I, 
IGFBP-3 and ALS levels, suggesting that the hepatic GHR is still functioning. It might 
well be that the post-GHR signaling was disturbed, for instance by the intracellular 
negative feedback loop of the suppressors of cytokine signaling (SOCS). Members 
of the SOCS protein family are rapidly induced upon exposure to cytokines, GH, 
growth factors and fasting and play an important role in the cellular response to GH 
(30, 31). In our study all children were fasted and had elevated cytokine levels and 
extremely so in the most severely ill. The combination of normal to elevated GH and 
low IGF-I levels with normal GHBP levels and elevated cytokines and a fasting 
condition might therefore be suggestive for post-GHR signaling induced GH 
resistance, particularly in the liver (31, 32). 
Proteolyzed IGFBP-3 (30 kD) has been considered to have a reduced affinity 
for IGF-I. During critical illness increased IGFBP-3 protease activity has frequently 
been reported (4, 33, 34) and held responsible, at least partly, for the lowering of 
IGFBP-3 levels. As expected we found decreased intact/total (= intact / intact + 
proteolyzed) IGFBP-3 ratios in the majority of children, suggesting increased 
protease activity. Surprisingly, however, we found the highest intact/total IGFBP-3 
ratio in the most severely ill children with the lowest levels of total IGFBP-3, thus very 
low levels of proteolyzed IGFBG-3. Moreover, the intact/total IGFBP-3 ratio 
correlated strongly and positively with IL-6 levels and PRISM. As serum protease 
activity and neutrophil protease levels in the acute phase of critical illness are 
generally elevated (35), these results seem in contrast to in vitro data showing the 
protease activity of neutrophil proteases to increase within hours and at higher 
concentrations of proteases (36). One explanation for the relatively high intact/total 
IGFBP-3 ratio, i.e. relatively low level of proteolyzed IGFBP-3, might be increased 
turnover of proteolyzed IGFBP-3 in the most severely ill children with septic shock.  
We found IGFBP-1 levels to strongly correlate with parameters of disease 
severity, i.e. IL-6 levels, and found extremely high levels in nonsurvivors. This is in 
accordance with data in critically ill adults, in whom IGFBP-1 levels were predictive 
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for mortality (37, 38). In contrast to normal conditions (39), we could not find a 
relation between IGFBP-1 and insulin. The manifold metabolic alterations that occur 
during critical illness might have caused this. Hepatic production of IGFBP-1 is 
acutely regulated by metabolic stimuli, of which in particular hepatic substrate 
deprivation is stimulatory (38). IGFBP-1 has been suggested to fulfill a 
counter-regulatory role by binding free IGF-I in order to block the insulin like activity 
of free IGF-I, thereby preventing hypoglycemia, for which the brain is especially 
vulnerable (3). In our study, IGFBP-1 levels were inversely related to free IGF-I 
levels and nonsurvivors had extremely high IGFBP-1 levels and the lowest free IGF-I 
levels. As a consequence, glucose uptake into cells might have been further 
decreased in the already existing situation of minimal nutritional supply due to septic 
shock and fasting. Together with the low levels of alternative metabolic substrates, 
such as NEFAs, many cells might have been deprived from energy in a situation of 
very high metabolic demands.  
In summary, our study shows that the majority of children with meningococcal 
sepsis had normal or elevated GH levels with decreased total IGF-I levels 
suggesting a GH resistance state on PICU admission, which was most striking in 
nonsurvivors. GH levels increased with increasing IL-6 levels and decreased with 
age and dopamine use. The bioactivity of serum GH turned out to parallel total GH 
levels. Surprisingly, GHBP levels were within the normal range and related positively 
to total IGF-I, IGFBP-3 and ALS levels. In the presence of extremely elevated 
cytokine levels, this might suggest reduced post-GHR signaling rather than 
decreased GHR function. IGFBP-1 levels increased with increasing disease severity 
and correlated inversely with free IGF-I levels, emphasizing its counter-regulatory 
role in critical illness.  
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Abstract 
Objectives: To evaluate GH-IGF-I axis before and after paediatric cardiac surgery 
and to determine influencing factors. Design: Observational study. Patients: 
Forty-nine children undergoing cardiac surgery. Measurements: GH profiles after 
surgery and IGF-I, IGFBP-3 and IGFBP-1 levels before, at end of surgery, 12 and 24 
hours thereafter, in infants (n=19), young children (n=20) and teenagers (n=10). 
Results: At start of surgery, IGF-I and IGFBP-3 SD-scores were lower than 
reference values and related to low weight SD-scores and cyanosis. At end of 
surgery, mean-GH levels were elevated and related inversely to high-dose 
glucocorticoid and dopamine administration, but not to IL-6 levels. Glucose levels 
were higher in patients who received glucocorticoids than in those who did not. At 
end of surgery, IGF-I and IGFBP-3 SD-scores related to the percentage plasma 
administered during surgery, and not to IL-6 or GH levels. At start of surgery, 
IGFBP-1 related to insulin levels, but at end of surgery to IL-6 levels. Twenty-four 
hours after cardiac surgery, IGF-I, IGFBP-3 SD-scores and IGFBP-1 levels returned 
to the initial values at start of surgery. Conclusions: At start of surgery low IGF-I 
related to an underweight and low IGFBP-3 to cyanosis. Glucocorticoids and 
dopamine had a significant influence on GH and percentage plasma on IGF-I and 
IGFBP-3 levels, whereas IL-6 levels had no significant influence. Glucocorticoid 
administration during surgery was associated with higher glucose levels. Already the 
day after surgery, IGF-I, IGFBP-3 and IGFBP-1 levels had returned to the initial 
values at start of surgery. 
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Introduction 
Critical illness leads to a biphasic spectrum of neuroendocrine and metabolic 
changes with substantial differences in the acute and chronic phase (1). Studies in 
adults show, that in the acute phase of critical illness GH resistance characterizes 
the alterations in the GH/IGF-I axis: normal to enhanced GH secretion, but low levels 
of IGF-I and IGFBP-3 (1, 2). The changes in the acute phase of critical illness are 
presumed to be adaptive, as it provides metabolic substrates to vital organs and 
postpones anabolism. Despite many studies on GH-IGF-I function in critically ill 
adults, only very limited research has been performed in children. In a previous pilot 
study in a group of children with meningococcal septic shock, we encountered very 
high levels of GH in nonsurvivors with concomitantly decreased IGF-I and IGFBP-3 
levels, suggesting GH resistance (3). High levels of GH with low levels of IGF-I were 
also found in children after cardiac surgery, however, pulsatile GH assessments 
were lacking (4, 5). Understanding of the hormonal response in children with critical 
illness or undergoing cardiac surgery might be essential for the clinical management 
of these children. We therefore thoroughly evaluated the GH-IGF-I axis in a large 
group of paediatric patients at start and after open-heart surgery and assessed the 
influence of age, disease severity and medical interventions.  
Materials and Methods 
Patients 
The group consisted of 49 paediatric patients – aged 2 months to 18 years – with 
congenital heart disease who underwent open-heart surgery (cardiac surgery with 
cardiopulmonary bypass) in the Erasmus MC between October 2001 and April 2004. 
Paediatric patients were operated for left-right shunt (n=18), Tetralogy of Fallot 
(n=9), partial cavo-pulmonary connection (PCPC, n=4), total cavo-pulmonary 
connection (TCPC, n=2), left ventricle outflow tract obstruction (n=8), right ventricle 
outflow tract obstruction (n=3), mitral valve annuloplasty (n=2), anomalous left 
coronary artery from pulmonary artery together with aortopulmonary window (n=1) or 
combined correction of atrial septum defect and ventricular septum defect with 
tricuspid valve correction (n=1). Patients were not eligible for the study if they had 
endocrine or chromosomal abnormalities or received radiation or chemotherapy 
within the previous 6 months. The Medical Ethics Committee of the Erasmus MC 
approved the study and written informed consent was obtained from the parents or 
legal representatives of each child and of all children aged >12 years.  
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Anaesthesia, peri-operative management and caloric intake 
All paediatric patients underwent elective cardiac surgery upon cardiopulmonary 
bypass support (CPB) and 45 of them underwent cardioplegic arrest. General 
anaesthesia and peri-operative management was performed as described earlier (6). 
Most patients received mild hypothermia (median 31°C) and one (aged 16.6 years) 
received deep hypothermia (22.5°C) during cardiac surgery. Thirty-two patients 
received one bolus of glucocorticoids during cardiac surgery, most of them 
methylprednisolone (30 mg/kg), one patient dexamethasone (1 mg/kg) and one 
hydrocortisone (2 mg/kg). The administration of glucocorticoids was not a standard 
procedure and depended on the anaesthetist’s choice. We calculated equivalent 
doses methylprednisolone, expressed per body surface (mg/m2) and per body weight 
(mg/kg), using the glucocorticoid equivalent potencies 30 / 5 / 1 for dexamethasone, 
methylprednisolone and hydrocortisone, respectively (7). Twenty-nine patients 
received inotropic support, which was initiated during cardiac surgery and lasted for 
median 18h; 21 of them received dopamine, 7 received dobutamine and one 
received both. Patients were fasted before surgery and received glucose 
intravenously (4–6 mg/kg/min) after surgery. Enteral and/or parenteral nutrition was 
initiated at the first post-operative day if clinically possible.  
Clinical parameters 
Anthropometrical measurements were taken the day before cardiac surgery. Weight 
SD-scores were calculated using Dutch age- and gender-specific reference values 
(8, 9) (www.growthanalyser.com). Patients were assigned to have congestive heart 
failure according to the criteria of Van der Kuip et al. adjusted for age (10). To 
assess severity of illness, levels of established biomarkers were measured, such as 
plasma interleukin-6 (IL-6) and arterial lactate. The presence of cyanosis, duration of 
cardiopulmonary bypass (CPB), aorta cross clamp time (AOX), medication, fluid 
infusion and outcome were recorded. The percentage plasma of total volume 
(referred to as ‘percentage plasma’), including the volume of the CPB circuit, added 
to the circulation during surgery was calculated to assess the influence of exogenous 
plasma on circulating levels of IGF-I and IGFBPs.  
Sample collection 
Arterial blood samples were obtained at start of surgery, at the end of surgery (after 
sternal closure), 12 and 24 hours thereafter. Six-hour GH-profiles were obtained 
starting at the end of surgery, with samples taken every 30 min. Before patients were 
connected to the CPB machine, a sample was drawn from the CPB circuit to assess 
the concentrations of IGF-I and IGFBPs in the CPB circuit. Serum and plasma were 
stored at -80° C until assay of GH, IGF-I, IGFBP-3, IGFBP-1 and cytokines. All other 
laboratory parameters were determined immediately.  
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Assays and reference values 
Serum GH levels were determined on an Immulite 2000 (Diagnostic Products 
Corporation, L.A., CA, USA). GH profiles were analysed using the PULSAR program 
(11), of which areas under the curve above zero (AUC0) and mean-GH levels were 
derived. The AUC0 was divided by 2 to rescale time and was similar when calculated 
by the trapezoidal method. Mean-GH levels were expressed as SD-scores, using 
sex- and Tanner stage-specific reference values (12). Plasma IGF-I levels were 
determined with an immunometric technique on an Advantage Chemiluminescense 
System (Nichols Institute Diagnostics, San Juan Capistrano, USA). Plasma IGFBP-1 
and IGFBP-3 levels were determined with specific RIAs (Utrecht Medical Center, 
Utrecht, The Netherlands) (13, 14). Extended sex- and age-specific reference values 
(SD-scores) were available for IGF-I and IGFBP-3 (14, 15). SD-scores between –2 
and +2 were considered normal. Serum insulin concentrations were determined with 
an immunoradiometric on an Immulite 2000 (DPC) (16). Plasma IL-6 levels were 
analysed with an enzyme-linked immunosorbent assay (Sanquin, Amsterdam, the 
Netherlands), with a detection limit of 10 pg/mL. Arterial lactate and glucose were 
determined on a blood gas analyser (ABL 725, Radiometer Copenhagen, Denmark) 
in a certified clinical chemistry laboratory (ISO 17025 and 9001). The reference 
values were <2.0 mmol/L for lactate and 2.6-11.0 mmol/L for glucose (fasted).  
Statistics 
Data were analysed with SPSS 11.5. Results were expressed as medians with range 
unless specified otherwise. IGF-I and IGFBPs were analysed with one-way ANOVA 
with post hoc Bonferroni analyses for group comparison at different time points and 
mixed model analyses for analysing the course and plotting the graphs. Paired 
t-tests were used to compare SD-scores with zero SD. For other parameters we 
used Kruskal-Wallis, Mann-Whitney U, chi-square or Fisher’s exact test, or Wilcoxon 
signed rank test, when necessary. Backward multiple regression analyses were used 
to assess the relationship between GH, IGF-I and IGFBPs and pathophysiological 
important parameters. Data were log-transformed when necessary. Two-tailed 
P-values <0.05 were considered statistically significant. 
Results 
The study group consisted of 49 paediatric patients (24 boys). They were divided 
according to age: less than one year (referred to as ‘infants’; n=19), between one 
and ten years (referred to as ‘children’; n=20) and older than ten years (referred to as 
‘teenagers’; n=10). Data will be discussed in chronological order.  
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Table 1. Clinical and laboratory parameters at start of surgery, divided according to age.  
 
Infants 
(n=19) 
Children 
(n=20) 
Teenagers 
(n=10) 
P-value 
 
Age (years) 0.4 (0.2 – 0.8) b c 3.3 (1.0 – 9.1) a c 14.2 (10.3 - 17.6) a b <0.001 
Male gender (%) 10 (53) 7 (35) 7 (70) 0.180 
Weight SD-score –1.2 (–3.4 to 1.4) –1.0 (–2.6 to 0.6) –0.3 (–1.8 to 1.5) 0.264 
BMI SD-score –1.5 (–4.4 to 0.1) –0.9 (–4.4 to 1.1) –0.4 (–2.8 to 1.3) 0.062 
Height SD-score –0.5 (–2.7 to 1.5) –0.2 (–1.8 to 1.7) –0.7 (–2.4 to 2.7) 0.611 
Congestive heart failure (%) 9 (47) 4 (20) 1 (10) 0.058 
Cyanosis (%) 8 (42) c 3 (15) 0 (0) a 0.021 
IL-6 (pg/mL) 10 (10 – 10) 10 (10 – 15) 10 (10 – 10) 0.484 
Lactate (mmol/L) 1.8 (0.6 – 1.3) 1.0 (0.7 – 1.6) 0.9 (0.7 – 1.4) 0.077 
Glucose (mmol/L) 4.5 (3.0 – 9.1) 4.6 (3.5 – 5.5) 4.9 (4.3 – 6.2) 0.092 
Insulin (pmol/L) 15 (5 – 173) 14 (14 – 27) c 37 (14 – 77) b 0.005 
Insulin / glucose (µM/M) 3.7 (1.2 – 42.3) 3.3 (2.7 – 5.3) c 6.2 (7.8 – 16.8) b 0.023 
Data are expressed as median (range) or numbers (percentage). P-values represent Kruskal-Wallis, 
Pearson χ2 or Fishers group comparisons, when significant differences were tested between groups: 
Significantly different compared to infants (a), children (b) and teenagers (c) at P < 0.05.  
 
At start of cardiac surgery 
Clinical and laboratory parameters at start of cardiac surgery are depicted in Table 1. 
Infants were significantly more often cyanotic than teenagers. Weight and BMI 
SD-scores were significantly lower than reference values (zero SD) in infants and 
children (P≤ 0.001), but not in teenagers. Height SD-scores did not significantly differ 
from zero SD. IL-6 levels were below the detection limit in all but one patient and 
arterial lactate levels were within the normal range in all. Glucose levels did not 
significantly differ among the age groups, but infants and children had significantly 
lower insulin levels and insulin/glucose molar ratio than teenagers. 
IGF-I and IGFBP-3 SD-scores were significantly lower than reference values 
(zero SD) in all patients (P<0.013 and P<0.003, respectively) (Figure 1). IGF-I 
SD-scores did not significantly differ among the groups, whereas IGFBP-3 
SD-scores were significantly lower in infants compared to children and teenagers. 
Multiple regression analysis showed that IGF-I SD-scores was only inversely related 
to weight SD-scores (Table 2), whereas not to IL-6 levels, congestive heart failure or 
preoperative cyanosis. IGFBP-3 SD-scores were inversely related to preoperative 
cyanosis, and not to weight SD-scores, congestive heart failure, IL-6 or lactate 
levels. 
IGFBP-1 levels varied considerably (median 8.2 nmol/L, range 0.7 – 19.3 
nmol/L). Both infants and children had significantly higher IGFBP-1 levels than 
teenagers (Figure 1). Before surgery, IGFBP-1 levels were inversely related to 
insulin levels, weight SD-scores and age (Table 2), and not to glucose levels, 
presence of cyanosis or congestive heart failure. 
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Table 2. Multiple regression analyses with depending variables IGF-I SD-score, IGFBP-3 SD-score 
and IGFBP-1 level at start of surgery. 
Dependent variable Independent variable B P-value R2 
IGF-I SD-score Weight SD-score 0.382 0.012 0.13 
IGFBP-3 SD-score Cyanosis (Yes=1, No=0) 1.036 0.003 0.17 
IGFBP-1 level Age (2Log (years)) -0.090 <0.001 0.74 
 Insulin level (2Log (pg/mL)) -0.185 <0.001  
 Weight SD-score -0.077 0.006  
 
During and at the end of cardiac surgery 
During cardiac surgery the depth of hypothermia, as well as ECC and AOX time did 
not significantly differ between the groups (Table 3). During surgery, infants and 
children received significantly more often dopamine than teenagers and tended to 
receive higher equivalent doses of methylprednisolone. As shown in Table 3, infants 
and children received significantly more total volume with significantly higher 
percentage plasma during surgery than teenagers. The concentrations of IGF-I and 
IGFBP-3 in the CPB circuit were higher in infants and children than in teenagers. 
Interestingly, glucose levels were significantly higher and the insulin/glucose molar 
ratios significantly lower in both infants and children compared to teenagers, 
whereas insulin levels did not significantly differ between the age groups. In addition, 
glucose levels were significantly higher in patients who received glucocorticoids 
compared to those who did not (9.5 vs. 7.4 mmol/L, P=0.001), whereas insulin and 
IL-6 levels did not significantly differ (P=0.337 and P=0.438, respectively).  
At the end of surgery, mean-GH levels did not significantly differ between the 
age groups (Figure 2). When compared to reference values, mean-GH SD-scores 
were significantly higher than zero SD in infants and children (P≤ 0.001), but not in 
teenagers, whereas mean-GH SD-scores did not significantly differ among the 
groups. Using multiple regression analysis, we found mean-GH levels to decrease 
with age, dopamine and glucocorticoid use (Table 4), whereas IL-6 levels and 
gender had no influence.  
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Figure 2. Mean-GH levels and SD-scores in children after cardiac surgery, divided according to age 
(12). 
 
At the end of surgery, IGF-I and IGFBP-3 SD-scores were lower than 
reference values in all patients. Surprisingly, IGF-I SD-scores at end of surgery had 
increased in infants compared to values at start of surgery, but had decreased in 
teenagers (Figure 1). IGFBP-3 SD-scores had increased in infants and had 
decreased in both children and teenagers. Multiple regression analysis showed that 
both IGF-I and IGFBP-3 SD-scores related positively with percentage plasma and 
initial SD-scores at start of surgery (Table 4), whereas mean-GH levels, IL-6 levels 
and steroid therapy had no additional influence.  
IGFBP-1 levels increased in nearly all patients during surgery (Figure 1). 
Using multiple regression analysis, we found IGFBP-1 levels at the end of surgery to 
be related to IL-6 levels and glucocorticoid use and inversely to age (Table 4), 
whereas IGFBP-1 at the end of surgery was not related to glucose and insulin levels. 
 
Growth factors during the first 24 hours of ICU stay 
All patients survived and one child (aged 9.1 years) needed resuscitation after 
cardiac surgery. The day after cardiac surgery 42 patients were discharged from the 
ICU to a medium care unit, whereas seven had a longer ICU-stay (range 1.8 – 11.0 
days).  
At 12h and 24h after surgery, both IGF-I as well as IGFBP-3 SD-scores were 
significantly lower than reference values (zero SD; P<0.001). In contrast to changes 
during surgery, IGF-I SD-scores decreased in infants during the first 24h of ICU stay. 
Compared to values at start of surgery, IGF-I SD-scores had decreased in all 
patients 24h after surgery (Figure 1). IGFBP-3 SD-scores decreased in infants and 
increased in both children and teenagers during the first 24h of ICU stay. IGFBP-3 
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SD-scores at 24h were significantly lower compared to values at start of surgery in 
children and teenagers, but not in infants. IGFBP-1 levels decreased significantly in 
all patients during the first 24h of ICU stay, resulting in lower levels at 24h compared 
to pre-surgery levels in infants and children. At 24h after surgery, multiple regression 
analysis showed that IGFBP-1 was again inversely related to age and insulin levels, 
whereas IGFBP-1 was not related to IL-6 levels, weight SD-scores, gender or steroid 
administration during surgery. 
 
Table 4. Multiple regression analyses with depending variables mean-GH level, IGF-I SD-score, 
IGFBP-3 SD-score, IGFBP-1 level at the end of surgery. 
Dependent variable Independent variable B P-value R2 
Mean-GH level Age (2Log (years)) -2.479 0.006 0.32 
 Dopamine use (Yes=1, No=0) -7.627 0.038  
 Steroid use (Yes=1, No=0) -11.082 0.001  
IGF-I SD-score Percentage plasma # 7.218 <0.001 0.41 
 IGF-I SD-score at start of surgery 0.445 0.001  
IGFBP-3 SD-score Percentage plasma # 7.218 <0.001 0.55 
 IGFBP-3 SD-score at start of surgery  0.031  
IGFBP-1 level Age (2Log (years)) -0.077 <0.001 0.54 
 IL-6 level (2Log (pg/mL)) 0.103 0.001  
 Steroid use (Yes=1, No=0) 0.133 0.047  
# Percentage plasma of total volume added to the circulation during surgery 
Discussion 
In this study, we found low SD-scores of IGF-I and IGFBP-3 at start of surgery, 
which were related to low weight SD-scores and preoperative cyanosis, respectively. 
At the end of surgery, mean-GH levels were higher than reference values in infants 
and children and related inversely to age and the use of dopamine and 
glucocorticoids, but not to IL-6 levels. Glucose levels were significantly higher in 
patients who received glucocorticoids than in those who did not. At the end of 
surgery, IGF-I and IGFBP-3 SD-scores were lower than reference values in all age 
groups, but during surgery values had increased in infants and decreased teenagers. 
IGF-I and IGFBP-3 SD-scores at end of surgery related to the percentage plasma 
patients received during surgery and the initial SD-scores at start of surgery, 
whereas not to IL-6 or GH levels. In contrast, IGFBP-1 levels at the end of surgery 
related to IL-6 levels, whereas the inverse relation between IGFBP-1 and insulin 
levels, as found at start of surgery, was lost. Already 24 hours after cardiac surgery, 
IGF-I, IGFBP-3 and IGFBP-1 levels had returned to values comparable with those at 
start of surgery.  
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At start of surgery, we found IGF-I and IGFBP-3 SD-scores to be significantly 
lower than reference values. Low IGF-I SD-scores related to low weight SD-scores 
and low IGFBP-3 SD-scores to preoperative cyanosis, suggesting that patients 
undergoing cardiac surgery have a pre-existing reduction in IGF-I and IGFBP-3 
levels, which might be due to an underweight and a compromised clinical status. 
Diminished levels of IGF-I and IGFBP-3 in combination with underweight is a well 
known problem in paediatric patients with congenital heart disease (4, 5, 17, 18). We 
found IGFBP-1 levels to relate inversely with insulin levels and age, which is in 
accordance with data of healthy non-stressed children (19-21).  
At the end of surgery, mean-GH levels were elevated in infants and children. 
Elevated random GH levels were previously reported after paediatric cardiac 
surgery, but in these studies no GH profiles were performed (4, 5). We found GH 
levels to be inversely related to age and dopamine and glucocorticoid administration 
during cardiac surgery. An interesting finding was the inverse relation between 
glucocorticoid use and GH levels. Patients in our study who received glucocorticoids, 
did receive a high dose (30 mg/kg methylprednisolone). This might have influenced 
GH levels as the acute administration of pharmacological doses may result in a 
suppression of GH secretion (22). In contrast to data on critically ill children suffering 
from meningococcal septic shock, we did not find a strong relation between GH 
levels and IL-6 levels (3). An explanation for this might be the mild elevations in IL-6 
levels in patients at the end of cardiac surgery, compared to the extremely elevated 
IL-6 levels found in children with meningococcal septic shock.  
At the end of surgery, we found low IGF-I and IGFBP-3 SD-scores with 
elevated GH levels, suggesting a GH resistance state. Surprisingly, IGF-I and 
IGFBP-3 SD-scores increased in infants and decreased in older patients during 
surgery and related strongly to the levels before surgery and the percentage plasma 
given during surgery. The fact that infants in our study received a relatively higher 
percentage of plasma, containing adult levels of growth factors, compared to 
teenagers, might explain the paradoxical increase in IGF-I and IGFBP-3 in the 
infants during surgery. 
In contrast, IGFBP-1 levels increased during cardiac surgery in nearly all 
patients. IGFBP-1 levels at the end of surgery related with parameters of disease 
severity, i.e. IL-6 levels. This is in accordance with data in critically ill children and 
adults, in whom IGFBP-1 levels increased with increasing disease severity (2, 3, 23, 
24). Interestingly, the inverse relation between IGFBP-1 and insulin levels, which 
was found at start of surgery, was lost at the end of surgery. The manifold metabolic 
alterations that occur during surgery, for instance the administration of 
glucocorticoids and the increase in IL-6 levels, might have interfered with the 
interaction between IGFBP-1 and insulin (2, 24).  
During the first 24h after surgery, the changes of IGF-I and IGFBP-3 
SD-scores occurred in an opposite direction compared to the changes during cardiac 
surgery: the levels decreased in younger patients and increased in older patients. 
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This might indicate that the effect of plasma perfusions was being washed out. 
Twenty-four hours after surgery, IGF-I and IGFBP-3 had returned to or were lower 
than the initial values at start of surgery. IGFBP-1 levels decreased in all patients to 
lower levels than at start of surgery. Furthermore, the inverse relation between 
IGFBP-1 and insulin levels had returned 24 hours after surgery.  
Glucocorticoid administration during cardiac surgery has traditionally been 
used to protect against the detrimental physiologic alterations induced by exposure 
of blood to the large areas of synthetic materials from the cardiopulmonary bypass 
that trigger the production and release of numerous chemotactic and vasoactive 
substances(25). Most research has focused on the immune modulatory actions of 
glucocorticoids, whereas only a few have reported on the metabolic side effects, 
such as hyperglycaemia. Although our study was not designed to investigate the 
direct effects of glucocorticoid administration on the GH-IGF-I axis and glucose 
metabolism, we found high doses methylprednisolone (30 mg/kg) to affect GH and 
IGFBP-1 levels and to result in significantly higher glucose levels at the end of 
surgery compared to levels in patients who did not receive glucocorticoids, whereas 
we did not find evidence for the attenuated effect of glucocorticoids on IL-6 levels. As 
recently has been shown that high blood glucose levels in adult critically ill patients 
are associated with higher morbidity and mortality and that tight blood glucose 
control with intensive insulin therapy has benefits in terms of morbidity and mortality 
(26, 27), the occurrence of hyperglycaemia in this group of children warrants 
attention. In this perspective, the effects of glucocorticoids (e.g. dose and type) need 
to be elucidated further (28, 29).  
In summary, our study shows that IGF-I and IGFBP-3 SD-scores were already 
low at start of surgery, which might have been related to underweight and 
compromised clinical status. At the end of surgery GH levels were elevated but IGF-I 
and IGFBP-3 SD-scores were decreased. GH levels were inversely related to 
dopamine and glucocorticoid use, whereas percentage plasma administered 
influenced IGF-I and IGFBP-3 SD-scores. In contrast, IGFBP-1 levels at the end of 
surgery related to disease severity, whereas the inverse relation between IGFBP-1 
and insulin levels found at start of surgery was lost at the end of surgery. 
Glucocorticoid administration during surgery was associated with higher glucose 
levels. Twenty-four hours after surgery, IGF-I and IGFBP-3 SD-scores and IGFBP-1 
levels returned to the initial values at start of surgery. Finally, glucocorticoid-induced 
hyperglycaemia warrants more investigation. 
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8.1 Introduction 
The understanding of the endocrine changes in critically ill children is important as it 
provides insights in the pathophysiology of the acute stress in children and its 
differences compared to adults. In addition, it may delineate prognostic factors for 
survival and may support the rational use of present and future pharmaceutical 
interventions. Much more than in critically ill adults, the acute phase of critical illness 
comes into prominence in critically ill children, as they show a very rapid and fierce 
course of disease, followed by a quick recovery if they survive.  
This thesis describes in detail the results of various studies undertaken to 
evaluate endocrine changes during the acute stress response in critically ill children. 
The studies were conducted at the pediatric intensive care unit (PICU) of Erasmus 
MC – Sophia Children’s Hospital and the intensive care unit (ICU) of Erasmus MC – 
Thorax center. The study population consisted of children admitted to the PICU with 
sepsis or septic shock with purpura and children who underwent open-heart surgery 
for congenital heart disease. The studies described three hypothalamic-pituitary-
end-organ axes:  
I. Hypothalamic-pituitary-adrenal (HPA) axis 
II. Hypothalamic-pituitary-thyroid (HPT) axis 
III. Growth hormone-insulin-like growth factor (GH-IGF-I) axis  
In the following section we discuss the main findings of the studies in relation 
to other published data and elaborate on the implications for clinical practice. We 
debate the limitations and recommend future research using the knowledge obtained 
from our studies and literature data.  
8.2 Hypothalamic-pituitary-adrenal axis 
Adrenal insufficiency in critical illness 
Stimulation of the HPA-axis is one of the most important hormonal reactions to 
critical illness. We found paradoxically lower cortisol levels with higher 
adrenocorticotropic hormone (ACTH) levels with increasing disease severity in a 
large group of children with meningococcal sepsis or septic shock on PICU 
admission (Chapter 2), suggesting a more compromised adrenal function with 
increasing disease severity. This is in accordance with previous reports (1-3).  
To date, criteria to define (relative) adrenal insufficiency in critically ill patients 
are not generally established and accepted, whereas data in children are very limited 
as well (4). Some authors have suggested to perform an ACTH-stimulation test to 
assess the integrity of the HPA-axis in critical illness (5-8), whereas others advocate 
cortisol levels in a random serum sample (9). Many issues relating to the use of the 
ACTH-stimulation test in critically ill children still have to be assessed, regarding 
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dose, cut-off values and timing. Concerning the use of a random cortisol value, many 
cut-off values for defining adrenal insufficiency have been suggested (9-12). Taking 
into account several of these cut-off values we found adrenal insufficiency to be 
present in 10 – 29 % of all children with septic shock and in 13 – 63 % of the 
nonsurvivors (Table 1).  
As cortisol is mainly bound to carrier proteins, the decline in serum cortisol 
may be the result of lower levels of carrier proteins. We found, however, normal 
corticosteroid-binding globulin (CBG) in most children with meningococcal disease 
on PICU-admission (Chapter 2). Our study showed that the low bio-available cortisol 
levels corresponded with low total cortisol levels, suggesting that bio-available 
cortisol levels were not more informative about adrenal function than total cortisol 
levels in this acutely critically ill pediatric population on PICU admission. This is in 
contrast to studies in critically ill adults reporting higher values of free cortisol in 
patients due to lowered serum CBG and/or albumin levels, especially during the 
acute phase of critical illness (13-15).  
 
Table 1. Incidence of adrenal insufficiency in relation with disease severity in our study population, 
according to various published definitions based on random cortisol assessment only. 
Definitions Incidence in our study population 
Cortisol Reference Nonsurvivors 
(n=8) 
Shock-survivors 
(n=43) 
Sepsis survivors 
(n=9) 
< 15 µg/dL (414 nmol/L) (5) 1 (13 %) 4 (9 %) 0 (0 %) 
< 18 µg/dL (496 nmol/L) (16) 2 (25 %) 4 (9 %) 0 (0 %) 
< 20 µg/dL (552 nmol/L) (7) 3 (38 %) 6 (14 %) 0 (0 %) 
< 25 µg/dL (690 nmol/L) (9) 5 (63 %) 10 (23 %) 1 (11 %) 
 
Factors associated with adrenal insufficiency 
In search for factors associated with adrenal insufficiency, we evaluated adrenal 
enzyme activity of 21-hydroxylase and 11β-hydroxylase, by determining ratios of 
serum 11-deoxycortisol to 17-hydroxyprogesterone and of cortisol to 
11-deoxycortisol. It turned out that decreased cortisol levels were related to 
decreased activity of 11β-hydroxylase, as depicted by decreased cortisol to 
11-deoxycortisol ratios, whereas 21-hydroxylase activity was not decreased (Chapter 
2) (Figure 1). Furthermore, decreased 11β-hydroxylase turned out to be related to 
etomidate use. This is in accordance with in vitro and in vivo studies showing that the 
anesthetic agent etomidate interferes mainly with 11β-hydroxylase (17-21). Taking 
into account clinical and laboratory parameters, we found IL-6 levels and etomidate 
use to be the major factors related to reduced adrenal function during acute septic 
shock in children. 
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Figure 1. A schematic representation of steroidogenesis in the human adrenal gland and the effect of 
etomidate. Etomidate inhibits 11β-hydroxylase (CYP11B1), 11β- & 18-hydroxylase (CYP11B2) and 
cholesterol side-chain cleavage enzyme system (CYP11A) (shaded enzymes) with decreasing 
effectiveness. Decreased CYP11B1 activity will lead to lower levels of cortisol and increased levels of 
the upstream precursor 11-deoxycortisol. Decreased CYP11B2 will lead to lower aldosterone and 
higher 11-deoxycorticosterone levels, whereas decreased CYP11A will lead to a generally decreased 
steroidogenesis. 3β-HSD, 3β-hydroxysteroid-dehydrogenase; CYP21, 21-hydroxylase; CYP17, 17-
hydroxylase & 17,20-lyase. 
 
For many years, the long use of etomidate has been withdrawn from 
long-term sedation regimens due to its reported association with increased mortality 
(22). One bolus administration of etomidate, however, has remained a first-line 
anesthetic agent in the setting of rapid sequence intubation, because of its favorable 
cardiopulmonary profile. It was assumed by many intensive care physicians to give 
only transient, clinically non-relevant hormonal changes (23-25). Although our study 
was not designed to examine the direct effects of etomidate for rapid sequence 
intubation, we found evidence of an impeded adrenal function by etomidate (Chapter 
3). Children who received etomidate for rapid sequence intubation showed more 
signs of adrenal insufficiency, which were specifically related to impaired 
11β-hydroxylase activity and were associated with decreased glucose levels, 
compared with children who did not receive etomidate (Table 2). Moreover, of all 
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children who received etomidate, those who died had received a significantly higher 
dose of etomidate than those who survived.  
 
Table 2. Incidence of adrenal insufficiency in relation with etomidate use in our study population, 
according to various published definitions based on random cortisol assessment only. 
Definitions Incidence of adrenal insufficiency 
Cortisol Reference Intubated with 
Etomidate  
(n=23) 
Intubated without 
Etomidate 
(n=8) 
Not intubated 
(n=29) 
< 15 µg/dL (414 nmol/L) (5) 4 (17 %) 1 (13 %) 0 (0 %) 
< 18 µg/dL (496 nmol/L) (16) 5 (22 %) 1 (13 %) 0 (0 %) 
< 20 µg/dL (552 nmol/L) (7) 8 (35 %) 1 (13 %) 0 (0 %) 
< 25 µg/dL (690 nmol/L) (9) 14 (61 %) 1 (13 %) 1 (3 %) 
 
Clinical implications 
The results of our studies highlight the importance for clinicians to be aware that 
children with septic shock with purpura may have adrenal insufficiency, especially 
those who were intubated with etomidate. Although to date there are no strict 
definitions on adrenal insufficiency assessment in critically ill children, adrenal 
insufficiency in the case of catecholamine-resistant septic shock may be assumed at 
a random cortisol level < 18 µg/dL (496 nmol/L) (16). In addition, a cortisol increase ≤  
9 µg/dL (248 nmol/L) after an ACTH-stimulation test may also be suggestive for 
adrenal insufficiency, although many issues concerning ACTH-stimulation tests in 
the situation of stress remain to be investigated, such as which dose and which 
cut-off values should be used and how to interpret the outcome in relation to the 
initial stress. To date the consensus tells clinicians to assess adrenal function, at 
least by sampling a baseline cortisol level, in children with catecholamine-resistant 
septic shock, and always before the initiation of glucocorticoid treatment (16). 
Awaiting future research, we advocate to simultaneously draw a baseline ACTH level 
together with the baseline cortisol level (Figure 2).  
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Figure 2. Resuscitation of pediatric septic shock. Adapted from Parker et al. (16). (#) We advise to 
simultaneously draw blood for a baseline ACTH level as well. PALS, pediatric advanced life support; 
MAP-CVP, mean arterial pressure–central venous pressure; ACTH stim, adrenocorticotropic hormone 
stimulation; PDE, phosphodiesterase; CI, cardiac index; ECMO, extracorporeal membrane 
oxygenation.  
 
Hydrocortisone therapy should be reserved for use in children with 
catecholamine-resistant shock and suspected, e.g. hypoglycemia, or proven adrenal 
insufficiency and in patients at risk for adrenal insufficiency, such as children who 
# # 
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have previously received steroid therapies for chronic illness and children with 
pituitary or adrenal abnormalities (16). Considering the dose of hydrocortisone 
therapy no consensus exists. Dose recommendations vary from 1 – 2 mg/kg for 
stress coverage to 50 mg/kg for empirical therapy of shock (16). Based on the 
scarce data in children (26, 27) and studies in adults (28, 29), clinicians should rather 
use a more ‘physiological dose’ or ‘low-dose’ corticosteroid treatment, as high-dose 
corticoid treatment may also be harmful due to side effects, such as insulin 
resistance or secondary infections. The duration of steroid therapy should be short, 
only during the phase of vasopressor support (16). Therapy should be initiated 
awaiting the results of adrenal function assessment. Finally, based on our results it 
seems of vital importance to take considerable caution using etomidate during 
intubation of children with septic shock and to consider combining its administration 
with glucocorticoids.  
8.3 Hypothalamic-pituitary-thyroid axis 
Euthyroid sick syndrome in critical illness 
We found all children with meningococcal sepsis or septic shock to have signs of 
euthyroid sick syndrome on PICU admission (Chapter 4 and Chapter 5), as depicted 
by low TT3 and TT4 levels and high rT3 levels without compensatory elevated TSH 
levels. This is in accordance with other studies in critically ill children (1, 30-33).  
Concerning the relationship between thyroid hormone levels and mortality, 
however, these studies reported different data. Some showed an association 
between low levels of TT4 (30) and TT3 (31) and mortality, whereas this relation was 
not found in other studies (32, 33). We found lower TT4 levels and paradoxically 
higher TT3/rT3 ratios on PICU admission to be related to mortality, but the predictive 
value was inferior to that of IL-6 levels (Chapter 4). This indicates that other factors 
influenced the development of the euthyroid sick syndrome in the early initial phase 
as well.  
In view of the involvement of thyroid hormones in regulating energy 
expenditure and protein synthesis, low activity of thyroid hormones could be 
beneficial when exogenous provision of substrate is reduced (34, 35), such as during 
the initial phase of critical illness (36-38). At this moment it is not yet known if the 
relatively weak signs of the euthyroid sick syndrome in nonsurvivors might have 
contributed to the adverse outcome or are due to a lack of time for adjustment to the 
progressing fulminant disease. 
Peripheral thyroid hormone metabolism in critical illness 
The peripheral inactivation of thyroid hormones plays an important role in critical 
illness, especially in the initial phase (38-40). Until recently, the increased rT3 at the 
expense of TT3 was assumed to be the result of down-regulation of type 1 
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deiodinase (D1) (39). This view changed since, in addition to D1 down-regulation, 
type 3 deiodinase (D3) was shown to be induced in critically ill adults (41) (Figure 3). 
We found lowered TT3/rT3 ratio in all children with meningococcal sepsis, indicating 
a decreased D1 activity, an increased D3 activity or both (Chapter 4 and Chapter 5). 
These alterations in peripheral thyroid hormone metabolism related inversely to the 
duration of disease before admission. Nonsurvivors had paradoxically higher 
TT3/rT3 ratios, as they experienced a more rapid course of disease than 
shock-survivors. This suggests that nonsurvivors from meningococcal septic shock 
lacked the time to develop full-blown euthyroid sick syndrome before PICU 
admission, although we cannot exclude that nonsurvivors could not sufficiently adapt 
their HPT-axis to conditions of acute critical illness.  
Next to deiodination, sulfation is another pathway of peripheral thyroid 
hormone metabolism (Figure 3) (40). Interestingly, we found low T4-sulfate (T4S) 
levels in critically ill children. As shown in Figure 3, T4S is exclusively and rapidly 
deiodinated by D1. Low T4S levels may indicate high D1 activity, whereas low 
T3/rT3 ratios suggest low D1 or high D3 activity. Therefore, the combination of low 
T4S and low T3/rT3 values in our study, suggests that changes in peripheral thyroid 
hormone metabolism are rather enacted by profound induction of D3 rather than by 
down-regulation of D1 in early phase of critical illness. Recently published data on 
T4S levels in critically ill adults, demonstrated T4S levels to be inversely related to 
hepatic D1 activity and found T4S levels to increase with length of ICU stay (42).  
Thyroid hormone binding in critical illness 
Because TT4, TT3 and rT3 are mainly bound to carrier proteins, differences in these 
hormone levels might also be based on varying concentrations of or altered binding 
to serum carrier proteins, such as thyroxine binding globulin (TBG) and albumin (43). 
It turned out that reduced TBG levels explained most of the variation in TT4 levels 
(Chapter 4), whereas albumin did not. In turn, levels of TBG were inversely related to 
levels of elastase, a serine protease that is released by activated neutrophils and 
capable of cleaving TBG (44). Taken together, with increasing disease severity both 
TBG and TT4 levels decreased and elastase levels increased, suggesting that 
increased turnover of TBG by elastase might have lowered TBG and thus TT4 levels 
and, as a result, might have exposed tissues to relatively high levels of T4 available 
for deiodination.  
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Figure 3. Peripheral thyroid hormone metabolism during normal homeostasis (A) and during critical 
illness (B). During critical illness deiodination is altered with reduced D1 activity (thin arrow) and 
increased D3 activity (thick arrow), which both result in increased rT3 levels at expense of TT3 levels 
(left side). Sulfated thyroid hormones, however, are exclusively deiodinated by D1 (right side) and 
reduced D1 levels will result in elevated levels of all sulfated thyroid hormones. Sulfation of thyroid 
hormones is indicated by dotted arrows.  
 
Influence of dopamine in critical illness 
The suppressive effect of dopamine on the pituitary gland has previously been 
described in critically ill adults and children as well as healthy volunteers (45-47). 
Dopamine directly inhibits anterior pituitary function through inhibitory dopamine 
receptors, resulting in diminished TSH release (48, 49). In contrast, cessation of 
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dopamine therapy results in an abrupt rise in TSH levels. Although our study was not 
designed to investigate the suppressive effects of dopamine, we did find signs of this 
suppressive effect of dopamine. On PICU admission, dopamine was found to 
suppress TSH secretion, but not thyroid hormone levels (Chapter 4 and Chapter 5). 
Only thereafter, during PICU stay, the suppressive effect on thyroid hormone levels 
came to light (Chapter 5). The relatively short duration of dopamine administration 
before PICU admission (median, 3.7 h), might explain why the suppressive effect on 
thyroid hormones was not found on admission.  
Time course of euthyroid sick syndrome 
Within the group of shock-survivors, the combination of TT4 levels on PICU 
admission with changes in TT4 and rT3 levels during the first 24 hours of PICU 
admission and the PRISM score turned out to be prognostic for length of PICU stay 
(Chapter 5). Although TT3 levels increased from admission onwards in 
shock-survivors with a short PICU stay, TT3 levels were still decreased at PICU 
discharge in those who were discharged within 3 days. As thyroid hormones exert 
anabolic actions (34), this suggests that short stay shock-survivors had still not fully 
returned to anabolism at PICU discharge.  
Clinical implications 
The results of our studies show that euthyroid sick syndrome is common in children 
with meningococcal sepsis on PICU admission. To date, there are no indications that 
the acute changes in the thyroid axis are harmful and require therapeutic 
interventions (36, 37, 50, 51), however, no data are currently available to support or 
refute this hypothesis (52). The setting in which thyroid hormone administration in 
the acute phase of critical illness has been studied, is short-term T3-administration in 
adults and children undergoing elective cardiac surgery (53-55). Although these 
studies show an improved post-operative cardiac function, they do not show an 
improved outcome. One must be careful extrapolating these data to other clinical 
settings of euthyroid sick syndrome, such as meningococcal septic shock. To date, 
we do not think that there is an indication for thyroid hormone therapy in the acute 
phase of meningococcal disease, whereas an indication in pediatric cardiac surgery 
should await the results of large controlled trials (56).  
Concerning the use of dopamine in critical illness, short-term administration 
might be useful in the acute management of circulatory failure (57), but as also 
stated by others, prolonged administration should best be avoided (58, 59), as it 
induces or aggravates central hypothyroidism and deteriorates catabolism and 
cellular immune dysfunction. Consequently, alternative inotropics, which do not exert 
a pituitary suppressive effects, might be used. 
 Concerning the use of thyroid hormones levels for prediction of outcome, 
results from our studies showed that thyroid hormone levels on admission were not 
superior over IL-6 in predicting mortality, as higher disease severity was not reflected 
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in more signs of euthyroid sick syndrome. On the other hand, a combination of 
thyroid hormone values on PICU admission and changes over the first 24 hours of 
PICU admission were predictive for length of PICU stay (Table 3) and might, thus, be 
a useful tool to identify those children at risk for a long stay at the PICU.  
 
Table 3. Prediction model for duration of PICU stay in shock-survivors (R2 = 0.64).  
PICU-stay (10log (days)) =  0.631  
– 0.004336 * TT4 on admission (nmol/L) 
– 0.007902 * change (24h – admission) in TT4 (nmol/L) 
+ 0.753 * change (24h – admission) in rT3 (nmol/L) 
+ 0.413 * PRISM score (over first 6h) 
8.4 Growth hormone-insulin-like growth factor-I axis in 
meningococcal disease 
GH resistance in critical illness 
We found in the majority of acutely ill children with meningococcal disease (Chapter 
6) normal to high GH levels in combination with low levels of total IGF-I, total 
IGFBP-3 and ALS on PICU admission, suggesting a GH resistance state. This is in 
accordance with data in critically ill adults and children (60-64). In order to evaluate 
whether the high levels of total GH in children with meningococcal disease were also 
bioactive, we determined bioactive GH levels as well. It turned out that total GH 
levels related very strongly with bioactive GH levels, indicating that the high 
circulating GH levels were bioactive. As GH resistance may be associated with 
reduced GH-receptor function and serum GHBP levels are assumed to reflect the 
extracellular part of the GH-receptor (GHR) (65), we determined GHBP levels. To 
our surprise, GHBP levels were within the normal range in most children and 
positively related with IGF-I, IGFBP-3 and ALS levels, suggesting that the 
extracellular part of GHR might be still functioning (Figure 4). This does not exclude 
a disturbance in the transmembrane or intracellular part of the GHR or the post-GHR 
signaling pathway, which cannot be investigated in serum samples. One of the 
possibilities might be that the GH-receptor signaling was blocked by an intracellular 
negative feedback loop induced by the suppressors of cytokine signaling, the 
SOCSs. SOCS proteins are rapidly induced upon exposure to cytokines, GH, growth 
factors and fasting, and play an important role in the cellular response to GH (66-68). 
Other levels of the post-GHR-signaling pathway might also be involved, such as Src 
homology 2-containing tyrosine phosphatase (SHP-2) or signal transducer and 
activators of transcription (STAT) (66, 69). In critically ill adult patients, 3 days after 
surgery and in protracted critical illness, decreased GHBP levels accompanied the 
GH resistance state, suggesting interference at the level of the extracellular part of 
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the GHR in the chronic phase of critical illness, by either by decreased expression or 
increased cleavage (70, 71). In children, however, the combination of normal to 
elevated GH, low IGF-I, normal GHBP, elevated cytokine levels and a fasting 
condition in the early phase of critical illness is more suggestive for a disturbed 
post-GHR signaling rather than a disturbance at the level of the extracellular part of 
the GHR. 
Factors related to GH levels 
In our study in children with meningococcal sepsis, GH levels varied between normal 
to extremely high. In search for factors related to circulating GH levels in the initial 
phase of critical illness, we found elevated IL-6 levels to be one of the major factors 
related to elevated GH levels, besides age and dopamine use, which were both 
inversely related to the GH levels. Interestingly, we found GH levels to be inversely 
related to cortisol levels. Both GH and cortisol exert direct substrate-mobilizing 
actions. As cortisol levels decreased with increasing disease severity, the extremely 
elevated GH levels in these children might have been an ultimate attempt of the 
body to provide essential substrates for survival in these children. Nevertheless, it 
might be that other factors affect both cortisol and GH levels. 
Factors related to IGFBP-1 levels 
In our study, IGFBP-1 levels correlated strongly with parameters of disease severity 
and were extremely high in nonsurvivors (Chapter 6). In critically ill adults, IGFBP-1 
levels have also been reported to increase with increasing disease severity and to be 
predictive for mortality (72, 73). In contrast to normal conditions (74) we did not find a 
relation between IGFBP-1 and insulin levels. The multitude of metabolic alterations 
that occur during critical illness might have caused this. IGFBP-1 has been 
suggested to fulfill a counter-regulatory role by binding free IGF-I in order to block 
the insulin like activity of free IGF-I, thereby preventing hypoglycemia, for which the 
brain is especially vulnerable (60). We found indeed evidence of the inverse relation 
between IGFBP-1 and free IGF-I levels. In our study, nonsurvivors had extremely 
high IGFBP-1 levels and the lowest free IGF-I levels. As a consequence, glucose 
uptake into cells might have been further decreased in the already existing situation 
of minimal nutritional supply due to fasting. Together with the low levels of alternative 
metabolic substrates, such as NEFAs (Chapter 6), many cells might have been 
deprived from energy in a situation of very high metabolic demands. 
Clinical implications 
In the initial phase of critical illness, the GH-IGF-I axis shows major disturbances. To 
date, it is unknown whether these alterations, such as high GH levels, are harmful, 
adaptive or just a side effect of many other factors that occur during the acute phase 
of stress. Future research is needed to clarify this.  
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8.5 Growth hormone-insulin-like growth factor-I axis before and 
after cardiac surgery 
IGF-I and IGFBP-3 levels at start of surgery 
We evaluated the GH-IGF-I axis in children before and after cardiac surgery and 
assessed the influence of age, disease severity and medical interventions. At start of 
surgery, we found levels of total IGF-I and IGFBP-3 to be significantly lower than 
reference values and to relate to lower weight and preoperative cyanosis. The 
combination of low levels of IGF-I and IGFBP-3 and underweight is a well-known 
problem in children with congenital heart disease (75, 76) and has also been found 
in other studies on pediatric cardiac surgery (62, 63). 
GH profiles at end of surgery 
At the end of surgery, mean-GH levels were higher than reference values in infants 
and children but normal in teenagers. Previous studies reported low random GH 
levels and low urinary GH levels in pediatric cardiac surgery (62, 63). We found GH 
levels to be inversely related to age and the use of dopamine and glucocorticoids 
during cardiac surgery, but not to IL-6 levels. An explanation for the latter might be 
that IL-6 levels were only mildly elevated. In addition, two-thirds of the children 
received high dose methylprednisolone, which might have inhibited the generation of 
IL-6.  
IGF-I and IGFBP-3 levels at end of surgery and 24 hours thereafter 
Despite elevated GH levels, we found low total IGF-I and IGFBP-3 SD-scores at the 
end of surgery. Surprisingly, total IGF-I and IGFBP-3 SD-scores had increased in 
infants and decreased in older patients during surgery. Compared to teenagers, 
infants received a relatively more human donor plasma, as depicted in higher 
percentage plasma of total volume, which contained thus higher concentrations of 
growth factors. This might well explain the increase in total IGF-I and IGFBP-3 
SD-scores in infants. At the end of surgery, total IGF-I and IGFBP-3 SD-scores 
related strongly to the levels before surgery and the percentage plasma of total 
volume given during surgery, whereas not to GH or IL-6 levels. During the first 24h 
after surgery, the levels in total IGF-I and IGFBP-3 SD-scores returned to values at 
the start of surgery. 
IGFBP-1 levels before and after surgery 
As in normal conditions, in which IGFBP-1 is GH-independently regulated and 
rapidly influenced by metabolic factors, primarily by insulin (74, 77-79), we found 
IGFBP-1 levels to be inversely related to insulin levels at the start of surgery. 
However, this relation had disappeared at the end of surgery. This is in accordance 
with data in critically ill children and adults, in whom IGFBP-1 levels increase with 
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increasing disease severity (60, 61, 73, 80). The multitude of metabolic alterations 
that occurred during open-heart surgery, for instance the use of glucocorticoids and 
the increase in IL-6 levels, might have had more influence on IGFBP-1 transcription 
than the suppressive effect of insulin. Interestingly, 24 hours after surgery, IGFBP-1 
levels had declined even below levels at start of surgery and related again inversely 
to insulin levels. 
Clinical implications 
In our study low total IGF-I levels were related to a underweight. Although this is a 
well-known problem in children with congenital heart disease (62, 63, 75, 76), these 
data suggest that nutritional support in this group of children still warrants more 
attention. Furthermore, one must take account of the amount of plasma used during 
surgery when interpreting serum levels of IGF-I and IGFBP-3 after surgery, as 
human plasma products contains growth factors. 
Although our study was not designed to investigate the direct effects of 
glucocorticoid administration on the GH-IGF-I axis and glucose metabolism, we 
found that high doses of methylprednisolone (30 mg/kg) affected GH and IGFBP-1 
levels and resulted in much higher glucose levels at the end of surgery compared 
levels in those who did not receive glucocorticoids. Glucocorticoid administration 
during cardiac surgery has traditionally been used to protect against the detrimental 
physiologic alterations induced by exposure of blood to the large areas of synthetic 
materials from the cardiopulmonary bypass that trigger the production and release of 
numerous chemotactic and vasoactive substances (81), but the metabolic effects 
have been underexposed. As it has been shown recently that tight blood glucose 
control with intensive insulin therapy has beneficial effects on morbidity and mortality 
in adult critically ill patients (82, 83), the effect of hyperglycemia on outcome in this 
group of children should be further evaluated. In this perspective, it may be 
discussed whether lower doses of glucocorticoids should be used (84, 85).  
8.6 Synthesis of the growth hormone-insulin-like growth factor-I 
axis 
We found in both study populations, children with meningococcal sepsis and children 
after cardiac surgery, sustained to enhanced GH levels, but low levels of IGF-1 and 
IGFBP-3 (Table 4). The patient groups differed, however, in several aspects, such as 
IL-6 levels and glucocorticoid use. IL-6 levels were much lower in children after 
cardiac surgery than in children with meningococcal sepsis, in whom IL-6 levels were 
extremely elevated. The lower IL-6 levels in children after cardiac surgery might have 
been due to lower disease severity and inflammation, but could also be due to the 
glucocorticoid therapy, which might have tempered cytokine generation (86). 
Children with cardiac surgery received more often glucocorticoid therapy and also in 
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much higher doses than children with meningococcal sepsis, whereas some children 
with septic shock experienced adrenal insufficiency. In addition, children with 
congenital heart disease suffered from preexisting underweight, whereas children 
with meningococcal sepsis did not (unpublished observations).  
High GH levels related to high IL-6 levels in critically ill children with sepsis, 
but not in children after open-heart surgery, whereas in both groups GH levels turned 
out to be inversely related to dopamine use. Furthermore, GH levels related 
inversely to cortisol levels in critically ill children with sepsis and inversely to high 
dose glucocorticoid treatment in children after open-heart surgery. This indicates that 
the GH secretion in critically ill children was stimulated by high IL-6 levels and 
inhibited by dopamine use and high cortisol levels. As in normal conditions, younger 
children in both populations had higher GH levels than older children.  
 Total IGF-I levels were lower than reference values in both populations, at 
PICU admission and after cardiac surgery. Total IGF-I levels related, however, 
inversely to IL-6 levels in children with sepsis, but to initial IGF-I values at the start of 
surgery in children with congenital heart disease. The latter values in turn were 
related to underweight. Both inflammatory cytokines and nutritional deficiency, have 
been suggested as causes of the low IGF-I levels in the initial phase of critical illness 
(60).  
As in normal conditions (74), IGFBP-1 levels related inversely to insulin levels 
before cardiac surgery, whereas this relation disappeared after open-heart surgery 
and did also not exist in septic children. The multitude of metabolic alterations that 
occurred during sepsis and open-heart surgery might have caused this. In both 
populations, IGFBP-1 levels related positively to IL-6 levels, whereas IGFBP-1 
related also to glucocorticoid use in children after cardiac surgery.  
In conclusion, our data emphasize that endocrine changes in the initial phase 
of critical illness show similarities, some of which were also related to disease 
specific factors. Therefore, one may not unreservedly extrapolate these endocrine 
changes from one disease state to the other.  
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8.7 Future perspectives 
More studies in different populations of critically ill children 
The endocrine changes in acutely critically ill children with meningococcal sepsis or 
after open-heart surgery showed differences and might therefore not unreservedly 
be extrapolated to critically ill children due to other diseases or with co-morbidity. 
Although limited data have recently been published, future research should explore 
the endocrine changes in different groups of critically ill children, due to for instance 
trauma, burns, respiratory distress and severe neurological status, and in children 
with co-morbidity (87, 88).  
Alternative tools for endocrine hypothalamic-pituitary-end-organ 
function assessment 
Future research should take effort in obtaining tissue samples from critically ill 
patients, preferably serially sampled and combined with serum samples, to assess 
hormone tissue levels and receptor density and/or function. For example, the 
intracellular activity of cortisol is subject to the cortisol-cortisone conversion under 
the influence of 11β-hydroxysteroid dehydrogenases (11β-HSD) and to 
glucocorticoid receptor expression. It will, however, be difficult to obtain tissue 
samples of vital organs, such as liver or muscle, from critically ill children. Not only 
because of the increased risk of bleeding due to coagulation disturbances in children 
with meningococcal septic shock, but also because many parents will refuse this 
kind of invasive assessment to be used in their critically ill child. Peripheral blood 
mononuclear cells (PBMCs) are relatively easy to obtain, via blood sampling, but as 
gene expression varies among tissues, PBMCs may not always reflect gene 
expression of other tissues. Another possibility to obtain tissue samples more easily 
are post mortem biopsies, as shown in studies on critically ill adults (41, 42, 89-91). 
Post mortem biopsies may however not reflect the acute phase of critical illness. In 
addition, many parents refuse post mortem investigations because of various 
personal reasons. Finally, although results from animal studies may not unreservedly 
be extrapolated to humans, these studies remain important in case of critical illness.  
Assessment of the influence of genetic factors 
Considerable work has already been done on exploring the influence of genetic 
factors on the host response to meningococcal sepsis (92, 93). The studies 
presented in this thesis showed hormonal responses in relation to disease severity of 
critical illness in children and found differences between survivors and nonsurvivors, 
some of which were related to medication use. It remains however to be explored 
whether genetic factors might play a role in the hormonal response to stress. 
Nonsurvivors might not have had the genetic constitution to adapt adequately to the 
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extreme demands of severe stress. Interesting genes for investigation of 
polymorphism might be the glucocorticoid receptor (94), GH-receptor, which belongs 
to the cytokine receptor super family, genes of the post GHR signaling pathway, 
some of which are shared by the post insulin receptor pathway (83), such as 
suppressor of cytokine signaling (SOCS) (66, 95, 96) and genes of the thyroid 
hormone pathway (97, 98).  
Hormonal intervention studies 
The studies described in this thesis had an observational nature and were therefore 
not designed to evaluate the effects of different hormonal interventions on the 
outcome of critically ill children. Although several hormonal interventions have been 
studies in critically ill adults (28, 82, 99-108), of which most were conducted in 
protracted critical illness, only a few hormonal interventions have been tested in 
children (55, 109-114). Given the rare occurrence of protracted critical illness in 
children and differences between the endocrine and metabolic adaptations between 
critically ill adults and children, the findings from studies in critically ill adults may not 
unreservedly be extrapolated to critically ill children. Future hormonal intervention 
studies in pediatric critical illness, will need large numbers of children and therefore a 
multi-center design may be indispensable. Future studies are needed to clarify for 
example specific situations in which corticosteroid replacement is beneficial and to 
determine the optimal dose and duration of replacement. 
Concluding remarks 
The results of our studies emphasize the importance of endocrine evaluation of 
critically ill children. Future research should further explore the endocrine 
adaptations to stress in order to clarify the endocrine changes in other clinical 
conditions with the ultimate aim to evaluate if influencing the various hormonal 
pathways would reduce mortality and morbidity of life-threatening diseases in 
children. 
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The understanding of the endocrine changes in critically ill children is important, as it 
provides insights in the pathophysiology of the acute stress in children and its 
differences compared with adults. Furthermore, it delineates prognostic factors for 
survival and supports the rational use of present and future pharmaceutical 
interventions. Much more than in critically ill adults, the acute phase of critical illness 
comes into prominence in critically ill children, as they show a very rapid and fierce 
course of disease, followed by a quick recovery if they survive. This chapter presents 
a comprehensive summary of the results of various studies undertaken to evaluate 
endocrine changes seen during the acute stress response in critically ill children 
suffering from sepsis or septic shock with purpura (Chapters 2 to 6) or undergoing 
open-heart surgery (Chapter 7). These studies evaluated three 
hypothalamic-pituitary-end-organ axes: 
 
I. Hypothalamic-pituitary-adrenal axis    (Chapter 2 and Chapter 3) 
II. Hypothalamic-pituitary-thyroid axis    (Chapter 4 and Chapter 5) 
III. Growth hormone / insulin-like growth factor axis (Chapter 6 and Chapter 7) 
 
Chapter 1 provides a general overview of these hormonal axes and the current 
knowledge on the changes during the acute phase of critical illness in children and 
adults.  
 
Chapter 2 describes several aspects of  adrenocortical function in relation with 
disease severity in children with meningococcal sepsis or septic shock on PICU 
admission. The most severely ill children had more signs of adrenal insufficiency, as 
depicted by lower median cortisol/ACTH ratios. In contrast with data in critically ill 
adults, bio-available cortisol levels were not more informative on adrenal function 
than total cortisol levels. Decreased adrenal function was strongly inversely related 
to IL-6 levels and at least partly to a decreased 11β-hydroxylase activity, but not to a 
decreased 21-hydroxylase activity. In addition to IL-6 levels, one single bolus of 
etomidate during intubation was related to a decreased adrenal function and 
11β-hydroxylase activity.  
 
Chapter 3 describes retrospectively the influence of one single bolus of etomidate 
used for intubation on adrenal function in children with meningococcal sepsis on 
PICU admission, 12 and 24 hours thereafter. Children who received etomidate had 
significantly more signs of impaired adrenocortical function, such as lower cortisol, 
higher ACTH and 11-deoxycortisol levels, than those who did not receive etomidate, 
independently of intubation. The median dose of the etomidate bolus was 
significantly higher in children who died compared with those who survived. All, 
except one, children who died had received etomidate. Within 24 hours 
cortisol/ACTH ratios increased significantly in children who had received etomidate, 
resulting in cortisol/ACTH ratios 24 hours after admission which were comparable to 
Chapter 9  
  151  
those in the children who had not received etomidate. Our data imply that even one 
single bolus of etomidate negatively influences adrenal function and thereby might 
increase risk of death. Therefore, considerable caution should accompany the 
administration of etomidate in children with septic shock. Future research should 
elucidate the potential role for concomitant steroid replacement when etomidate 
remains in use. 
 
Chapter 4 describes several aspects of the thyroid function in relation with disease 
severity in children with meningococcal sepsis or septic shock on PICU admission. 
The study shows that all critically ill children with sepsis or septic shock had signs of 
euthyroid sick syndrome on PICU admission, as depicted by a decreased TT3/rT3 
ratio. More signs of euthyroid sick syndrome did not inevitably reflect higher disease 
severity at the time of PICU admission, indicating that other factors influenced the 
development of euthyroid sick syndrome in the early initial phase as well. Alterations 
in peripheral deiodination were related to duration of illness and seemed enacted by 
a profound induction of type 3 deiodinase rather than down regulation of type 1 
deiodinase, suggesting that children who died from meningococcal septic shock 
lacked the time to develop full-blown euthyroid sick syndrome before PICU 
admission. Low TT4 levels were related to increased cleavage of TBG by elastase. 
Dopamine-treated children showed only a reduction of TSH levels and no difference 
in other thyroid hormone levels compared to the non-dopamine-treated children at 
the time of PICU admission. Values of TT3/rT3 and TT4 were predictive for mortality, 
but not more informative than IL-6 levels. 
 
Chapter 5 evaluates thyroid function in relation to length of PICU stay in children 
who survived septic shock with purpura during the first 48 hours of PICU stay. All 
children surviving from meningococcal septic shock showed features of the euthyroid 
sick syndrome. Changes in thyroid function on admission were influenced by the 
duration of illness prior to admission. Changes in thyroid hormone levels over the 
first 24h of admission, especially the TT3 drop and the rT3 increment were 
prognostic for length of PICU stay, in addition to TT4 levels on admission and 
PRISM score. Thyroid hormone concentrations at PICU discharge were still not 
normalized in short stay shock-survivors, suggesting that those children had still not 
fully returned to anabolism at PICU discharge. Dopamine was found to have an 
influence on the course of thyroid levels.  
 
Chapter 6 describes several aspects of the GH-IGF-I axis in relation with disease 
severity in children with meningococcal sepsis or septic shock on PICU admission. 
The majority of children with meningococcal sepsis had normal or elevated GH 
levels with decreased total IGF-I levels, suggesting a GH resistance state on PICU 
admission. This was most striking in the most severely ill children. The bioactivity of 
serum GH paralleled total GH levels. Surprisingly, GHBP levels were within the 
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normal range and related positively to total IGF-I, IGFBP-3 and ALS levels, 
suggesting reduced post-GHR signaling rather than decreased GHR function. 
IGFBP-1 levels increased with increasing disease severity and correlated inversely 
with free IGF-I levels, emphasizing its counter-regulatory role in critical illness. 
 
Chapter 7 describes the GH-IGF-I axis in children before and after open-cardiac 
surgery and determines influencing factors. At start of surgery, IGF-I and IGFBP-3 
SD-scores were already low, which might have been related to underweight and 
compromised clinical status. At the end of surgery GH levels were elevated but IGF-I 
and IGFBP-3 SD-scores were decreased. GH levels were inversely related to 
dopamine and glucocorticoid use, whereas the plasma administered influenced IGF-I 
and IGFBP-3 SD-scores. IGFBP-1 levels at the end of surgery related to disease 
severity, whereas the inverse relation between IGFBP-1 and insulin levels found at 
start of surgery was lost at the end of surgery. Glucocorticoid administration during 
surgery was associated with higher glucose levels. Twenty-four hours after surgery, 
IGF-I and IGFBP-3 SD-scores and IGFBP-1 levels returned to the initial values at 
start of surgery.  
 
In Chapter 8 we describe the results of our studies in the context of the literature 
and elaborate on the implications for clinical practice. We discuss the limitations and 
recommend future research.  
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Het hormonale stelsel speelt een belangrijke regulerende rol in stofwisseling van 
mens en dier, zowel in gezondheid als in ziekte. Hormonen zijn in het lichaam 
gevormde chemische stoffen die via de bloedstroom bepaalde organen tot 
werkzaamheid aanzet. Dit proefschrift beschrijft de hormonale veranderingen die 
optreden tijdens de acute fase van levensbedreigde ziekte in kinderen, de “acute 
stress reactie”; in het bijzonder van kinderen opgenomen op de pediatrische 
intensive care vanwege bloedvergiftiging (sepsis en septische shock) met de 
meningokok bacterie (Neisseria meningitidis) (Hoofdstukken 2 tot en met 6) of na 
een open-hartoperatie (Hoofdstuk 7). Met dit onderzoek beoogden we de kennis en 
het inzicht in de hormonale regelmechanismen van de acute stress reactie bij 
kinderen met acuut levensbedreigende aandoeningen te verbreden, het 
therapeutisch handelen in relatie hiermee te evalueren en indien mogelijk aan te 
passen. Tevens beoogden we hormonale parameters te vinden om een prognose te 
kunnen stellen voor de duur van de ziekte en overleving.  
 
In dit hoofdstuk geven we een beknopte samenvatting van de resultaten van onze 
onderzoeken naar de hormonale aspecten van de acute stress reactie tijdens ernstig 
zieke. Drie hormonale assen worden beschreven:  
I. Hypothalamus-hypofyse-bijnier as    (Hoofdstukken 2 en 3) 
II. Hypothalamus-hypofyse-schildklier as  (Hoofdstukken 4 en 5) 
III. Groeihormoon-insulin-like growth factor as (Hoofdstukken 6 en 7) 
 
Hoofdstuk 1 geeft een introductie van de drie hormonale assen en de kennis 
omtrent veranderingen van deze drie hormonale assen tijdens de acute stress 
reactie in kinderen en volwassenen.  
Hypothalamus-hypofyse-bijnier as 
Het stresshormoon cortisol speelt een belangrijke rol in het instandhouden van de 
bloeddruk, het vrij maken van energie en het voorkomen een te sterke, waardoor 
schadelijke, afweerreactie. Cortisol wordt geproduceerd in het schors van de 
bijnieren, onder invloed van verschillende enzymen. De activiteit van deze enzymen 
is indirect te meten door verhoudingen te berekenen van de tussenvormen van 
cortisol in het bloed. Het aanzetten van de productie van cortisol in de bijnier staat 
onder invloed van het adrenocorticotroop hormoon (ACTH) dat in de hersenen wordt 
geproduceerd. Cortisol remt weer de productie van het stimulerende hormoon 
ACTH, zodat niet te veel cortisol wordt geproduceerd, dit mechanisme heet 
“negatieve terugkoppeling”. In het bloed wordt cortisol gebonden aan 
bindingseiwitten, waardoor minder dan 10% vrij in het bloed circuleert. Het vrije 
cortisol is biologisch actief. Als te weinig cortisol wordt geproduceerd tijdens 
levensbedreigende ziekte (bijnierinsufficiëntie) heeft dit tot gevolg dat de bloeddruk 
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te laag wordt en niet meer goed reageert op bloeddruk verhogende medicatie, de 
glucose productie te kort schiet en het afweersysteem niet adequaat genoeg 
reageert.  
 
Hoofdstuk 2 beschrijft verschillende aspecten van de bijnierschorsfunctie in relatie 
tot de ernst van ziekte bij kinderen met meningokokken sepsis bij opname op de 
pediatrische intensive care. Met toenemende ernst van ziekte werden meer tekenen 
van bijnierinsufficiëntie gevonden, zich uitend in lagere cortisol spiegels en hogere 
ACTH spiegels. In tegenstelling tot ernstig zieke volwassen patiënten, bleken in deze 
ernstig zieke kinderen de niet-gebonden cortisol spiegels goed overeen te komen 
met de totale cortisol spiegels en waren de vrije cortisol spiegels dus niet 
informatiever over de bijnier functie dan de totale cortisol spiegels. Verminderde 
bijnierfunctie bleek voornamelijk gerelateerd aan interleukine (IL-6), een parameter 
voor ernst van ziekte, en aan een verminderde activiteit van het bijnierenzym 
11β-hydroxylase. Daarentegen bleek de activiteit van het bijnierenzym 
21-hydroxylase niet verlaagd. Naast de ernst van ziekte bleek het eenmalig gebruik 
van het narcosemiddel etomidaat bij intubatie gerelateerd te zijn aan verminderde 
11β-hydroxylase activiteit en verminderde bijnierschorsfunctie. 
 
Hoofdstuk 3 beschrijft de studie naar de invloed van het eenmalig gebruik van 
etomidaat op de bijnierfunctie van kinderen met meningokokken sepsis bij opname, 
en 12 en 24 uur daarna. Kinderen die etomidaat hadden gekregen bij intubatie 
toonden significant meer tekenen van verminderde bijnierschorsfunctie dan kinderen 
die geen etomidaat hadden gekregen bij intubatie. Bij deze groep kinderen werden 
lagere spiegels van cortisol en hogere spiegels van ACTH en 11-deoxycortisol (een 
voorloper van cortisol) gevonden. Van alle kinderen die etomidaat hadden gekregen, 
was de gemiddelde dosis etomdiaat significant hoger in kinderen die overleden 
vergeleken met de kinderen die overleefden. Vierentwintig uur na opname was de 
cortisol/ACTH ratio significant gestegen bij kinderen die etomidaat hadden 
ontvangen, wat resulteerde in vergelijkbare cortisol/ACTH ratio’s 24 na opname 
vergeleken met kinderen die geen etomidaat hadden ontvangen. De data lieten zien 
dat zelfs een enkele dosis etomidaat de bijnierschors negatief beïnvloedt en 
daarmee een extra risicofactor is voor overlijden. Derhalve dient het gebruik van 
etomidaat bij kinderen met septische shock ter discussie te staan. Het tegelijkertijd 
geven van een dosis glucocorticoïden dient sterk overwogen te worden. 
Hypothalamus-hypofyse-schildklier as 
Onder invloed van het thyroïd stimulerend hormoon (TSH) uit de hersenen, 
produceert de schildklier het hormoon thyroxine (T4). In de lever, nieren en spieren 
van gezonde mensen zetten enzymen, die deiodinasen heten, T4 om in het actieve 
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schildklierhormoon T3. Dit heet ook wel het perifeer schildkliermetabolisme, waarbij 
type 1 deiodinase een belangrijke rol speelt. Het schildklierhormoon T3 heeft een 
voornamelijk anabole invloed op de stofwisseling, met andere woorden een 
stimulerende werking op groei en ontwikkeling. De regulatie van de hypothalamus-
hypofyse-schildklier as gaat via een negatieve terugkoppeling: als er voldoende T4 
en T3 is wordt de afgifte van TSH geremd. Tevens worden ook T4 en T3 gebonden 
in het bloed aan bindingseiwitten, met name T4-bindend eiwit (TBG), en is het effect 
afhankelijk van het ongebonden, biologisch actieve hormoon.  
Tijdens ziekte wordt het T4 omgezet in het inactieve reverse T3 (rT3) en wordt 
het actieve T3 versneld afgebroken, zonder dat het TSH stijgt wat normaliter zou 
gebeuren door de negatieve terugkoppeling. Deze veranderingen worden samen het 
“euthyroid sick syndrome” genoemd en men veronderstelt dat dit een adaptatie van 
het lichaam is om energie te sparen en eiwit opbouw voor groei uit te stellen ten 
gunste van overlevingsstrategieën.  
 
Hoofdstuk 4 beschrijft de evaluatie van de schildklierfunctie in relatie tot ernst van 
ziekte in kinderen met meningokokken sepsis of septische shock bij opname. Alle 
kinderen hadden tekenen van “euthyroid sick syndrome” bij opname, zich uitend in 
een verlaagde T3/rT3 ratio zonder verhoogde TSH spiegels. Bij opname was echter 
een toename van ziekte ernst niet gerelateerd aan meer tekenen van “euthyroid sick 
syndrome”. Dit geeft aan dat bij opname ook andere factoren dan ernst van ziekte 
invloed hadden op het ontwikkelen van het “euthyroid sick syndrome”. De duur van 
ziekte voor opname bleek gerelateerd te zijn aan de schildklierwaarden. Hoe korter 
ziek hoe minder tekenen van het “euthyroid sick syndrome”. De veranderingen in het 
perifere schildkliermetabolisme bleken meer gerelateerd aan de inductie van het 
enzym type 3 deiodinase dan aan de vermindering van het enzym type 1 deioninase. 
Daarnaast waren lage T4 spiegels in het bloed gerelateerd aan een verhoogde 
afbraak van TBG, het belangrijkste bindingseiwit van T4, door elastase. Het 
bloeddrukverhogende middel dopamine bleek alleen een associatie te hebben met 
lagere spiegels van TSH, echter niet op de spiegels van andere schildklierhormonen. 
Tenslotte bleken hogere T3/rT3 ratio’s en lagere T4 spiegels een voorspellende 
waarde te hebben voor mortaliteit. Hun predictieve waarde was echter niet 
belangrijker dan die van verhoogde IL-6 spiegels, een bekende parameter voor ernst 
van ziekte.  
 
Hoofdstuk 5 beschrijft verschillende aspecten van de schildklierfunctie in relatie tot 
ernst van ziekte in kinderen die de meningokokken septische shock overleefden, 
tijdens de eerste 48 uur na opname. Alle kinderen hadden tekenen van “euthyroid 
sick syndrome” bij opname. De T3/rT3 ratio, een maat voor perifeer 
schildkliermetabolisme, was omgekeerd gerelateerd aan de duur van ziekte voor 
opname op de pediatrische intensive care. Veranderingen in de schildklierhormoon 
spiegels gedurende de eerst 24 uur na opname, vooral de daling in T3 en de stijging 
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in rT3, waren voorspellend voor de opnameduur op de intensive care. Daarnaast 
waren lagere T4 spiegels bij opname en de hogere ziektescore “PRISM score” 
voorspellend voor een langere opnameduur. Bij ontslag van de intensive care waren 
de schildklierhormoon spiegels nog niet normaal hetgeen suggereert dat er nog 
geen volledig herstel is van de anabole functies.  
Groeihormoon-insulin-like growth factor as 
Groeihormoon (GH) heeft een anabole invloed op de stofwisseling, zowel direct als 
indirect via insulin-like growth factor-I (IGF-I). GH wordt geproduceerd in de 
hersenen en komt voor in diverse vormen met bijbehorende verschillende 
biologische activiteiten. GH bindt aan een GH-receptor, die bestaat uit drie delen: het 
extracellulair, transmembraneus en intracellulair. Activatie van de GH-receptor, door 
middel van dimerisatie, resulteert met name in de lever in de productie van 
groeifactoren zoals IGF-I en bindende eiwitten zoals insulin-like growth factor binding 
protein (IGFBP-3) en acid-labile subunit (ALS). Als het extracellulaire deel van de 
GH-receptor wordt gekliefd komt het in het bloed als het GH bindende eiwit “GHBP”. 
De regulatie van de GH-IGF-I as loopt ook via een negatieve terugkoppeling: IGF-I 
remt de afgifte van GH. IGF-I wordt in het bloed gebonden aan bindingseiwitten, met 
name IGFBP-3. De activiteit van IGF-I wordt bepaald door het ongebonden, 
biologisch actieve deel (vrij IGF-I).  
Tijdens ziekte worden lage spiegels van IGF-I en IGFBP-3 gevonden, terwijl 
de spiegels van GH normaal blijven of verhoogd zijn. Deze veranderingen worden 
samen ook wel “GH resistentie” genoemd. 
 
Hoofdstuk 6 beschrijft de evaluatie van de GH-IGF-I as in relatie tot ernst van ziekte 
in kinderen met meningokokken sepsis of septische shock bij opname op de 
pediatrische intensive care. Het merendeel van de kinderen had normale of 
verhoogde spiegels van GH met verlaagde spiegels van IGF-I, hetgeen past bij een 
beeld van GH resistentie. De GH resistentie was het meest uitgesproken bij de 
meest zieke kinderen. De spiegels van het biologisch actieve GH was vergelijkbaar 
met de spiegels van het immunoreactieve, totale GH in het bloed. Tegen de 
verwachtingen in werden normale spiegels van het GHBP gemeten, die positief 
correleerde met de spiegels van totaal IGF-I, IGFBP-3 en ALS. Deze bevindingen 
suggereren dat de GH resistentie veeleer veroorzaakt wordt door verminderde 
functie van het traject na de GH-receptor, de “post-GH-receptor signaaltransductie”, 
dan door een verminderde expressie van het extracellulaire deel van de GH-
receptor. Spiegels van het IGF bindingseiwit IGFBP-1 stegen met toenemende ernst 
van ziekte en correleerde omgekeerd met de ongebonden (vrij) IGF-I spiegels. 
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Hoofdstuk 7 beschrijft de studie naar de GH-IGF-I as in kinderen vóór en na open-
hartoperatie en de evaluatie van de verschillende factoren die van invloed zijn op de 
GH-IGF-I as. Aan het begin van de operatie waren de standaard deviatie (SD) 
scores van IGF-I and IGFBP-3 spiegels al verlaagd vergeleken met gezonde 
kinderen van dezelfde leeftijd. Tevens bleek dat lagere SD scores voor IGF-I en 
IGFBP-3 gerelateerd waren aan lage SD scores voor gewicht en een verminderde 
klinische conditie van de kinderen. Aan het einde van de operatie werden hoge GH 
spiegels gevonden en verlaagde IGF-I and IGFBP-3 SD scores. De GH spiegels 
waren omgekeerd gerelateerd aan de toediening van de medicamenten dopamine 
en glucocorticoïden, terwijl het gebruik van donorbloedproducten de SD scores van 
IGF-I en IGFBP-3 positief beïnvloedde. IGFBP-1 spiegels aan het einde van de 
open-hartoperatie waren gerelateerd aan de ernst van ziekte en niet meer aan de 
insuline spiegels, zoals aan het begin van de open-hartoperatie. Het gebruik van 
glucocorticoïden tijdens open-hartoperatie was gerelateerd aan hoge glucose 
spiegels. Vierentwintig uur na de open-hartoperatie, waren IGF-I, IGFBP-3 en 
IGFBP-1 spiegels weer teruggekeerd naar het niveau van aan het begin van de 
operatie. 
 
Hoofdstuk 8 bespreekt de resultaten van de diverse studies in relatie met de 
literatuur, bediscussieerd de klinische implicaties, bespreekt de beperkingen en geeft 
suggesties voor toekomstig onderzoek.  
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